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The uterine smooth muscle, or the myornetrium, provides the powerful rhythmic 
contractions required for parturition. Myometrial contractility is associated with changes in 
membrane potential which in turn are brought about by the movement of ions through 
membrane-spanning channels. In this study, voltage-gated Caý' and K' ion channel 
currents were measured and characterised in freshly dispersed human myometrial smooth 
muscle cells (EMSMCs), obtained from non-labouring pregnant women at caesarean 
section, using the whole cell patch clamp technique. 
The Caý' channel current (Ic. ) in HMSMCs had a fast, low threshold (T-type) 
component and a slow high threshold (L-type) component. The cyclooxygenase-II 
inhibitor and tocolytic agent, nimesulide, inhibited both L- and T-components of Ac. in 
HMSMCs, as well as spontaneous myometrial contractions in vitro. Nimesulide inhibited 
L-type channels predominantly in resting and inactivated states, in a prostaglandin- 
independent manner and with greater potency at lower pH. Block of myometrial Ac, by 
nimesulide may contribute to its myometrial relaxant ability in vitro and to its effectiveness 
as a tocolytic agent in vivo. 
Three voltage-gated W channel currents, IKI, IK2 and I", were identified in 
HMSMCs. IKI was a delayed rectifier with a low threshold of activation and inactivation, 
slow activation kinetics, very slow inactivation kinetics, and was blocked by clofilium and 
TEA but not 4-AP. AK2 was a delayed rectifier with a high threshold of activation and 
inactivation, faster activation and inactivation kinetics than IKI and was blocked by 
clofilium and TEA and, in contrast to AKI, also by 4-AP. IKA was an A-like current with a 
low threshold of activation and inactivation, very fast activation and inactivation kinetics, 
and was inhibited by 4-AP and C&' but not TEA. The characteristics of these currents 
suggest possible fimctions in the control of slow wave depolarisations and action potential 
generation and hence myometrial contraction. 
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1.1. GENERAL INTRODUCTION 
I. I. I. THE MYOMETRIUM 
The uterus is a muscular organ that remains quiescent during gestation, grows as the fetus 
grows, and at parturition (or labour), produces powerful rhythmic contractions to expel 
the fetus. In pregnancy, the uterus comprises three parts: the fundus or uterine body, the 
isthmus or lower segment, and the cervix. The myometrium, the smooth muscle of the 
uterus, consists of more than one population of smooth muscle fibres, the organisation of 
which differs between species. In pregnant humans there is an external layer of which there 
are two sub-layers, one (internal) with circular fibres and the other (external) with 
longitudinal fibres; an intermediate layer where fibres are diagonally interlaced; and an 
internal layer of circular fibres. At term, the external longitudinal layer is localised to the 
fundus, whereas the inner circular layer is predominant in the isthmic region (Devedeux et 
aL, 1993). 
The myometrium is an excitable tissue that is capable of spontaneous or myogenic; activity. 
During most of pregnancy however, this activity is suppressed or reduced until, at term, 
during parturition and post partum, motility is augmented. This inherent spontaneous 
activity is regulated and modified by endogenous and exogenous factors that include the 
steroid hormones estrogen and progesterone and the uterotonins oxytocin and 
prostaglandins E2 (PGE2) and F2, (PGF2, ). 
1.1.2. THE INITIATION OF LABOUR 
Although much is now understood about the mechanisms underlying uterine contractility, 
and it is known that labour is associated with an increased production of prostaglandins* 
within the uterus (Skinner & Challis, 1985; Romero et aL, 1988), the processes through 
which labour is triggered in man are stiff not fully understood. This contrasts with sheep 
*and increased oxytocin receptors and gap junctions. 
where a specific hormonal trigger has been identified. This is known as the fetal 
hypothalamo-pituitary-adrenal axis, whereby an increased cortisol secretion by the fetal 
adrenal gland stimulates a switch from progesterone to estrogen production in the 
placenta, which then stimulates PGF2,,, synthesis in the uterus, thus triggering labour 
(Schellenberg & Liggins, 1994). The substrate for cortisol action in sheep (placental 17- 
alpha hydroxylase) is absent in man and no other connecting hormonal pathway between 
elevated fetal cortisol and prostaglandin synthesis in the uterus has been found. 
Three principle prostaglandins are produced in the uterus during pregnancy: PGE2 in the 
amnion, PGE2 and PGF2. in the decidua and PG12 (prostacyclin) in the myornetriurn 
(Norwitz et aL, 1992; Lobaccaro-Henri et al., 1996; Kobayashi et aL, 1998; Arntzen et 
aL, 1998). PGE2 and PGF2. are stimulatory, via phospholipase C (PLC) and PG12 is 
inhibitory, via adenylate cyclase (Senior et aL, 1993; Asboth et aL, 1996). Oxytocin (OT) 
may be involved in the initiation of labour. OT is the most potent natural agent known to 
elicit uterine contractions. Its effects are two-fold: as well as a direct contractile action via 
PLC and receptor-gated ion channels, it stimulates prostaglandin production. Although 
plasma levels of OT do not rise sharply in the early stages of labour, there is a marked 
increase in OT receptor density in the decidua and myometrium towards term and during 
labour (Fuchs et al., 1984; Kimura et aL, 1992). 
Recent studies have suggested a role for G proteins in the initiation of labour. G proteins 
are the transduction fink between agonists such as OT, prostaglandins and noradrenaline 
and effectors such as PLC, adenylate cyclase and ion channels (see Fig I. S. ). In rats, the 
expression of G protein subunits during pregnancy is such that agonists stimulating 
adenylate cyclase are favoured over those that stimulate PLC, thus promoting quiescence 
(Lopez-Bernal et al., 1995). In humans, Ga,, Gai, Gaq and Ga. are all expressed in 
myometrium. Expression of Gai, Gaq and Ga. do not change in labour or pregnancy, 
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whereas Gcc. is increased during pregnancy (Europe-Finner et aL, 1993), and then reduced 
again in labour (Europe-Finner et aL, 1994)? ý' 
1.1.3. MYOMETRIAL CONTRACTILITY 
The excitability and rhythmic spontaneous contractions of the uterus are intimately 
associated with rhythmic bursts of electrical activity initiated by anatomically indistinct 
pacemaker cells within the uterus (Lodge & Sproat, 1981; Harding et al., 1982; 
Parkington et al., 1988; Buhimschi et aL, 1997; Parkington et aL, 1999). This relationship 
changes during pregnancy and especially during labour and parturition when, in 
conjunction with increased expression of gap junctions, which. allow electrical coupling 
between ad acent cells (Sims et aL, 1982; Miller et al., 1989; Sakai et aL, 1992), co- 
ordinated contraction of the entire uterus is enhanced (Buhimschi et aL, 1997). 
As was first described for the squid giant axon (Hodgkin & Huxley, 1952) and later for 
smooth muscle (Bulbring & Tomita, 1970), myometrial electrical activity at the tissue level 
and membrane potentials at the cellular level result from changes in the permeability of the 
plasma membrane to various ions, including sodium (Ni), calcium (C2'), potassium (K), 
and chloride (CI), via the opening and closing of ion-selective membrane-spanning ion 
channels. Compared with other excitable tissues, relatively little is known about the types 
of ion channel currents in the myometrium and their respective functions in uterine 
contractility. 
In this chapter, current knowledge of ion current characteristics in myometrium, their 
function with respect to action potentials and excitation-contraction coupling, and 
knowledge concerning their involvement in myometrial quiescence during pregnancy and 
its ultimate activity during parturition is described. 
18 
1.2. MEMBRANE POTENTIALS IN THE MYOMETRIUM 
The membrane potentials that comprise uterine electrical activity at the muscle bundle or 
single cell level have two components: the passive component or resting potential and the 
active component, which itself is composed of slow waves and action potentials 
(Parkington & Coleman, 1990) (Fig 1.1. ). 
1.2.1. RESTING MEMBRANE POTENTIALS 
The excitability of the cell is influenced by the resting membrane potential. This is the 
potential difference between the net negative charge inside the cell and net positive charge 
outside. Depolarisation or hyperpolarisation of the resting membrane potential, brings the 
cell either closer to or further away from the threshold for the triggering of action 
potentials, respectively. Resting membrane potentials of spontaneously active smooth 
muscles, including the myometrium, are generally smaller (ie less negative) than those of 
non-spontaneous tissues such as most vascular smooth muscle (Burnstock et aL, 1963). 
Some measurements of myometrial resting membrane potentials in term non-labour 
myometriurn are listed in Table 1.1. 
19 











Drawing of slow waves, action potentials and associated contractions in 
pregnant human myometrium, based on data in Kawarabayashi (1986b), Inoue 
et aL, (1990) and Nakao et aL (1997). 
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In three of the studies listed in Table I. I. resting membrane potential in rats was also 
measured during early and mid pregnancy (but not in non-pregnant) and was on average 
more negative (by 5-10 mV) than at term (Anderson et aL, 1981; Kuriyama & SuzukL 
1976a; Lodge & Sproat, 1981). This early sustained hyperpolarisation of the myometrium 
renders the tissue less electrically excitable and therefore contributes to its quiescence, 
whereas the depolarisation towards the end of pregnancy increases its excitability and 
probably contributes to its preparation for contractility. 
TABLE I. I. 
Resting Membrane Potentials in 
Pregnant Myometrium (mV) 
Species Mv 
I 
Author(s) Species Mv Author(s) 
Rat -36 to Anderson et aL Mouse -45 Osa (1974) 
-46 (1981) 
Rat -41 Kao & Sheep -50 Parkington (1985) 
McCullough (1975) 
Rat -54 Kuriyana & Suzuki Human 49 Pressman et aL (1988) 
(1976a) 
Rat -56 Lodge & Sproat Human -51 Nakao et al. (1997) 
(1981) 
1 
Rat -55 Mollard et aL Human -65 Kumar & Barnes (196 1) 
(1986) 
Rat -50 to Amadee et aL Human -50 Inoue et aL (1990) 
-60 (1987) 1 
Rat -50 Miyoshi et aL Human -47 Anwer et aL (1993) 
(1991) 
Rat -55 to Casteels & Human -45 Nakajima (1971) 
-65 Kuriyama (1965) 
Guinea- -50 Coleman & Human -59 Parkington et aL (1999) 
pig Parkington (1987) 
21 
1.2.2. SLOW WAVES 
Slow waves, also known as pacemaker pre-potentials or pacesetter potentials (Marshall, 
1962; Reiner & Marshall, 1975; Kuriyama & Suzuki, 1976a; Lodge & Sproat, 1981) are 
characteristic regular oscillations of the membrane potential and occur either 
spontaneously, or in response to agonist binding or current injection that depolarises the 
resting membrane potential. Slow wave amplitude is small (2-10 mV, depending on initial 
resting level, Nakao et aL, 1997) and frequency varies from once every several seconds to 
once a minute. Slow wave frequency (determined by the rate of rise of the slow 
depolarisation) determines the frequency of contractions (Reiner & Marshall, 1975; 
Kuriyama & SuzukL 1976a). In pregnant human myornetrium, slow wave depolarisations 
alone are not sufficient to trigger contractions. Contractions occur when the slow 
depolarisation reaches the threshold for regenerative action potential generation 
(Kawarabayashi et al., 1986a). 
1.2.3. ACTION POTENTIALS 
The amplitude of spontaneous or stimulated regenerative action potentials in pregnant rat 
and sheep myometriurn is commonly large, around +50 ffiV with a positive overshoot of 
around 10 mV (Kao & McCullough, 1975; Mollard et aL, 1986; Parkington, 1985). In 
pregnant human myometrium, action potential amplitudes are variable, having been 
recorded to be as small as only 4 mV (Kawarabayashi et al., 1986a), between 10 and 20 
mV (Young et aL, 1991; Nakao et aL, 1997) or of similar magnitude as those in the rat 
(Inoue et aL, 1990; Parkington et aL, 1999). The commonest form of action potential in 
smooth muscle is the simple spike which occurs in rapid bursts superimposed on each slow 
wave. The frequency of spikes in these bursts is in the order of 10 Hz (Kuriyama & 
SuzukL 1976a). In general, the frequency and amplitude of spike potentials determine the 
amplitude and duration of contractions. 
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Sometimes bursts of short spikes are replaced by complex action potentials, which 
comprise an initial spike or series of spikes, followed by a sustained plateau depolarisation 
(Vassort, 1975; Parkington, 1984). In rats and guinea-pigs, the occurrence of simple spike 
vs. complex action potentials varies during gestation and between muscle layers 
(Parkington & Coleman, 1988; Anderson et aL, 1981; Parkington, 1983; Bengtsson et aL, 
1984; Kawarabayashi & Marshall, 1981; Wilde & Marshall, 1988). The association of 
complex action potentials with contractions is also variable (Parkington & Coleman, 
1988). In term pregnant human myometrium, simple spike, plateau or complex plateau 
with spike types of action potentials may all be observed, either in bundles of smooth 
muscle cells (Kawarabayashi et al., 1986a; Nakao et aL, 1997; Parkington et aL, 1999), or 
in single freshly dispersed cells (Inoue et al., 1990). 
1.2.4. IONIC NATURE OF MEMBRANE POTENTIALS 
Resting Membrane Potential 
The resting membrane potential is the result of opposing inward (Naý, Ca2) and outward 
(K', Cl) ionic fluxes. The importance of Naý to the resting membrane potential in rat and 
human myornetrium, is demonstrated by the hyperpolarisation resulting from removing 
external sodium (Kao & McCullough, 1975; Mollard et aL, 1986; Inoue et al., 1990; 
Parkington et al., 1999). By contrast, it has been shown that inhibition of W efflux by 
loading pregnant rat myometrial strips with Cs' or by applying the K* efflux blockers 4- 
aminopyridine (4-AP) and iberiotoxin, causes a steady depolarisation of the resting 
membrane potential sufficient to trigger action potential generation (Jmari et al., 1986a; 
Wilde & Marshall, 1988; Anwer et aL, 1993). Also, in pregnant human myornetriurn strips, 
2 m. M tetraethylammonium (TEA) caused a 5-10 rnV depolarisation of theresting 
membrane potential (Parkington et aL, 1999). The resting membrane potential steadily 
hyperpolarises as gestation progresses and then depolarises in the days preceding labour, 
and in the rat it has been suggested that these changes are caused by increases in W 
permeability and increases in Ni' permeability, respectively (Casteels & Kuriyama, 1965). 
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Slow Waves 
The ionic nature of this slow depolarisation has been partially characterised. In rats, it is 
associated with an increased membrane resistance which is attributed to a decrease in W 
permeability (Kuriyama & SuzukL 1976a). The slow depolarisation also disappears when 
external Nd' is removed suggesting that Ne influx is involved (Reiner & Marshall, 1975). 
In isolated pregnant human myornetrial. cells, the passive electrotonic response to 
hyperpolarisation was enhanced in CW"-free and Nd+ deficient solution suggesting that 
membrane excitability is influenced by both CW' and Ne (Inoue et aL, 1990). Both inward 
and outward movement of ions is therefore involved in slow wave depolarisations and the 
size and slope of the slow wave probably results from the shifting balance between slow 
inward currents and outward rectifying currents (Wilde & Marshall, 1988). In murine 
colonic smooth muscle (a rhythmic tissue), 4-aminopyridine, a blocker of voltage-gated K+ 
channels (see section 1.4. ) inhibited slow wave repolarisation, producing a continuous 
depolarisation (Koh et al., 1999). 
Spike-Type Action Potentials 
Electrically4nduced contraction of the rat myometrium requires Caý" influx (Mironneau, 
1973). Furthermore, the overshoot amplitude of spontaneous or electrically stimulated 
action potential spikes in single cells of rat and human myometrium and strips of sheep 
myometrium is dependent on external C2* concentration, but not that of external Na+, and 
is reduced by CP influx blockers (divalent cations and dihydropyridines), but not blockers 
of Ne influx (tetrodotoxin) even after prolonged hyperpolarising current injection to 
reactivate inactivated Na channels (Kuriyama & Suzuki, 1976a; Kao & McCullough, 
1975; Bengtsson et aL, 1984; Mollard et aL, 1986; Amedee et aL, 1986b; Parkington, 
1985; Inoue et al., 1990; Parkington et aL, 1999). The regenerative spike potential 
therefore involves mostly C2' entry. 
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Repolarisation of the spike potential involves a reduction of the C2' influx via inactivation 
and closing of Ca2" channels and an increased W efflux. C2' channel inactivation and 
hence rate of spike repolarisation is dependent on both membrane potential and 
intracellular calcium concentration. The intracellular C2' dependence is illustrated by 
replacing external C2' with B2' or Sr2" which lengthens the duration of action potentials 
in pregnant rat myometrium. Qmari et aL, 1986; Amedee et aL, 1987). These mechanisms 
are detailed later in this chapter. 
Evidence for the involvement of W efflux was provided by experiments in strips and single 
cells of pregnant rat myometrium. Loading the cells with CS' increases action potential 
amplitude when the depolarisation of the resting membrane potential was compensated for 
by current injection (Jmari et al., 1986). Furthermore, when cells are not perfused with CS+ 
to block the W currents, W efflux blockers TEA and 4-AP increase the amplitude and 
duration of action potentials (Mollard et al., 1986). A similar increased amplitude in 
prostaglandin-induced plateau type action potentials was caused by the W efflux blockers 
charybdotoxin and 4-AP in strips of pregnant human myometrium. (Parkington et al., 
1999). 
The W efflux itself may also be dependent on C2" influx. This is implied by the reduction 
in outward rectification under current clamp conditions by the addition of TEA and 
removal of external C2' in strips of human myometrium (Pressman et aL, 1988), and the 
fact that one of the K' efflux channels is activated by intracellular Ca" (Coleman & 
Parkington, 1987). 
Complex Action Potentials 
In complex action potentials of pregnant rat myometrium, the ionic nature of the spike 
component also involves C2% since it is reduced by removing external C2+ and by the 
C2' channel blocker D-600 (Wilde & Marshall, 1988). The plateau component, involves a 
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considerable conductance (Wilde & Marshall, 1988) and in the rat is affected by altering 
external cr concentration, but not those of Ca2' or Na' (Parkington, 1984), but in humans 
is inhibited by nidfedipine and verapamil, blockers of CW' entry through voltage-gated 
channels (Parkington et aL, 1999). The duration of the plateau potential in rat myornetriurn 
is dependent on external C2' concentration, suggesting an inward CP-activated current, 
possibly involving cr efflux through a large conductance channel, is clamping the plateau 
potential (Parkington, 1984; Parkington & Coleman, 1988; Arnaudeau. et al, 1994). 
Sustaining the depolarisation at this level maintains a slow CP influx and prolongation of 
the contraction. In the rat, the amplitude of the plateau phase was also increased by 
the inhibitor of K' efflux, TEA, which also reduces the outward rectification and 
membrane conductance during the plateau, suggesting the involvement of W cfflux- 
hyperpolarisation opposing the cr efflux depolarisation (Wilde & Marshall, 1988). 
Eventual repolarisation of the plateau probably involves a decline in the cr efflux and slow 
C2' influx and the predominance of a slow W efflux (Vassort, 1975). In pregnant human 
myometrial strips, the duration of the PGF2,, or PGE2 induced plateau potentials was 
increased by the W channel blockers, 132', 4-AP and charybdotoxin (Parkington et aL, 
1999). 
1.2.5. EFFECTS OF STEROID HORMONES ON MEMBRANE 
POTENTIALS 
The resting membrane potential and hence excitability of the cell, is influenced by steroid 
hormones. In the spayed rat, pre-treatment (> 24 hrs) with estrogen or progesterone 
individually hyperpolarises the myometrial resting membrane potential to a level similar to 
that of the mid-pregnant rat, whereas combined application of the two hormones produces 
a depolarisation similar to that observed at the end of pregnancy when estrogen levels are 
high (Kuriyama. & Suzuld, 1976a). 
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Action potentials are also influenced by prior treatment with steroid hormones. In estrogen 
treated ovarectornised rats complex action potentials are induced (Kuriyama & Suzuki 
1976b; Parkington, 1984). Estrogen also increases the action potential amplitude, the 
length of the burst and the frequency of spikes in a burst (Marshall, 1959). The effects of 
progesterone on action potentials are dependent on the presence of estrogen, since in the 
term pregnant rat it induces action potentials similar to those of the mid-pregnant rat 
(Kuriyarna & Suziki, 1976a). Progesterone also reduces the amplitude and frequency of 
action potential spikes (Marshall, 1959; Kuriyama & Suzuki, 1976a). How these changes 
may involve ion channels are discussed in later sections. 
1.2.6. EFFECTS OF UTEROTONINS ON MEMBRANE POTENTIALS 
The physiologically and clinically important uterotonins, oxytocin (OT) and the 
prostaglandins PGE2 and PGF2. have complex and variable effects on membrane potential 
which are dependent on the concentration or on the gestational and hormonal status. In the 
rat, responses to OT include increased frequency and number of action potential spikes in 
a burst, decreased interval between bursts of action potentials and induction of plateau 
phase action potentials which replace the bursts of spike potentials (Kuriyama & SuzukL 
1976b). In term pregnant human myometriurn by comparison, oxytocin at low 
concentrations evoked plateau phase action potentials and increased the amplitude, 
frequency and duration of spontaneous plateaux potentials (Nakao et al., 1997; 
Kawarabayashi et aL, 1990), whereas at higher concentrations it depolarised the resting 
membrane potential and reduced membrane resistance (Nakao et aL, 1997). In single 
myometrial cells from pregnant rat in primary culture OT induces depolarisations that are 
powerful enough to trigger regenerative action potentials (Arnaudeau et al., 1994). 
In pregnant mouse myornetrium, low concentrations of PGE2 increased the frequency and 
number of spilces in a burst of action potentials without affecting the resting or peak 
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membrane potential, whereas at higher concentration it depolarises the membrane and 
produces continuous spike generation (Suzuki & Kuriyama, 1975). In pregnant human 
myometrium, low concentrations of PGE2and PGF2,, (10-100 nNI) evoked depolarisations 
without triggering action potentials, but at high concentrations (10 PM) they both 
induced-plateau type action potentials or enhanced the amplitude of spontaneous action 
potentials and induced large after-hyperpolarisations (Parkington et aL, 1999). 
1.3. CALCIUM, SODIUM AND CHLORIDE CURRENTS 
1.3.1. VOLTAGE-GATED CALCIUM CHANNELS 
CW' channels exist in most if not all types of excitable cell and are necessary for 
excitation-contraction coupling in cardiac, skeletal and smooth muscle cells, as well as 
neurotransmitter and endocrine secretion in nerves and neuroendocrine cells. Voltage- 
dependent CW' (as well as Ne and K) channels exist in three principle states, the closed 
or resting state, the open state and the inactivated state (Hodgkin & Huxley, 1952) (Fig 
1.2. ). The characteristics of channel opening, closing and inactivation differ between 
channel subtypes and determine their current kinetics and voltage-dependencies (see 
below). 
28 
FIG 1.2. THREE PRINCIPLE STATES OF VOLTAGE-GATED ION 
CHANNELS 
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Channels open in response to membrane depolarisation (moving from resting to 
open states) and upon repolarisation, close, returning to the resting state (also 
known as deactivation). Prolonged depolarisation however causes channel 
closing by inactivation, which requires a further period of prolonged 
repolarisation, during which the channel eventually returns to the resting state, 
before it is capable of opening again. Prolonged subthreshold depolarisation 




Structure and Voltage-Sensitivity 
Voltage-dependent C2" channels (VDCCs) are heteromeric complexes of membrane- 
spanning proteins, which show a high level of electrophysiological and pharmacological 
diversity. There are at least five classes of VDCC, which to date include L-, T-, N-, P/Q-, 
and R-type channels. L- and T-type are the predominant VDCC in smooth muscle. The 
channel unit is comprised of at least 4 classes of subunit, termed a,,, a2-8, P and y. The 
most important of these is the a, subunit, which in smooth muscle L-type channels is the 
cloned ajC (CaCH2b) protein (Hoffinam et al., 1994), and in neuronal and cardiac T-type 
channels, the ajG and ajH proteins, respectively (Perez-Reyes et al, 1998; Cribbs et aL, 
1998). These comprise four homologous transmembrane units each composed of six 
transmembrane domains linked by cytoplasmic loops and with cytoplasmic amino (N) and 
carboxy (C) termini domains (Fig 1.3. ). The al subunit contains the pore with a C2+- 
selective filter which binds one C2+ ion with high affinity (non-permeate state) or two with 
low affinity (allowing permeation) (Yang et aL, 1993) The al subunit also contains a 
voltage sensor which controls the voltage-dependence of channel opening. This is 
contained within the fourth membrane-spanning domain of each repeat and cont i 
positive charged residues at each turn of the helix which move in the extracellular direction 
on depolarisation thus opening the pore (Catterall, 1995). Inactivation mechanisms are not 
yet determined but may involve structural rearrangement of the sixth membrane-spanning 
domain of the first repeat (Zhang et al., 1994). 
The membrane anchored largely extraceffular (X2-43 subunit, the cytoplasmic P subunit, and 
the transmembrane y subunit interact with the a, subunit (see Fig 1.3. ), influencing 
voltage-dependence of activation (often causing hyperpolarising shifts in activation) and 
kinetics of activation and inactivation. There are at least six (xi, four P, and one a2-8 
genes, many of which encode multiple splice variants, accounting for the extensive 
heterogeneity of native VDCC current characteristics (Walker & De Waard, 1998). 
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FIG 1.3. STRUCTURE OF VOLTAGE-GATED Ca 2+ CHANNELS 
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Pharmacology 
L-type CW' channels contain high affinity binding sites within the cc, subunit for three 
structurally different subclasses of organic calcium antagonists, the dihydropyridines (eg 
nifedipine, (+)-isradipine), the phenylalkylamines (eg verapamil) and the benzothiazepines 
(eg diltiazem) which are not shared by T-, N-, P/Q- or R-type channels (Streissnig et aL, 
1998). With a few exceptions, such as the agonist BAYK8644, these drugs are all 
antagonists of the channel. The C2+ binding site and the presence of C2+ are important 
for the action of these drugs, but the mechanisms of block vary between the three classes 
(discussed in chapter 4). There are also organic antagonists selective for T-type channels in 
smooth muscle cells (e. g. rnibefradil) (Mishra & Hermsmeyer, 1994; Ertel et aL, 1997). 
Modulatory Mechanisms 
L-type, but not T-type, channel inactivation has a Ca2"Aependent component which is 
faster than the voltage-dependent component and is influenced by extracellular C2+ 
concentration (and hence amount of C2" entering the cell) and is not mimicked by 
replacement of C2+ with B2+ (Ganitkevitch et aL, 1987) (see also Fig 1.5. ). The 
mechanisms involved are not yet determined but probably involve intracellular CaF' binding 
to a site close to the channel pore. 
L-type C2' current is inhibited by lowering both intracellular and extraccUuIar pH, the 
mechanisms of which are still unclear, but probably involve masking of surface charge at 
or around the site of the pore by 11' , preventing access of C2' to the pore (Olunori & 
Yoshii, 1977; Shmigol et al., 1995). 
Protein kinases influence C2' channel opening in smooth muscle by phosphorylating the 
channel protein. cAMP-dependent PKA and phospholipase C-dependent PKC both 
stimulate channel activity, whereas the cGMP-dependent PKG may inhibit (Beech & 
McHugh, 1996). The requirement for ATP of C2' channel activity appears to vary 
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between cell types, being essential for prevention of current run-down (time-dependent 
decay) in some, including smooth muscle (Beech & McHugh, 1996; Lorenz & Paul, 
1997). 
There is evidence for both stimulatory and inhibitory pathways involving G proteins. 
Agonist stimulation (e. g. by histamine) activates smooth muscle L-type C2" current via 
Gq coupling to phospholipase C, diacylglycerol production and hence PKC activation (see 
Fig 1.5). P-adrenoceptor stimulation by contrast, inhibits L-type CP current in smooth 
muscle possibly via direct interaction of the channel with Gs a-subunit, independent of 
cAMP production (Khac et aL, 1992; Beech & McHugh, 1996). There is also evidence 
that neuronal non-L-type C2' channels may be inhibited by direct binding of GPy subunit 
to the channel (Dolphin, 1998). 
1.3.2. MYOMETRIAL CW" CURRENTS 
Early voltage-clamp studies of ion currents in myometriurn used the double sucrose gap 
method in small bundles of pregnant rat myometrium. (Anderson et aL, 1971; Mironneau, 
1973; Kao & McCullough, 1975) or estrogen-treated non-pregnant guinea-Pig 
myornetrium (Vasort, 1975). Although inward and outward currents were not examined 
individually and the high resistance of these preparations rendered much of the quantitative 
data uninterpretable, some of the qualitative data remains of value. With normal 
extracellular C2% Na+ and W concentrations, depolarising voltage steps elicited early 
transient inward currents followed by slower sustained outward currents (Kao & 
McCullough, 1975; Vasort, 1975). The amplitude of the transient inward current was 
attenuated by the reduction of both external C2+ and Ni' concentrations (Anderson et aL, 
1971; Kao & McCullough, 1975), suggesting the presence of either a C2+ or a Na+ 
current, or both, in these preparations. However, the near complete inhibition by W' and 
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D600, suggested that C2' was the major charge carrier of this current (Miromeau, 1973; 
Vasort, 1975). 
The inactivation mechanisms of the Caý' current in pregnant rat myometriurn were first 
investigated by Jmari et aL (1986) using the sucrose gap technique in small strips of 
muscle and blocking the outward W currents with Csý. The CW' current was inactivated 
by conditioning pre-pulses to positive potentials up to 0 mV, but this inactivation was less 
pronounced at more positive potentials as less CP entered the cell during the conditioning 
pre-pulse. Replacement of external CP with BP resulted in slower decay or inactivation 
of the current, whereas the inactivation rate was enhanced by raising the external CP 
concentration but not by raising the external 132' concentration. It was concluded that 
inactivation of the CP current is sensitive to both voltage and intracellular CP 
concentration but that inactivation of the BP substituted current was purely voltage- 
dependent. This current was therefore characteristically of the L-type. The ionic selectivity 
of the channel carrying this inward current was CP >> B2+ = Sr2+ > Ne (Jmari et al., 
1987). 
L-Type CC12+ Current 
The above described inactivation characteristics and ion selectivity of the L-type C2+ 
current in pregnant rat myometrium were later confirmed in single cells using the 
intracellular microelectrode or patch-clamp methods and with either Csý in the patch 
pipette or with 4-AP in the external solution (Amedee et al., 1987; Honore et aL, 1989a). 
Furthermore, with 1-2 mM C2+ in the bath solution, the half-inactivation potential was -38 
mV, the activation threshold was between -50 and -35 mV, and the peak amplitude was 
between -10 and 0 mV (Honore et aL, 1989a; Ohya & Sperelakis, 1989; Inoue & 
Sperelakis, 1991). The amplitude of 1c., threshold of activation and peak amplitude are a 
shifted positively by increasing the external Ca2+ concentration (Yoshino, et aL, 1997) 
whereas replacement with BP shifts these parameters slightly in the negative direction 
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(Ohya & Sperelakis, 1989; Yoshino et al., 1997). The decay of the L-type current is 
relatively slow (with respect to other transient inward currents such as T-type Caý' and 
fast Naý, being incomplete within 200 ms at potentials close to the threshold (Ohya & 
Sperelakis, 1989; Inoue & Sperelakis, 1991). The predominance of the L-type current in 
pregnant rat myometriurn is also confirmed pharmacologically by the near complete 
inhibition with low concentrations of D-600, nifedipine, isradipine or nisoldipine and the 
divalent cations Cd 2+ 9 
W+ or C02+ , 
but not by the specific blocker of voltage-gated Ne 
channels, tetrodotoxin (Amedee et aL, 1987; Honore et aL, 1989a; Miyoshi et aL, 1991; 
Ohya & Sperelakis, 1989; Inoue & Sperelakis, 1991; Yoshino el al., 1997). The Ica in 
pregnant rat myometrium. is also enhanced by BAY8644 (Kyozuka et al., 1987; Yoshino et 
aL, 1997). Amplitude of L-type Caý+ current in pregnant rat myometrium. is dependent on 
phosporylation by enzymes such as tyrosine kinase and protein kinase C (Kusaka & 
Sperelakis, 1995; Shimamura. et al., 1994a). 
The first description of L-type Ca2+ channels in human myometrium was by Batra & 
Popper (1989) who demonstrated the presence of high affinity dihydropyridine binding 
sites in pregnant and non-pregnant human myometrium. This was later confirmed 
, electrophysiologically with the whole cell patch clamp method (see below). 
T-Type Ca2* Current 
In the study by Honore et aL (1989), using a more negative holding potential of -70 niV, a 
second population of C2' currents with a more negative range of inactivation was 
observed in a small proportion of cells (I I %). They suggested this may represent a T-type 
CP current. Ohya & Sperelakis (1989) by contrast ruled out the existence of T-type C2+ 
current in 18 day pregnant rat myornetriurn because when using a voltage protocol 
designed to maximally activate the T-current (holding potential of -90 rnV and test 
potential of -20 m. V), the current was completely blocked by a low concentration of 
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nifedipine. In retrospect, the second population of currents described by Honore et aL 
(1989) may have been the fast Nd" current. 
A C2' current has also been described in myometriurn of adult non-pregnant rats. In these 
cells, the current did not have two clearly defined components but possessed a relatively 
negative inactivation threshold of between -44 mV and -55 mV, was only partially 
sensitive to I pM nifedipine, and was more sensitive to block by N? + than by Cd2+ (Rendt 
et al., 1992). Whether this means that the T-type CP current predominates in non- 
pregnant rat and is then down regulated or replaced by L-type current during pregnancy is 
unclear. If such changes occur, they may involve the influence of steroid hormones. 
In pregnant human myometrium, studies using the single cell patch clamp method have 
identified two distinct types of C2+ current, in contrast to the pregnant rat. With C2' in 
the bath solution and Csý in the patch pipette, the resultant inward current was blocked by 
removing external C2' and by low concentrations of nicardipine or D-600, characteristic 
of the L-type C2' current (Inoue et al., 1990). When the holding potential was shifted 
we 
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aokerv, from -60 to -100 however, two popuIatio currentVihe first demonstrated a slow 
decay, threshold at around -50 mV, and peak amplitude at 0 mV. The second exhibited a 
faster decay, a lower threshold of below -60 mV and peak amplitude between -30 and -20 
mV. The relative peak amplitudes of the two currents were similar in these cells. The slow, 
high threshold current was present at both holding potentials and represents the L-type 
current. The fast, low threshold current was only present at the -100 mV holding potential, 
characteristic of the T-type C2' current (Inoue et al., 1990). Young et al., (1991 & 1993) 
also described two populations of inward current that were both inhibited by C02', but in 
contrast to Inoue et aL (1990), found that the fast, low threshold current predominated by 
a factor of 3-4 fold. Inactivation experiments were performed on these two currents, 
isolating T-type from L-type with the L-type blocker, nifedipine and different test 
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potentials. The half inactivation was -70 mV for T-type current and -27 mV for L-type 
current (Young et aL, 1993). 
Inoue et aL (1990) also performed single channel studies isolating the two currents by 
adjusting the voltage protocol. From a holding potential of -100 mV, voltage steps up to - 
20 revealed a 12.2 pS conductance whereas from a holding potential of -60 mV, steps 
between -30 and +10 revealed a conductance of 28.8 pS. The larger conductance is that of 
L-type channels. The smaller conductance was still present in 100 mM BaF+ and in the 
absence of external Nd, ruling out the possibility of a fast Ni' current, and therefore 
probably represented the T-type current. 
Gestational and Hormonal Effects on Ca 2+ Currents 
As part of the mechanism preparing the uterus for labour, myometrial ion channel 
expression may be altered. Inoue & Sperelakis (1991) found that the amplitudes of Ca2+ 
current in pregnant rat myornetrium. increased slightly from day 5 and peaked at day 9. 
Yoshino et aL (1997) however, found that it increased during the first trimester of 
pregnancy, decrease gradually in the second (days 7-14) and third trimester (days 15-21) 
up to day 18 and then declined dramatically post-partum. The decline in the second and 
third trimesters was attributed to a 3-4 fold increase in cell size at this time without a 
similar increase in current amplitude (Yoshino, et al., 1997). Despite the above described 
fitH in current density toward term, mRNA expression of L-Type C2' channel al-subunits 
in pregnant rat myometrium increases gradually during pregnancy to a 7-fold level on day 
22 compared to day I and then decrease during labour (Mershon et al., 1994; Tezuka et 
al., 1995). In freshly isolated porcine myometrial cells the amplitude of C2' current (using 
B2+ as charge carrier) was increased in late pregnancy by 2-3 fold compared with non- 
pregnant (ZhuGe & Hsue, 1994). 
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In non-pregnant adult rat, the C2* current is larger in diestrus than in estrus and is 
increased by prior progesterone injection (Rendt el aL, 1992). In contrast, progesterone 
injection during pregnancy inhibits term delivery and prevents the normal increase in C2" 
channel a, -subunit expression at this time, whereas antiprogesterone treatment 
significantly increases expression (Tezuka et aL, 1995). 
Acutely, 17p-estradiol causes a leftward shift in the inactivation curve of the Ca 2+ current 
in rat myometrial cells thus reducing cell excitability (Yamamoto, 1995). This differs from 
the long term effect of raised circulating estradiol leveLi at the end of pregnancy, where 
expression of the channel is increased (Mershon et aL, 1994; Tezuka et aL, 1995). 
Furthermore, chronic in vivo treatment of non-pregnant ovariectomised rats results in an 
increase of both 45Ca influx in contracting strips of myornetrium and density of nitrendipine 
binding sites in membrane fractions (Batra, 1987). OT also influences C2+ current in 
isolated cells of rat and porcine myometrium, although in some studies it caused an 
inhibition (Inoue et aL, 1992) whereas in others it stimulated (Zhuge & Hsu, 1994; Zhuge 
et al., 1995). 
1.3.3. VOLTAGE-GATED SODIUM CHANNELS 
Voltage-gated Ni+ channels are essential for rapid transmission of electrical impulses in 
neurons as well as excitation-contraction coupling in cardiac and skeletal muscles. Na+ 
channels are also present in many smooth muscles but their function remains to be fully 
characterised. As with voltage-gated C2+ channels, these channel exist in three principle 
states; the resting, open and inactivated states. Voltage-gated Na+ channels are 
characterised by their extremely fast activation and inactivation gating kinetics. 
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Structure and Pharmacology 
The basic structure of voltage-gated sodium channels is similar to that of voltage-gatcd, 
C2' channels: The Na-selective pore and voltage-sensor are both contained within an a- 
subunit which consists of four internally homologous domains each containing six 
transmembrane segments (Marban et aL, 1998). The alpha subunit is associated with two 
P-subunits, which enhance channel function by increasing peak amplitude, accelerating 
activation and inactivation gating and producing hyperpolarising shifts in the voltage- 
dependence of inactivation. As with C2' channels, activity is further influenced by 
phosphorylation by PKA and PKC (producing current inhibition) (Marban et aL, 1998). 
Voltage-gated Ne channels are selectively blocked by neurotoxins such as tetrodotoxin 
(TTX) and saxitoxin (STX). 
1.3.4. MYOMETRIAL Na" CURRENTS 
The presence of voltage-gated Nd" currents in pregnant rat myornetriurn was not readfly 
apparent from early sucrose gap experiments although it was implied by the effects of 
removing external Na+ (Kao & McCullough, 1975). This ambiguity was probably due to 
the difficulty in resolving very fast currents under conditions of very high capacitance and 
series resistance. As the techniques improved, fast Nd' currents began to be reported. This 
current was described as a fast component of the inward current that was blocked when 
external Ni' was removed and when a low concentration of tetrodotoxin (TTX) was 
added, but remained when the slower CW+ current was blocked with W' (Ohya & 
Sperelakis, 1989; Miyoshi et al., 1991; Inoue & Sperelakis, 1991; Yoshino et al., 1997). 
The activation threshold and potential of peak amplitude of this current was similar to that 
of the Caý' current (Ohya & Sperelakis, 1989; Myoshi et aL, 1991; Inoue & Sperelakis, 
1991), but the half inactivation potential was more negative (-59 m. V; Yoshino et aL, 
1997). The speed of decay of the Ne current was very fast (, r = 0.5 ms at +10 rnV 
compared to 32 ms for L-type Caý+ current (fast component at +10 m. V) (Ohya & 
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Sperelakis, 1989; Yoshino et aL, 1997). The amplitude of this current in the late pregnant 
rat myometriurn was low compared to that of the Caý' current. 
The Na, 2.3 sodium channel, which is part of a gene family distinct from the channels 
predominating in brain and skeletal muscle, has been immunolocalised to mouse uterine 
smooth muscle, and is co-localised with the gap junction protein, comexin 43 (Knittle et 
aL, 1996). It was proposed that this channel may either be involved in the spread of 
depolarisation through the tissue, hence the co-localisation with gap junctions, or it may 
act to inhibit or even reverse Nd+/Caý+ exchange thus elevating cytoplasmic CW+ (Savineau. 
et aL, 1987; Knittle et aL, 1996). 
Despite evidence for mRNA expression of voltage-gated Ne channels in human uterus 
(George et aL, 1992; Boyle & Heslip, 1994), three studies have been unable to detect fast, 
TTX-sensitive Na' currents in freshly dispersed myocytes of human myometrium. (Inoue et 
aL, 1990; Young et aL, 1991 & 1993) in contrast with the pregnant rat myometrium. 
However, in primary culture of pregnant human myometrium. and a human uterine 
leiomyosarcoma cell line, a fast TTX-sensitive current with activation and inactivation 
characteristics of voltage-gated Na current is present (Young & Hemdon-Smith, 1991; 
Kusaka & Sperelakis, 1996). It is likely that these differences reflect changes in channel 
expression occurring during the culture process since in the cultured cells no evidence for 
T-type C2' current was provided, even though it is the predominant inward current in 
freshly dispersed pregnant human myometrial. cells (Inoue et aL, 1990; Young et aL, 1991 
& 1993). 
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1.3.5. GESTATIONAL EFFECTS ON MYOMETRIAL Na* 
CURRENTS 
Whole tissue expression of Nav2.3. mRNA increases during pregnancy in mouse (Knittle 
et aL, 1996) and there is a similar rise in overall IN. density (Inoue & Sperelakis, 1991). 
Yoshino et al. (1997) agreed that the occurrence of IN. in rat myometrium increased 
steadily during gestation until at term it was the dominant current. However, they found 
that the current density increased during the first trimester of pregnancy, decreased in the 
second trimester and then increased by up to Mold between days 17 and 21, compared to 
day 0. The density of IN. declined dramatically post-partum. 
1.3.6. NONSELECTIVE CATION AND CHLORIDE CURRENTS 
Many agonists including oxytocin, and some prostaglandins, stimulate C2' influx through 
G-protein dependent receptor binding (Nebigil & Malik, 1993). OT induces at least two 
slow inward currents when the cell membrane potential is clamped at or near the resting 
level (Shimamura. et al., 1994b; Arnaudeau et aL, 1994). The first requires external C2+ 
but is not blocked by nifedipine or Nfi? + (Shimamura et aL, 1994b). The second is affected 
by changing Nd' and cr levels inside and outside the cell, is not induced by OT when 
EGTA is perfused into the cell (thus requiring intraceHular C2), but is not blocked by 
isradipine or C&+ (Arnaudeau. et aL, 1994). These two currents probably represent a 
calcium-activated-cr current (Icl, c. ) (Coleman & Parkington, 1987) and a non-selective 
cation current (carried by Na' and Ca2), respectively. The resultant W influx and cr 
efflux depolarises the cell, thus opening voltage-gated C2+ channels and contributing to 
the plateau-type action potential often observed in the myornetrium (Coleman & 
Parkington, 1987). A large conductance cr current has also been identified at the single 
channel level in pregnant guinea-pig and rat myornetrium. (Coleman & Parkington, 1987; 
Wang et al., 1998). 
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Even though OT induces contractions and elevations of intracellular &' in rat and human 
myometrial which are inhibited by C2+ antagonists, (Batra, 1986; Kawarabayashi et aL, 
1986b; Tasaka et al., 1991; Thornton et aL, 1992a), a direct action of OT on C2+ influx 
through voltage-gated L-type C2' channels, as suggested in the pig by ZhuGe et al. 
(1995), is unlikely because OT also produces contractions in rat, guinea-pig and human 
myometrium. under prolonged depolarisation with high W (Kawarabayashi et al., 1986b; 
Thornton et al., 1992a) or in nominally C2+-free solution (Coleman, McShane & 
Parkington, 1988; Chien et al., 1996) (see below). The non-selective channel is probably 
activated by receptor gating to aG protein, whereas the Icl, c, current is probably activated 
indirectly via elevation in intracellular C2+. 
1.4. POTASSIUM CURRENTS 
channels are present in all excitable tissues contributing to the control of membrane 
potential (as described earlier in this chapter) and in smooth muscle are essential for 
maintaining the tissue in a quiescent state, thus preventing or inhibiting contraction. 
Outward currents in myometriurn were first identified as being carried by Ký ions using the 
sucrose gap method in guinea-pigs and rats (Vasort, 1975; Kao & McCullough, 1975). 
This current was later found to comprise multiple components which varied in their 
characteristics between species and gestational or hormonal status (Mironneau & 
Savineau, 1980; Toro et al., 1990a; Miyoshi et aL, 1991) or between experimental 
conditions. Many of these K' currents remain to be fully characterised. 
1.4.1. VOLTAGE-GATED K* CHANNELS 
Basic structure 
Voltage-gated K' channels (Kv channels) are the most extensive and diverse group of ion 
channels. There are at least four sub-families of functional mammalian Kv channels. These 
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include the Kvl, Kv2, Kv3 and Kv4 families, corresponding to the four Drosophila shaker, 
shab, shaw and shal genes, respectively. All of these channels share a common structure of 
six membrane-spanning domains, resembling one of the four repeated domains of the Naý 
and Caý' a-subunits (Catterall, 1995; Deal et al., 1996) (Fig 1.4. ). Because of this 
similarity, these W channels are likely to be tetrameric in structure (MacKinnon, 199 1). As 
with voltage-gated Na and Caý+ channels, all Kv channels contain a voltage-sensor which, 
in response to depolarisation, produces a conformational change allowing the channel pore 
to open. Inactivation of Kv channels is also voltage-dependent and occurs through at least 
two mechanisms, one called N-type inactivation, where the cytoplasmic face of the pore is 
occluded by a ball-like peptide at the amino-terminus of the channel subunit, and the other 
C-type inactivation, which involves closing of the pore itself (Rasmussen et aL, 1998). 
In addition to homotetrameric channels, Kv a-subunits are capable of forming 
heterotetrameric channels composed of diffierent members of the same a-subunits family, 
with gating and pharmacological properties distinct from the sum of the properties of the 
two component subunits (Roberds et aL, 1993). This diversity is complicated further firstly 
by the existence of at least 3 types of P-subunit, which combine with a-subunit tetramers 
(see Fig 1.4. ) and alter their activation and inactivation properties in a similar manner to P- 
subunits of Na" and Caý' channels (Kukuljan et al., 1995; Deal et aL, 1996), and secondly 
by at least four additional families of a-subunit, which in themselves are electrically silent 
but, in combination with Kvl, 2,3 and 4 cc-subunits, produce channels with unique 
properties (Salinas et aL, 1997). 
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(ý) Amino-terminus "ball pepticle" 
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Diversity of kinetics and voltage-sensitivity 
All Kv channels demonstrate outward rectification, that is, from the resting state, under a 
normal [KI gradient, they open outwardly in response to depolarisation, the open 
probability increasing as the membrane potential becomes more positive, and do not 
readily open in the reverse direction upon 
, 
repolarisation. Kv channel a-subunits fall 
into three classes on the basis of their electrophysiological properties and the function of 
corresponding native currents. The delayed rectifier channels activate with a short delay 
after a depolarising step and display little or no inactivation over short periods. In the 
mammalian heart, these channels conduct outward current during the action potential 
plateau, thus controlling the timing of repolarisation and duration of the action potential 
(Roden & George, 1997). The second class of channels conduct "A-like" currents. These 
are characterised by very fast activation and inactivation kinetics, and in the heart are 
believed to be responsible for the transient repolariation that follows the initial Spike 
depolarisation and precedes the plateau potential (Roberds et al., 1993). The third class of 
channel is a very slowly activating delayed rectifier with no detectable inactivation. This 
channel is formed by a combination of KvLQT1 with the single membrane-spanning unit, 
minK and in the heart also controls action potential duration (Roden & George, 1997). As 
with voltage-gated C2' and Na channels, Kv channels cycle between at least three states 
in response to membrane potential changes (Fig 1.2. ). Most voltage-gated K' channels 
demonstrate strong outward rectification. This means that they are more likely to open at 
membrane potentials positive of the reversal potential, thus conducting hyperpolarising 
outward currents, than at membrane potentials negative of the reversal potential, where 
they would otherwise conduct depolarising inward current. Some of the cloned Kv 
channels and their electrophysiological properties are listed in table 1.2. 
45 
TABLE 1.2. ELECTROPHYSIOLOGICAL PROPERTIES OF SOME 
CLONED MAMMALIAN Kv CHANNELS 
Channel Current Activation Inactivation Conduct Found Authors 
Type -ance in 
Rate Threshold Rate V0.5 uterus 
Kv1.1 DelRec fast below slow 10 PS Grissmer 
-6OmV 
KvI. 2 DelRec fast -40 mV slow -15 mV 14 or no 
Hart 
or 18 PS (dog) 
(1993) 
Grissnw 
-60 mV (1994) 
Kv1.3 DelRec fast -60 mV slow 14 pS 
Grissm 
(1994) 
KvI. 4 A-like very fast -66 mV Roberds 
fast (1993) 
Kv1.5 DeRec fast -40 mV slow -21 mV 8 or yes Overturf 
or 10 PS (dog) 
(19CA) 
Gdssmer 
-60 mV (1994) 
Kv2.1 DelRec slow -30 mV very -25 mV 9 PS Pav, 1991a 
with to slow to 
Patel, 1997 
l(lemic, 
delay -50 MV -45 mV im 
Kv2.2 DeRec slow -20 mV very -16 mV 15 PS yes Schm& 
with slow (dog) (19N) 
delay 
Kv3.1 DelRec fast -20 mV slow 27 pS Gftsrw 
Kv4.1 A-like very -50 mv fast -69 mV Pak 
(mShal) fast (1991b) 
KvLQT1 very very -30 mV very yes Boyle 
ImInK slow slow very (rat) 
(1987a) 
DelRec slow 
DelRec = delayed rectifier 
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TABLE 1.3. PHARMACOLOGICAL PROPERTIES OF SOME 
CLONED MAMMALIAN Kv CHANNELS 
Channel Current Inhibitor (ECso) Author(s) 
Type 
4-AP TEA C10filium 
Kv1.1. fast 290 pM 0.3pM (mouse) >20 pM Grissmer, 1994 
delrec Suessbrich, 
20 mM (human) 1997 
Kv1.2. fast 74 - 590 pM >100 mm 174 pM Grissmer, 1994 
delrec Hart, 1993 
Yamagishi, 
1995 
Kv1.3. fast 200 - 300 pM 10mM(mouse) 60pM Attali, 1992 
delrec (human) 30 mM (human) Grissmer, 1994 
50 mM (rat) 
Kv1.4. A-like 700 pM >50 mM > IMM Roberds, 1993 
Yamagishi, 
1995 
Kv1.5. fast 50 pM (human) >100 mm 0.15-1 PM Overturf, 1994 
delrec (human), Grissmer, 1994 
270 pM (dog) Fedida, 1993 
50 pM (dog) Deal, 1996 Malayev, 1995 
Kv2.1. slow >20 mM 5 mm Pak, 1991 a 
delrec Kirsch, 1993 
Kv2.2. slow voltage- 3 mM Schmalz, 1998 
derec dependent 
Kv3.1. fast 30 - 100 pM 0.2 mM Grissmer, 1994 
delrec Kirsch, 1993 
Kv4.1. A-like >2 mM insensitive Pak, 1991b 
(mShal) 
Kv4.2. A-like 1.5 mM 15 mm >20 pM Deal, 1996 
Suessbrich, 
1997 
minK/ very >>3 mM 20 mM 80 pM Attall, 1992 
KvLQT1 slow 
I delrec 
ueiKec = aeiayea rectmer 
Most Kv channels are also blocked by high concentrations of Ca 2+ channel 
antagonists nifedipine, verapamil and diltiazern and partially blocked by high 
(pM) concentrations of charybdotoxin (Grissmer et aL, 1994). 
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Pharmacology of Kv Channels 
Kv channels are sensitive to block by a wide range of pharrnacological agents, the potency 
of which varies considerably between channel types. The effects of some of these drugs, 
which include tetraethylarmonium (TEA), 4-arninopyridine (4-AP), charybdotoxin 
(ChTX), iberiotoxin (IbTX) and clofiliurn (U), on some of the cloned Kv channels, are 
listed in Table 1.3. 
1.4.2. MYOMETRIAL Kv CURRENTS 
The existence of voltage-gated W currents in myometriurn was first indicated by the effect 
of the K+ channel blocker 4-AP, which inhibited both transient and sustained components 
of the outward K' current in guinea-pig and rat myometriurn and their insensitivity to low 
concentrations of TEA (Vasort, 1975; Mironneau. & Savineau, 1980; Miromeau et aL, 
1981; Nfiyoshi et al., 1991). This current often had transient and sustained components, 
the occurrence of which, as well as 4-AP sensitivity, often varied between studies. 
Transient or "A-like" K* Currents 
Early studies describe a transient component of the W current in myometriurn of pregnant 
and non-pregnant rats, immature rats, non-pregnant guinea-pigs and non-pregnant humans 
which was completely blocked by 1-10 mM 4-AP but not 2-20 m. M TEA and was 
activated by hyperpolarising conditioning pre-potentials or by holding potentials negative 
of -70 mV (Vasort, 1975; Mironneau & Savineau, 1980; Mironneau. et aL, 1981; Myoshi 
et aL, 199 1; Piedras-Renteria, 199 1; Erulkar et aL, 1993; Inoue et al., 1993; Erulkar et aL, 
1994; Wang et aL, 1998). 
Electrophysiological analysis of this current confirmed that it inactivated in a voltage- 
dependent manncr but calculations of half-inactivation (Vo. 5) vary considerably between 
studies (eg -41 mV, Myoshi et aL, 1991; -24 mV, Erulkar et aL, 1993; 48 mV, Erulkar et 
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aL, 1994; -77 mV, Wang et aL, 1998). Because of its fast activation, fast inactivation and 
relatively negative threshold of activation (between -60 and -40 mV) this current often 
overlapped with inward calcium currents (Mironneau et aL, 1981; Erulkar et aL, 1993; 
Erulkar et aL, 1994; Inoue et aL, 1993; Wang et al., 1998). 
The differences in the voltage-sensitivity of inactivation of the A-current in the different 
'Nhe different concentrations of external C2' used. There is some studies may be due 
evidence to suggest that the A-like current in myometriurn is C2'-sensitive and Wang et 
aL (1998) demonstrated that raising the external [C2] from 1 to 30 mM overcame the 
inactivation of the current at a holding potential of -50 mV (hence shifting the inactivation 
threshold to the right). Although Vasort (1975) found that the transient current was 
inhibited by D-600 and W', implicating modulation by [Caý']j, Piedras-Renteria et aL 
(1991) showed that it was not inhibited by putting EGTA in the pipette solution, 
suggesting that it was sensitive to external [C2'] and not [C2']i. 
Abundance of the A-Eke current appeared to be dependent on gestational or hormonal 
status. For example, in leiomyoma cells of human myometrium it was more abundant than 
in normal non-pregnant tissue (Erulkar et aL, 1993). Similarly, it was frequently present in 
myometrium of adult non-pregnant rat (50 % of cells) but absent in late-pregnant rat 
(Wang et aL, 1998). In immature rat myometrium this current occured in the majority of 
cells (79 % of cells) but was Wubitcd by estrogen treatment (30% of cells) (Erulkar et aL, 
1994). 
"Delayed Rectiflee'-Like W Currents 
In addition to the transient component of the W current, there is a sustained or slowly 
decaying component which in early studies in rat and guinea-pig myometrium. was 
inhibited by 4-AP with a comparable potency to that demonstrated against the transient 
component, but, unlike the transient current, it was also partially sensitive to TEA (Vasort, 
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1975; Mironneau & Savineau, 1980; Toro et aL, 1990a; Nfiyoshi et aL, 1991). A similar 
current was then found in cultured non-pregnant human myornetrium, characterised by 
partial block with 4-AP (I mM), partial block with 2 mM TEA, slow decay and threshold 
of activation near -40 rnV (Erulkar et aL, 1993). In immature rat myometrium by contrast, 
a 4-AP sensitive component of the sustained W current was not present (Erulkar et al., 
1994). To add to this, in pregnant rat myometrium, the existence of an (at that time) 
uncharacterised K' current was implied by the incomplete inhibition with high 
concentrations of either 4-AP (10 mM) or TEA (50 mN1) (Inoue et al., 1993). A major 
criticism of these earlier studies is therefore that detailed electrophysiological 
characterisation of the sustained current (ie voltage-dependence of inactivation) was not 
performed and care was not taken to isolate it (or them) from the CW'-activated W 
current. 
However, in a recent study in pregnant and non-pregnant rat myometrium, a very detailed 
electrophysiological and pharmacologic description of these currents was presented (Wang 
et aL, 1998). The slowly decaying component of the K' current was found to be reduced 
by 50 % in non-pregnant and by 70 % in pregnant myometrium when the holding potential 
was changed from -80 mV to -50 mV, suggesting voltage-dependence of inactivation. In 
both pregnant and non-pregnant myometrium, this inactivation was found to be biphasic 
suggesting the existence of two voltage-gated W currents, distinct from the Mike current, 
one with a Vo. 5 of around -60 mV (called CI), the other with a Vo. 5 of around -20 mV 
(called C2). C, also had a negative threshold of activation (below -60 mV). 
Pharmacologically, C, was partially blocked by TEA, but only weakly sensitive to ChTX, 
IbTX and 4-AP, WhereasC2was partially blocked by TEA, ChTX but more sensitive to 4- 
AP (EC5o I mW. 
Another very slowly activating and slowly decaying W current is also present in rat 
myometrium, which demonstrates voltage-dependence of activation and is upregulated 
50 
under conditions where estrogen levels are higher (Boyle et aL, 1987a; Boyle et al., 
1987b). This current is similar to that described for the cloned KvLQTI channel from rat 
uterus and heart (Folander et aL, 1990). 
Single Channel Kv Currents 
The single channel conductances of myornetrial Kv currents are largely unexplored. In 
addition to the large conductance BKc. channel (see below), two smaller conductances 
(-20 pS and -50 pS) were reported in pregnant rat myornetrium and cultured human 
myornetriurn (Wang et aL, 1998; Anwer et aL, 1993), but apart from confirming r- 
selectivity, the pharmacological and electrophysiological properties of these channels were 
not investigated further. 
1.4.3. LARGE CONDUCTANCE, Ca 2+ -ACTIVATED K+ CHANNELS 
Large conductance CW+4ctivated channels (BKc. or maxtK) are characterised by a large 
conductance (up to 280 pS; Wallner et aL, 1995) and a dependency on membrane 
potential and intracellular calcium for channel opening. As with the voltagc-gated W 
channels, BKc. channels prefer outward rectification, conducting outward current upon 
depolarisation rather than inward current in response to hyperpolarisation. 
Basic Structure 
BKc. channels share the basic structure of Kv channels, the pore-forming a-subunit having 
six transmembrane domains, including a voltage-sensor and a distinct pore domain. In 
addition they have a large carboxyterminal domain, possibly responsible for the C2+- 
dependency (Wei et al., 1994). BKc, channels in mammalian smooth muscle are coded 
from a single family of Slo genes and mRNA for hSlo has been cloned from human 
myometrium. (Wallner et aL, 1995). In smooth muscle, BKc. a-subunit function is 
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modulated by association with a P-subunit which enhances channel C2+ sensitivity, 
causing a hyperpolarising shift In the threshold of activation (Tanaka et al., 1997). 
Pharmacology 
BKc. channels are blocked by TEA (EC50-250 pNo, IbTX (EC50<20 nM), ChTX (EC5o 
<40 W), paxilline (effect dependent on [Caý']), and intracellular B2", and are insensitive 
to 4-AP, apamin and the ATP-sensitive W channel opener lemakalim (Wallner et aL, 
1995; McCobb et aL, 1995). 
1.4.4. MYOMETRIAL BK, ca AND BK CURRENTS 
Whole Cell Currents 
Early sucrose gap studies in non-pregnant guinea-pig and pregnant rat indicated that a 
component of the outward current was reduced by lowering external [C21 or the addition 
of C2' channel antagonists, as well as TEA, and was increased by increasing external 
[C2'] and was either transient (Vasort, 1975) or sustained (Mironneau & Savineau, 
1980). The dependence on Ca2' and sensitivity to TEA (EC50 Of 0-1 to I mM) but not 4- 
AP was later confirmed by single cell patch clamp in pregnant human and pregnant and 
non-pregnant rat myometrium (Inoue et aL, 1990; Piedras-Renteria et al., 1991; Anwer et 
aL, 1993; Wang et al., 1998). Apamin, the selective blocker of small conductance C2+- 
activated W current had little or no effect on K* current in pregnant rat myornetrial cells 
(Wang et aL, 1998). 
Single Channel Currents 
The large conductance C2-activated W channel (BKc, ) is the most frequently recorded 
W conductance in single channel studies, with conductances ranging between 140 pS and 
260 pS in myometrium. of non-pregnant and pregnant rats, non-pregnant and pregnant 
humans and an immortalised human myornetrial cell line (Toro et aL, 1990b; Perez et al., 
* extemal appfication. 
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1993; Anwer et aL, 1993; Khan et aL, 1993; Perez & Toro, 1994; Meera et aL, 1995; 
Khan et al., 1997; Wang et aL, 1998). By increasing [C21 on the cytoplasmic side of the 
patch from 10-100 nM (close to the physiological concentration) to 10-100 PM, the 
membrane potential dependence of activation of this channel is shifted in the negative 
direction by up to 50 mV, due to an increased channel open probability (Toro et al., 
1990b; Khan et aL, 1993; Perez et aI, 1993; Khan et aL, 1997). IK(c. ) in the myometrium 
is also blocked by cytoplasmic application of micromolar B2" and TEA and external 
application of TEA and charybdotoxin (Khan et aL, 1993; Perez et aL, 1993; Khan et al., 
1997). 
Intracellular Modulation of BKca 
BKc. is modulated by phosphorylation via protein kinases such as PKA and by G protein 
binding. In rat myometrial lipid bilayers IK(c. ) is activated by GTP or GTPyS in the 
presence of Mgý +, an effect which is potentiated by the P-agonist isoprenaline, suggesting 
direct activation of the channel by aG protein (Toro et aL, 1990b). The effect of PKA on 
IK(c. ) depends on gestational or hormonal status, channel open probability being reduced by 
PKA in non-pregnant rat myometrium and enhanced in pregnant rat and human 
myometrium (Perez & Toro, 1994). PKA-dependent activation of BKc. is stimulated by 
the uterine relaxant relaxin (Meera et aL, 1995). 
In human myometrium from women in labour, Khan et aL (1993 & 1997) found that BKc. 
is replaced by BK, a channel of similar conductance but which was insensitive to [C2']i 
and was not voltage-dependent (ie was open with equal probability at all potentials 
between -60 and +60 mV). This channel differs in its sensitivity to Ba2' and TEA and, in 
cell-attached patch mode, exhibits either very sparse activity compared to inside-out patch 
mode or develops cyclical opening behaviour over a period of minutes, suggesting that it is 
being inhibited or modulated by intracellular factors. 
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1.4.5. INWARD RECTIFIERS AND ATP-SENSITIVE K* CHANNELS 
Inward rectifier channels (KIR) are structurally dissimilar to Kv channels, having only two 
transmembrane segments and lacking a voltage-sensor component, enabling them to open 
at all potentials (Roden & George, 1997). For example, at potentials positive of the W 
reversal potential KIR channels conduct outward (repolarising) current but at potentials 
negative of the reversal potential they conduct inward (depolarising) current. They do 
however demonstrate voltage-dependence but, in contrast to the Kv channels, the open 
probability decreases as the membrane potential becomes more positive, hence producing a 
negative outward rectification, which becomes an inward rectification when the reversal 
potential is shifted to zero by symmetrical internal and external [K*]. In cardiac muscle, 
this means that KIRchannels are able to set a negative resting membrane potential without 
interfering with action potential generation. 
The pore, forming subunitsof KATp channels are structurally related to inward rectifiers 
(KIR), but are weakly voltage-dependent, demonstrating linear current voltage relationships 
in symmetrical W solutions, or weakly outwardly rectifying current-voltage relationships 
in physiological K' solutions (Quayle et aL, 1997). Association of the KIR6.1 subunit with 
the sulphonylurea. receptor, a regulatory sub-unit of the KATp channel (Yamada et d, 
1997), confers sensitivity of the channel to intracellular ATP. Binding of ATP inactivates 
the channel and dissociation of AT? from this site activates it- KATPchannels are therefore 
sensitive to the metabolic status of the cell, and may open during metabolic compromise, 
hence causing relaxation (Quayle et d, 1997)- KATP channels are inhibited by 
sulphonylurea. drugs such as glibenclamide (Quayle et aL, 1997). 
1.4.6. MYOMETRIAL KIRAND KATPCURRENTS 
Hyperpolarisation in guinea-pig myometrium, under voltage-clamp conditions, induces a 
slow inward current (Parkington and Coleman, 1988) wbich may correspond to the inward 
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rectification recorded in intestinal smooth muscle (Benham et aL, 1987). The presence of 
KATp current in myometrium is implied by the relaxant effects of drugs that open KATp 
channels, such as chromakalim, aprikalim and levchromakalim on contracting myometrium 
and their antagonism by glibenclamide (Piper et aL, 1990; Cheuk et aL, 1993; Morrison et 
al., 1993). Glibenclamide also partially (50%) inhibits cyanide-induced 8'Rb efflux in strips 
of pregnant rat myometrium (Heaton et aL, 1993). These effects suggest that KATP 
channels, along with BKc. and Kv channels contribute to setting the resting membrane 
potential in myometrium and may contribute to relaxation in response to metabolic 
changes. Direct measurements of Ka or KATP currents in myometrium, either at the whole 
cell or single channel level, however, remain to be performed. 
1.4.7. Na + IK + ATPase 
The Na /K' ATPase is electrogenic, exchanging 3K (out) for 2 Na' (in) thus 
hyperpolarising the membrane. This pump probably contributes to the resting membrane 
potential in myometrium since inhibition of the pump by ouabain (a selective blocker of the 
NPW ATPase) caused depolarisation and hence activation of voltage-gated Caý+ 
channels, and in the rat this resulted in regular but short-lived phasic contractions which 
were inhibited by nifedipine (Ausina et al., 1996). There is also evidence in the pregnant 
human myometrium. that the NPW AT? ase is responsible for the large hyperpolarisation 
that follows the plateau-type action potentials induced by PGE2 and PGF2,, (Parkington et 
aL, 1999). 
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1.5. RELATIONSHIP BETWEEN Ca 2+ -INFLUX, K+-EFFLUX 
AND EXCITATION-CONTRACTION COUPLING 
1.5.1. EFFECT OF Ca2+-CHANNEL ANTAGONISTS ON 
MYOMETRIAL CONTRACTION 
It is now established that spontaneous contractions are always preceded by action 
potentials and that the depoharisation requires C2' influx (Mironneau, 1973; Amedee et 
al., 1986a). In all smooth muscles, an increase in free intraceffular C2" is essential for both 
depolarisation-induced and agonist-induced contractions (Himpens & Somlyo, 1988), 
acting via the calmodulin/myosin light chain kinase pathway (Horowitz et aL, 1996). 
Removing external C2' abolishes spontaneous contractions of pregnant rat and human 
myornetrium. in vitro, whereas elevating the C2' concentration increases contraction 
amplitude (Granger et aL, 1986; Ballejo et aL, 1986; Poli et aL, 1990). Furthermore, a 
wide range of L-type C2' channel-selective antagonists, as well as micro- or milli-molar 
concentrations of divalent cations such as C02+ , C&+ and Mi? 
+ (Sipowicz et al., 1995; 
Mogami & TodoroK 1997), inhibit spontaneous and agonist-induced contractions of the 
rat, sheep and human myornetriurn in vitro (see Table 1.4. ). C2+ channel antagonists also 
shift C2+ -contraction dose responses to the right (Granger et aL, 1986; Ballejo et al, 
1986), proving the functional coupling of contraction with calcium influx through voltage- 
gated channels. In vivo, C2+ channel antagonists prevent spontaneous and OT or PGF2. - 
induced labour in rats (Csapo et aL, 1982), inhibit contractions of the non-pregnant rat 
uterus (Abel & Hollingsworth, 1985), but have variable or limited effects on uterine 
contraction in pregnant women in labour (Higby et aL, 1993). The blocker of voltage- 
gated Ne channels, TTX (I pNl) is ineffective at inhibiting oxytocin-induced contractions 
of pregnant rat myornetrium and spontaneous contractions of pregnant human 
myornetriurn in vitro (Poli et aL, 1990; Phillippe & Basa, 1997a; Parkington et aL, 1999). 
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TABLE 1.4. 
Inhibition of Myornetrial Contraction In vitro by Ca2" Channel 
Antagonists 
Species Preparation Contraction Drug (dose*) Author(s) 
Rat pregnant single Spontaneous & D-600 (1 pM) Amedee et aL 
cells, Ca 2*2mM K*-induced 1986a 
Rat Non-preg strips, W or ACh & verapamil (1-10 pM), lchida et aL 
Ca 2"' 3 mM 5-HT-Induced diltiazem (1-10 pM) 1984 
Rat Pregnant strips Spontaneous gallopamil (100 nM), Granger et aL, 
Ca 2+ 1.3 mM or W-induced diltiazern (0.5-1 pM), 1986 
nifedipine (10 nM), 
cinnarizine (I OnM-5 pM) 
Rat Non-preg strips BAYK-8644- nifedipine (1 -10 pM) Chien et aL. 
Ca 2+ 1.8 MM induced 1996 
Rat Non-preg strips Oxytocin- nifedipine (1 pM) Phillippe & 
Induced Basa, 1997a 
Rat post-parturn spontaneous nicardipine (1 00pg/ml) Csapo et aL, 
strips 1982 
Sheep pregnant strips, electrically- verapamil (I pM) Parkington, 
Ca 2+ 2.5 mM induced 1985 
Human pregnant strips spontaneous & nifedipine, Maigaard et aL, 
W. PGF2,, OT nitrendipine 1983 
& VP- induced 
Human pregnant strips, spontaneous & diltiazem (10 g/ml) & Kawarabayashl 
Ca 
2+ 
2.5 mM OT-induced (10-4 g/Ml) etat, 1986b 
Human pregnant strips, spontaneous nifedipine (0.01-1 pM), Ballejo et aL, 
Ca 2+ 2.5 mM & W-Induced verapamil (1-10 pM), 1986 
cinnadzine (100 pM) 
Human pregnant strips, spontaneous nifedipine (0.1-1 nM), Poli et aL, 1990 
Ca2+ 1.9 mM verapamil (10-100W), 
diltiazern (1-10 pM) 
Human pregnant strips, spontaneous nifedipine (11 pM) Parkington 
Ca 2+ 2.5 mM & PG-induced verapamil (10 pM) et aL, 1999 
* concentration producing 50-100% inhibition of contraction. ACh= acetylcholine, 
5-HT= seretonin, VP= vasopressin, OT=oxytocin. 
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The importance of C2" influx to myometrial contraction is also illustrated by the actions of 
the dihydropyridine derivative, BAYK-8644, an L-type C2+ channel agonist, which 
induces or enhances phasic contractions in isolated strips of pregnant rat and human 
myometrium (Poli et al., 1989; Chien et al., 1996; Phillippe & Basa, 1996; Kyozuka et al., 
1987), antagonises the inhibitory action of nifedipine (Poli et al., 1989; Poli et al., 1990) 
and shifts the concentration-dependency of contraction to K' to the left (Kyozuka et al., 
1987). 
1.5.2. EFFECTS OF K+ CHANNEL BLOCKERS AND OPENERS ON 
MYOMETRIAL CONTRACTION 
There is also functional evidence for the importance of W currents in the prevention or 
suppression of spontaneous myornetrial contractions. The selective inhibitor of BKc. 
channels, iberiotoxin (IbTX, 50 nM) induces spontaneous contractions in quiescent strips 
of pregnant human myornetrium. (Anwer et aL, 1993). This effect is probably via 
depolarisation and subsequent opening of voltage-gated CP channels and elevation of 
[C21i. IbTX (40 nM) and TEA (5 mM) also increase the frequency and force of 
spontaneous contractions of non-pregnant rat myornetrium in vitro (Anwer et aL, 1993; 
Taggart & Wray, 1998). In pregnant human myometriual strips, both 4-AP (5 mN4) and 
charybdotxin (10 nM) prolonged PGF2,, and PGE2-induced contraction duration whereas 2 
mM TEA increased the frequency of spontaneous contractions (Parkington et aL, 1999). 
In contrast, spontaneous and 10-20 mM KCI or OT-induced phasic contractions of 
pregnant rat and human myornetrium. have been inhibited by drugs that stimulate opening 
of KATp and/or BKc. channels (Piper et al., 1990; Cheuk et al., 1993; Morrison et aL, 
1993; Khan et aL, 1998). 
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1.5.3. CONTROL OF INTRACELLULAR Ca 2+ CONCENTRATION 
(SUMMARISED IN FIG 1.5. ) 
Intracellular Ca 2+ stores 
Although C2' influx may be an essential trigger for contraction, an intracellular CP 
concentration sufficient for the activation of the contractile apparatus may also require 
release of stored C2'. In human myometrium, the relative importance of CP stores is 
poorly understood, but much work has been performed in the rat. 
In all smooth muscles intracellular C2' is stored in the sarcoplasmic reticulum (SR) and its 
release is stimulated by at least two different mechanisms. The hydrolysis product of 
phospholipase C, inositol 1,4,5, trisphosphate UP3) is generated in response to G-protein 
coupled receptor stimulation (Berridge el aL, 1993) by such agonists as oxytocin. IP3 
binds to receptors on the IP3-sensitive C2' store (ISCS) and triggers C2' release. This 
binding is itself influenced by C2", which forms a positive feedback at less than 300 nM 
Ca2' and a negative feedback at higher concentrations (Ino & Tsukioka, 1994). The 
second principle mechanism is C2-induced-C2-release (CICR) which involves 
stimulation of C2' release from a C2+-sensitive C2' store (CSCS) through the opening of 
C2'-gated channels, also known as ryanodine receptors (Lynn et aL, 1993; Giannini et a1, 
1995). CP also feeds back negatively on the ryanodine receptor at higher concentrations. 
C2+ is pumped back into the SR through C2+-ATPases (Wu et aL, 1995), although in the 
inyometrium. the relative importance of this pathway to myometrial contractility remains a 
matter of debate (Phillippe et al., 1995b; Taggart & Wray, 1998; Tribe et al., 1999). 
Refiffing of stores in myometrium appears to be dependent on extraceHular C2+ influx 
(Thornton et aL, 1992a). In some cell types, this may occur directly from the extracellular 
C2' pool without an intermediate rise in [Ca2']i, through a mechanism called capacitative 
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C2' entry (Horowitz et aL, 1996). C2' may also be sequestered, either in the cytoplasm 
by endogenous buffer molecules, or in the mitochondria (Horowitz et aL, 1996). 
Plasma Membrane Ce Pumps and Transporters 
As well as being controlled by internal stores, the intracellular C2' concentration in the 
myometrium is also reduced by extrusion from the cell through a C2AFI+ATPase pump 
and a C2'Ne transporter which exchanges 3Ne for each C2' and is bidirectional 
(Grover et aL, 198 1; Ver et aL 1989; Morgan et al., 1993a). 
Calcium Oscillations 
Oscillations in free intracellular C2' concentration occur in many cell types, including 
smooth muscle (Berridge & Gallione, 1988). In a small percentage of cultured human 
myometrial. cells in vitro (2-15%), spontaneous oscillations in intracellular C2' occur 
(Thornton et al, 1992b; Morgan et aL, 1993b; Lynn et aL, 1993). The mechanism(s) by 
which these oscillations occur or how they are related to phasic contractions in the 
myometrium. are not My understood, but as in other cell types they are believed to involve 
cyclic release and re-uptake of C2' from both types of store, under the control of multiple 
positive and negative feedback loops as well as Stimulus from IP3 (see Fig I. S. ) and in rat 
myometrium are triggered by extraceffular CP influx (Chien et aL, 1996). 
Rhythmic contractions of the rat myornetriurn in vitro are induced or enhanced (increased 
frequency and amplitude) by drugs or hormones that induce IP3 generation (eg OT; 
acetylcholine), or facilitate extracellular CW' influx, either via opening of voltage-gated 
CW' channels directly (eg DAYK 8644), or indirectly via depolarisation (eg 10-30 mM W) 
(Morrison et aL, 1993; Phillippe, ' 1994; Phillippe et aL, 1995a; Chien et aL, 1996; Phillippe 
& Basa, 1997b). These contractions are inhibited by agents that block IP3 production, 
block CW-induced-CW-release, activate PKC and inhibit CW'-influx through L-type CW+ 
channels (Phillippe, 1994; Chien et al., 1996; Phillippe & Basa, 1996). In a more recent 
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study by contrast, cyclopiazonic acid (CPA), a blocker of the SR CP ATPase, enhanced 
contraction amplitude and duration or caused tetanic contractions, in myometrium from 
non-pregnant rats and pregnant rats, respectively (Taggart & Wray, 1998). Similarly, in 
human myornetrium, CPA did not inhibit contractions or alter frequency but increased 
contraction duration in strips from non-labouring term pregnant women and caused tetany 
in those from women in labour at term (Tribe et al., 1999). The relationship between 
rhythmic contractions and intracellular Caý+ oscillations therfore requires further study (Fig 
1.5. ). 
Effects of Uterotonins 
Many agonists cause elevations in intracellular C2+ via multiple mechanisms. Oxytocin 
mobilises C2' from internal stores via G protein linked receptors coupled to production of 
IP3. in guinea-pig, human, porcine and rat myometriurn (Marc et aL, 1986; Schrey et al. 
1987; Coleman, et aL, 1988; Anwer & Sanborn, 1989; Zhuge et aL, 1995) as wen as 
stimulating extracellular C2+ influx. On continuous perfusion at low concentrations (IpM- 
InNo, OT induces intracellular C2+ oscillations in cultured human myometrial cells which 
are dependent on extracellular C2+ (Thornton et aL, 1992b), and in rat myometrial strips 
in vitro these OT-induced oscillations occur simultaneously with phasic contractions which 
are inhibited by L-type C2+ channel blockade (I gM nifedipine) but not fast Ne channel 
blockade (I pM TTX) (Phillippe & Basa, 1997a). In the cultured cells, each transient is 
preceded by a slow increase in baseline C2' (similar in appearance to the pacemaker 
potentials or slow waves that precede action potentials) (Thornton et al., 1992b). 
The effects of prostaglandions on intracellular C2' are complex. It is suggested by 
Thornton et aL (1992a) that unlike oxytoch the PGE2 is unable to stimulate [C2']i 
transients in the absence of extracellular C2' in cultured human myometrium. or in the 
presence of high external K' concentration, so is probably acting entirely on C2' influx 
(probably via receptor-gated non-selective cation channels and subsequent 
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depolarisations). However, Asboth et al (1996) have demonstrated, also in cultured 
human myometrium, that PGE2 may also activate increase intracellular CP via IP3 
production. The response to PGF2. also appears to involve multiple mechanisms. In non- 
pregnant and pregnant human myometrium it has raised [C2']i, an effect that was 50-100 
% blocked by verapamil and was dependent on external C2" (Molnar & Hertelendy, 1990; 
Parkington et aL, 1999). It has also caused contraction at least in part through release of 
stored C2' but possibly via an IP3 independent pathway (Schrey et aL 1987), either via an 
influence on Ca2*-induced C2"-rclease or cytoplasmic C2' sequestration (Coleman et aL, 
1988), or via a sensitization of the contractile proteins to C2' (Izumi et al., 1996). 
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FIG 1.5. REGULATION OF INTRACELLULAR Ca 2+ 
Depolarisation, 
Cal+ 





0ý movement of Ca 
ISCS'. IP3-sensitive Ca 2+ store; CSCS Ca 2+-sensitive Ca 2+ store; ROCC: receptor- 
operated Ca 2+ channel; VOCC: voltage-operated Ca2+ channel; SOCC: store- 
operated Ca 2+ channel; IP3-R: IP3 receptor; R-R: ryanodine receptor; PIP2. 
phospatidylinositol; IP3: inositol trisphosphate; DAG: diacylglycerol; PLC: 
phospholipase C; PKC: protein kinase C; G: G protein; R receptor; A: agonist; 
Mit: mitochondria; EB: endogenous buffer. 
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stimulation (+) or inhibition (-) 
1.6. PREVENTION OF PRETERM LABOUR (TOCOLYSIS) 
Preterm labour occurs in 5 to 10 % of pregnancies and is the principle cause of perinatal 
mortality (70 %), and in those preterm infants who survive there is a 50 % chance of a 
wide range of associated short and long-term morbidities (eg. respiratory disease and 
intracranial haernorrhage) (Cooper et al, 1993; Carroll et al., 1996). It is therefore 
essential for the future health of the infant that preterm delivery be prevented or at least 
postponed until after 32 weeks, while glucocorticoids are given to accelerate fetal lung 
maturation. Unfortunately, finding drugs that are effective at preventing or inhibiting 
labour without causing potentially harmful side effects in the mother and fetus has proven 
difficult. Many of the classes of drug which have been used or are being used as tocolytics 
are listed in table 1.5. 
Another class of drug which may prove useful in tocolytic therapy is the potassium channel 
openers. Although not yet tested in vivo in humans, these drugs which include openers of 
KATpand BKc. channels such as pinacidil, chromakalim and lemakalim have proven to be 
effective inhibitors of spontaneous contractions of pregnant human myometrium in vitro 
(Piper et aL, 1990; Cheuk et aL, 1993; Morrison et aL, 1993; Khan et aL, 1998). A 
potential drawback of these drugs, as of the known classes of C2' channel blockers, is 
that they would not be expected to be utero-specific, since they are also effective inhibitors 
of contraction in vascular smooth muscle (Quayle et aL, 1997). There are as yet no drugs 
known to selectively open voltage-gated W channels. If voltage-gated W channels specific 
to the uterus were found and if drugs were developed to selectively open these channels 
such drugs may prove useful and safe tocolytics. 
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TABLE 1.5. CLASSES OF TOCOLYTIC DRUG 
Drug Effectiveness Maternal Fetal 
in vivo side-effects side-effects 
P-agonists variable increased heart increased heart 
& short-term rate & blood rate & blood 
eg. ritodrine, salbutamol, pressure pressure hexaprenaline, 
isoprenaline pulmonary edema potentially harmful 
potentially harmful 
MgS04 little at safe various, various, 
dose potentially harmful potentially harmful 
Oxytocin in ongoing trials requires requires 
further study further study 
antagonists 
COX inhibitors effective in late gestation: 
necrotising 




Ca 2+ channel effective vasodilatation requires further 
but short term but requires study blockers further study 
eg nifedipine, verapamil 
NO donors requires further ripens cervix requires further 
study study 
eg glyceryl trinitrate 
The information provided in this table is derived mostly from the reviews of Higby 
et aL (1993) and Lopez-Bernal et al. (1995). 
65 
1.7. AIMS OF THE STUDY 
1). To characterise the electrophysiological and pharmacological properties of whole-cell 
voltage-gated Caý' channel currents in human myometrial smooth muscle cells (RMSMCs) 
from pregnant women. 
2). To characterise the C2" channel antagonist properties of the COX-2 selective 
cyclooxygenase inhibitor nimesulide in IMSMCs from pregnant women, with respect to 
its ability to inhibit spontaneous myometrial contractions in vitro and its potential for 
tocolysis. 
3). To dissect the components of the whole cell outward W current in HMSMCs with 
respect to sensitivity to TEA and 4-AP and speed of decay (transient or sustained), and 
compare them in HMSMCs from pregnant and non-pregnant women. 
4). To further characterise, the transient 4-AP sensitive outward K' current (A-current) and 
its relationship with inward C2' current in HMSMCs. 
5). To provide preliminary evidence for glibenclamide-sensitive W current in HMSMCs. 
6). To provide finiher detailed electroPhysiological and pharrmcological characterisation 




Electrophysiology Theory, Methods and 
Materials 
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2.1. TISSUE COLLECTION AND CELL ISOLATION 
2.1.1. TISSUE COLLECTION 
Approval for the use of human myometrial samples from St Thomas', and occasionally 
from Guy's or Queen Charlotte's Hospitals, London, was obtained from the respective 
Ethics Committees. Written, informed consent was obtained from patients prior to surgery. 
Myometrial biopsies were taken from the middle of the upper edge of the lower segment 
incision in pregnant women undergoing routine elective caesarean section at term but not 
in labour (38-40 weeks). 'Me commonest reasons for caesarean section were breech 
presentation or the mother having had a previous elective section. Samples were also taken 
from non-pregnant women of pre-menopausal age (<45 years) at hysterectomy. Biopsies 
were collected, transported and stored in physiological saline solution (PSS, with 1.5 mM 
CP see 2.5. ) at 4 `C . The samples were chopped into small 1-2 rnrný pieces and stored in 
PSS at 4 'C for up to 2 days prior to use. There was no evidence to indicate that storage 
for this period of time altered the amplitude or characteristics of currents under 
investigation in this study. 
2.1.2. CELL ISOLATION 
5-6 tissue pieces were incubated in nominally Ca2'-free PSS (PSS containing 50 pM Caý+ 
see 2.5. ) for 20 min at 37 'C, then transferred to a2 ml mixture of collagenase type 1 (2.5 
mg, 289 U/mg, Sigma) and collagenase type M (2.5 mg, 1450 U/mg, Sigma) in nominally 
C2+4ree PSS for 50-60 min at 37 *C. After the enzymatic digestion, tissue pieces were 
transferred to 4 ml of fresh nominally C2+4ree PSS, allowed to cool slowly to 4 OC and 
then dispersed by gentle trituration (sucking up and down through a wide-bore pipette). 
Cells were stored at 4 *C for up to 6 hours prior to use. For each experiment, 0.2 - 0.5 ml 
of cell suspension was placed on a glass coverslip fixed to perfusion chamber and cells 
were given 5-10 min to settle before perfusion was begun. 
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2.2. WHOLE CELL PATCH-CLAMP METHOD 
2.2.1. THEORY 
The principle of patch clamping is to maintain a potential difference across the cell 
membrane that is set by a user-defined command voltage. In voltage-clamp, voltage is 
controlled and the resultant flow of ions producing a current is measured. In current clamp 
by contrast, a constant controlled flow of current is put through the cell membrane and 
changes in membrane potential that result are measured. 
From an electrical point of view, the cell membrane may be considered as a variable 
resistor (R. ) and a capacitor (C. ) in parallel with each other and in series with the 
resistance of the pipette (series resistance or Rs) (Fig 2.1. ). Total membrane current (I. ) is 
equal to current through the resistor (Ij) plus the capacity current (1c). Ac however, is 
transient, only existing when the capacitor is charging or discharging. The amplitude of Ic 
changes with respect to the change in voltage with time: 
Ic = C, - dVldt. (Equ. 2.1. ) 
The patch clamp method used in this study was first described by Hamill et aL, (1981). 
Previous methods used two high resistance intracellular electrodes, one to measure the 
potential difference across the cell membrane and the other to inject current and maintain 
the cell voltage at the command level. In whole cell patch clamp a single low resistance 
pipette electrode is used to perform both functions. This, in theory, allows the induced 
potential difference across the pipette electrode to be maintained while simultaneously 
measuring the current. Voltage "clamping" is performed by an operational amplifier in the 
headstage. This compares two input voltages, Vc the user-defined command voltage and 
Vp the measured pipette voltage, and outputs a single voltage Vo which is proportional to 
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the difference between Vc and Vp. Input Vp and output Vo are connected via a negative 
feedback resistor (Rf) where the signal fed back to Vp through the resistor is proportional 
to Vo. This feedback drives Vp towards Vc, thus controlling the pipette voltage. (Fig 2.2. ). 
FIG 2.1. CELL MEMBRANE AS AN ELECTRICAL CIRCUIT 
Rs = series (pipette) resistance 
Rm = membrane (input) resistance 
Cm = membrane capacitance 
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Because of the high feedback resistance of the amplifier (500 MCI), any current flowing 
through the cell membrane and hence the pipette input, is equal and opposite to the current 
flowing through the feedback loop (If). The current across the membrane can therefore be 
measured as the voltage drop across Rf. The time it takes for Vo to settle to a final value is 
determined by the size of the feedback resistance (Rf) and its associated capacitance (CRf) 
where T= RfCRf. Clamping of the pipette potential is accelerated and accuracy of current 
measurement is improved with the involvement of additional amplifiers in a boost circuit, 
wherein the relatively low frequency cycling of Rf is increased and junctional potentials 
between the pipette electrode and surrounding solutions are cancelled (see below). 
Despite the boost circuit however, clamping at the cell membrane is still relatively slow 
because of the time it takes to charge the ceH capacitor, wherein T= RpC.. Under voltage- 
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clamp therefore, membrane potential remains constant at a user-specific value (Vc) 
assuming that Vp=Vc. This is only true if current causes a negligable voltage drop across 
the pipette resistance. * 
2.2.2. PIPETTE AND CELL CAPACITANCE 
There are two main types of capacitance, the fast capacitance and the slower cell 
membrane capacitance. The fast capacitance is composed of 1) capacitance across Rf, as 
described above, 2) other sources within the amplifier, 3) across the holder and pipette to 
adjacent grounded surfaces and 4) across the pipette wall to the bath solution. The fourth 
type of fast capacitance may be reduced by increasing the thickness and hardness of pipette 
glass and by coating the tip of the pipette with Bee's wax or other hydrophobic substance. 
Capacitances generated within the amplifier and across Rf however, have to be 
compensated electronically and there is a circuit within the amplifier for this purpose. This 
is performed routinely for each new pipette immediately after Giga seal formation. 
Cell capacitance, as described above, results in slow voltage clamp and may also obscure 
fast activating currents. There is also a parallel circuit for slow or cell capacitance 
compensation. This was not routinely used in this study because cell capacitance was 
occasionally found to be too large for the compensation circuit and because there is the 
chance that small changes in series resistance during the experiment (which slow the decay 
of the capacitance artefact) will potentially result in overcompensation. Cell capacitance in 
human myometrial cells was calculated from the area under a capacitive current induced by 
a -10 mV step from a holding potential of -50 mV where: 
C. (pF) = area (pA. ms)/step size (mV) 
In 382 cells, C. was 98.7± 3.4 pF. 
(Equ. 2.2. ) 
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2.2.3. SERIES RESISTANCE 
Series resistance (which is equivalent to the pipette resistance in series with the membrane 
potential in the patched cell (Fig 2.1. ), was calculated in human myometrial cells by 
measuring the decay rate (r) of the capacitative current induced by a -10 mV step from a 
holding potential of -50 mV: 
In 382 cells, r was 1.06 ± 0.04 ms and, using the equation: 
Rs(Mf)) =, r(ps)/C,,, (pF) 
Rs was 10.9 A: 0.3 MQ. 
(Equ. 2.3. ). 
The series resistance is a source of error in membrane potential control. This is because, as 
has been described above, it is the pipette potential not the membrane potential which is 
clamped at the command voltage (Vc). If Rs, which is in series with Vp, is high there will be 
a large voltage drop across Vp. According to Ohm's Law, this voltage drop will be 
proportional to both Rs and membrane current (1), where: 
V(mV) = Rs (MCI) 01 (pA). (Equ. 2.4. ) 
In pulmonary artery myocytes, the voltage discrepancy between Vc and Vp as measured 
with a second microelectrode was shown to be virtually identical to the predicted value 
(Smirnov & Aaronson, 1994). In addition, since Rs is in series with C., and the time 
constant of C. decay, r, is equal to RsC., a large Rs would result in slower clamping of 
voltage. There is a circuit for series resistance compensation in the wnplffler and, in early 
experiments, compensation was attempted. Unfortunately this did not prove useful in this 
study because small changes in series resistance (increase or decrease) during experiments 
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resulted in severe "ringing" capacity current oscillations. However, in this study, peak 
amplitudes of myornetrial, C2+ channel currents were never greater than I nA and 
amplitudes of W channel currents at the most depolarised membrane potential (usually 
+60 mV) were on average no greater than I nA. This means that the inaccuracy in steady- 
state voltage clamp (Equ. 2.4. ) was on average no greater than 10 mV. Attempts were 
made to minimise Rs principally by using pipettes with as low a resistance as possible while 
still achieving a good Giga-seal (see below). 
2.2.4. MEMBRANE RESISTANCE 
Membrane or input resistance, which is equivalent to the resistance of the cell membrane 
to the passage of ions, was estimated in 18 HMSMCs, using normal physiological saline as 
bath solution and a high W pipette solution. In the whole cell configuration, the mean of 
current measured at -90, -80 and -70 m. V (potentials as which no active current would be 
expected) in each cell was calculated. Using the equation: 
R. = (Vm-E, )II Equ 2.5. 
where R. is the membrane resistance, V. is the membrane potential, E, is the reversal 
potential (-83 mV) and I is current, R. was calculated in 18 cells as 0.96 ± 0.19 M. 
2.2.5. JUNCTION POTENTIALS 
The potential recorded by a microelectrode in the bath solution (when compared to the 
grounded reference electrode) should ideally be zero. There is however an offset potential 
that arises from potential differences at the junction between the silver electrode and the 
pipette filling solution and between the pipette filling solution and the bath solution 
Ounction potentials). The potential between the silver electrode and pipette filling solution 
is minimised by coating the electrode with silver chloride making it a non-polarisable, 
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reversible Ag/AgCI electrode. The potential between pipette flag solution and bath 
solution is influenced by the properties of the glass pipette and the size of the tip opening, 
causing restriction of ionic movement in and out of the pipette, and can therefore be 
minimised by using wide, low resistance pipettes. The remaining offset potential is 
compensated for by a potentiometer in the patch-clamp amplifier which adds +/- m. V to the 
command potential while the pipette is in the bath solution. The reference electrode is also 
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Ag/AgCl in composition. 
2.2.6. GIGA-SEAL AND WHOLE-CELL PATCH FORMATION 
The procedure for producing whole-cell patches is summarised in Fig 2.3. A very high 
resistance seal of the pipette tip (usually several Giga Ohms (GO)) onto the cell surface is 
achieved by prior heat-polishing of the pipette tip by bringing it close to near-red hot 
platinum wire for a few seconds and attempting to produce dispersed cells free of 
extracellular connective tissue proteins. The resistance is monitored by applying a 
continuous rapid 10 mV step and observing the amplitude of the current step induced. 
With the pipette in the bath, current amplitudes range from 1-3 nA, giving pipette 
resistances of 3-10 MO. The pipette tip may be kept clean by applying slight positive 
pressure while lowering the pipette towards the cell. Giga-seal is usually achieved by slight 
suction after initial contact of the pipette with the cell. When suction is applied, the current 
amplitude is reduced to between 0.5 and 2 pA, giving seal resistances of between 5 and 20 
GO. 
Following Giga-seal formation, slightly stronger suction is applied to the pipette in order 
to rupture the patch of membrane contained within the tip of the pipette and gain electrical 
access to the inside of the cell. Successful electrical access to the cell interior is determined 
by the appearance of large cell capacititive current transients. The advantages of high seal 
resistances are two-fold. Firstly, the background noise is reduced allowing small currents 
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FIG. 2.3. PROCEDURE FOR TIGHT-SEAL WHOLE-CELL PATCH 
FORMATION 
Plipeft 











(-I pA) to be recorded, and secondly, the inner surface of the cell membrane becomes 
electrically isolated, allowing it to be voltage-clamped without the need of a second 
microelectrode (Sigworth & Neher, 1980). 
2.2.7. PIPETTE PULLING 
Electrode pipettes were pulledfrom 225 pcs. borosilicate glass capillaries (1.5 mm O. D. x 
0.86 mm I. D., Clark Electromedical Instruments) using a two-step heat-adjusted pipette 
puller (Narishige, Japan) and polished with a hot platinum wire. 
2.2.8. ELECTROPHYSIOLOGY SET-UP 
Pipettes were fixed and supported in an HL-U pipette holder connected to the headstage. 
The holder was connected to a valve-operated syringe for the application of suction. 
Vibration was minimised by mounting both microscope (Nikon Diaphot 300) and micro- 
manipulator (NT-285, Sutter Instrument Company) on a gas-inflated table (Melles Griot). 
50 Hz electrical noisewas minimised by surrounding sensitive equipment in a Faraday cage 
and grounding to the amplifier signal ground socket. Cells were continuously perfused 
with bath solution with an approximate flow rate of I n-A per minute (input by gravity feed 
and output by vacuum pump). Exchange of solutions was rapid: complete exchange, as 
assessed by monitoring the change in pipette resistance when saline was replaced with 
distilled water, was in 10-20 seconds. The organisation of the electrophysiology set-up is 
surnmarised in Fig 2.4. (below). 
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2.3. SOLUTIONS AND CHEMICALS 
2.3.1. BATH SOLUTIONS FOR Ca 2* AND K+ CHANNEL CURRENTS 
The standard constituents of bath solutions are listed in Table 2.1. C2' channel currents 
were recorded using either 1.5 mM C2+ (Ac. ) or 10 mM BP (IB. ) as charge carrier. Ac. 
and AB. were recorded in the presence of 4 mM TEA and I mM CsCl to inhibit residual 
current. 
78 
TABLE 2.1. BATH SOLUTIONS FOR RECORDING Ca 
24' 
AND K+ 















NaCI 120 120 130 130 
KCI - - 5 5 
MgC12 1.2 1.2 1.2 1.2 
CaCI2/BaCI2 1.5 (Ca 2+ 10 (Ba+) 1.5 (Ca 2+) 0.015 (Ca+) 
CSCI 1 1 
TEA-Cl 4 4 - - 
HEPES 10 10 10 10 
glucose 10 10 10 10 
K+ channel currents were recorded using norrml PSS or Ca 2+ -free PSS. The same two 
solutions were used for storage and enzymatic dispersal of myometrial tissue, respectively. 
Any additions or alterations to bath solutions are described in the relevant chapters. All 
bath solutions were corrected to pH 7.4 with NaOH unless otherwise stated in individual 
chapters. 
2.3.2. PIPPETTE SOLUTIONS FOR Ca 2+ AND K+ CHANNEL 
CURRENTS 
The standard constituents of the pipette solutions are listed in Table 2.2. For Ic, or IB., 
NaCl was replaced by CsCl to inhibit outward Ký currents and isolated inward Caý' 
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currents. ATP was present in pipette solutions to prevent run-down of C2+ channel 
current by acting as a substrate for channel phosphorylation by kinases (Lorenz & Paul, 
1997). Mg2' was also required as a co-factor for phosphorylation. The combination of 1.5 
mM CW+ and 10 mM ethylene glycol-bis(P-aminoethyl ether)-N, NN', N'-tetraacetic acid 
(EGTA) in the pipette solution resulted in a free intracellular Caý' concentration of 8 nM 
(Fabiato & Fabiato, 1979). Any additions or modifications to pipette solutions are 
described in the relevant chapters and, unless otherwise stated, pipette solutions were 
buffered to pH 7.2 with NaOH. All pipette solutions were filtered (0.2 pM pore size) 
immediately prior to use to avoid clogging of the pipette tip. 
TABLE 2.2. PIPETTE SOLUTIONS FOR RECORDING Ca 2+ AND K+ 
CHANNEL CURRENTS (mM) 
Pipette solution For Ical/Ba For IK 
cSCI 135 - 
KCI - 110 
MgC12 2.5 2.5 
MgATP 5 1 
CaC12 1.5 - 
HEPES 10 10 
EGTA 10 10 
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2.3.3. DRUGS AND CHEMICALS 
Paxilline, tetraethylammonium. (TEA), 4-aminopyridine (4-AP), oxytocin, indomethacin 
and prostaglandins F2,, and E2 were all purchased from Sigma UK. Clofiliurn tosylate was 
obtained from R. B. I. Research Biochemicals (Natick, MA, USA). Nimesulide (N-(4-nitro- 
2-phenoxyphenyl)-methane-sulfonilaniide) was a gift from Dr Robert Sawdy (Queen 
Charlottes Hospital, London). Mibefradil {(IS, 2S)-2-[2[3-(2-benzimidazolylpropyl) 
methylamino]ethyl]-6-fluoro-1,2,3,4-tetrahydro-l-isopropyl-2-mphthyI methoxyacetate 
dihydrochloride) was a gift from Dr Mike Shattock (Rayne Institute, London). PSS 
constituents were obtained from BDH (Poole, UK). Nimesulide, indomethacin, paxilline, 
clofilium, 4-AP and the prostaglandins were prepared from stock solutions in 
dimethylsulphoxide (DMSO). All other drugs were dissolved in distilled water. 
2.4. DATA AQUISITION AND ANALYSIS 
Currents were recorded, via CV 203BU headstage, Axopatch 200B amplifier and Digidata 
1200-series interface (Axon Instruments Inc., CA, USA), onto computer (Elonex MTX- 
623351), using pCLANT version 6.03 (CLANTEX component) software (Axon 
Instruments Inc. ). 11igh frequency noise was reduced during recording with the amplifier 
lowpass bessel filter set to I KHz for C2' currents or 2 or 5 KHz for W currents. 
2.4.1. TRACE ANALYSIS AND LEAK SUBSTRACTION 
Raw data was analysed using the CLAWFIT component of pCLAW 6 software. Data 
(current measurements or selected traces) was then exported, first into Microsoft Excel for 
statistical analysis, and then into SigmaPlot (version 4.1. ) for non-linear regression curve 
fitting and/or graph plotting (see relevant chapters for curve equations). 
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Leak subtraction was performed in CLAWFIT, rather than during recording. Currents 
were only recorded from cells where the passive "leak7' (defmed as current flowing at 
membrane potentials not expected to open voltage-sensitive ion channels under the 
conditions used) was below acceptable levels. This was usually less than 10 % of total 
current. CLAWFIT contained an algorithm which, using the measured current at the 
holding potential (either -50 or -80 mV) and the estimated input resistance (assumed to be 
a linear relationship between leak current amplitude and membrane potential), calculated 
the component of leak current scaled to all points in the voltage protocol and subtracted 
this from the current trace. The advantage of this technique was that changes in leak from 
one trace to the next could be corrected individually. 
2.4.2. STATISTICS 
Statistical comparisons between two sample means were made using Student's two-tailed 
un-Paired West when comparing groups of data derived from different cells, or two-tailed 
paired t test when comparing groups of data obtained from the same cells. Comparisons 
between three or more sample means were made using two-tailed. analysis of variance 
(ANOVA). Differences were considered significant when P< 0.05. 
AR data are expressed as the mean and standard error of the mean (S. E. M. ).. 
82 
Chapter 3 
Calcium Channel Currents in HMSMCs of 
Pregnant Women 
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3.1. METHODS AND RESULTS 
3.1.1. EFFECT OF Ba2+ AND Cd 2+ ON INWARD CURRENT IN 
HMSMCS 
All experiments in this chapter were performed with freshly dispersed EMSMCs from 
pregnant women at term who were not in active labour. Experiments in this chapter were 
performed using the CsýA-containing PSS bath solutionwith either 1.5 MM C2' for 
Ac., or 10 mM 132' for IB. (Table 2.1. ), and the Cs+-containing pipette solution, designed 
to inhibit W currents (Table 2.2. ). The inward current recorded from a holding potential 
(VH) of -50 mV via a depolarising step to 0 mV with 1.5 mM C2+ in the bath solution (Ac. ) 
was enhanced by replacement of C2+ with 10 mM B2+ (IB. ). Peak current amplitude 
(measured at 20-30 ms for Ac. or 30-50 ms for IB. ) in 6 cells was increased 5.9 ± 1.2 times. 
In addition, decay of IB. was significantly slower than that of Ac.. In the 6 cells, current at 
the end of 300 ms depolarisations to 0 mV had decayed by 99 -J- 11 % in CP and by 62.7 
± 6.9 % in B2+ (P <0.05). 
Ca 2+ channel current was also inhibited in a dose dependent fashion by CdCI2, both Ic. and 
IB. being inhibited by micromolar concentrations. The dose-dependence of the effect on Ic, 
was determined at +10 mV from VH-50 mV (Fig 3.1. ). The data in Fig 3. LB is fitted to a 
4-parameter logistic function (Langmuir equation): 
y= (I 00-a)l(l + ((ECso/x)Ab)), equ. 3.1., 
where y is the percent inhibition at each concentration, x is the micromolar concentration, 
EC5o is the half-maximal inhibitory concentration, a is the residual component of inhibition 
and b is the HiH coefficient. 
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The ECso of the fitted curve was 1.47 VK a was 4.64 and the HUI coefficient was 1.4. 
Complete inhibition of all inward current by CdCI2 (either Ic, or IB., see Fig 3. I. C) was 
achieved with 50 pM or higher. Block with CdCl2was completely and readily reversible 
(not shown). Because of the greater current amplitude and consequent ease of analysis, 
most of the subsequent CW' channel current experiments were performed with B2' as the 
charge carrier (IB. ). 
3.1.2. ELECTROPHYSIOLOGICAL CHARACTERISTICS OF 1B. 
The electrophysiological characteristics of Caý' channel currents (using IB. ) were 
determined by investigating the voltage-dependence of activation (with current voltage (I- 
P)-relationships) and inactivation (availabilities). Figure 3.2. shows the I- V of IB., from VH 
-80m. V and -50 m. V (Figure 3.2. A). The current activated at a relatively negative potential 
(-60 m. V) from VH -80 mV, and demonstrated an initial rapid component of decay which 
was not apparent when the holding potential was -50 mV, in which case the apparent 
threshold of activation was around -40 rnV. When the currents elicited from VH -50 mV 
were subtracted from the currents evoked from VH -80 mV, a rapidly inactivating current 
with negative threshold of activation was observed. This rapidly-inactivating component of 
current reached a maximal amplitude at -20 rnV, while the slowly-inactivating current 
evoked from VH -50 rnV reached its peak between +10 and +20 mV (Figure 3.23). The 
differences in kinetics and voltage-dependence of current activation are suggestive of T- 
type and L-type currents respectively. The terms T-component and L-component are 
hereafter used to describe the two current components. The difference in decay rate of L- 
and T-components of IB. was confirmed by fitting current traces to a single component 
exponential function: 
y= A*exp(-t*, r) +B equ 3.2., 
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where A is the current amplitude at any given time point, t is the time point, r is the rate 
constant and B is the non-decaying component. r for the L-component at +10 rnV from MH 
-50 mV (211 ± 29 ms, n 12) was significantly greater than for the T-component at -20 
m. V from VH-80 m. V (37 4 ms, n= 7) (P < 0.001). 
Figure 3.3A shows the availability of IB. at +20 mV and -20 rnV test potentials, observed 
6, tt-wcaan 
using a range of 5s conditioning potentials from -100 mV and +20 mV. The current at 
+20 m. V, measured at its peak (shown in Fig 3.3. B, open squares), demonstrated a 
biphasic inactivation curve which was fitted with a double component sigmoidal equation 
(also known as a Boltzmann function): 
y= A/[ I+ (exp((V. - Vo. 5T)IkT)] + B/[ I+ exp((V. - 
VO. 5L)IkL)l +C Eqn 3.3., 
where y is the normalized current at any potential, V. is the membrane potential, VO. ST and 
VULare the half-inactivation potentials, kTand kL are the slope factors of the low threshold 
(A, T-component) and high threshold (B, L-component) currents, respectively; and C is 
the component of current not inactivated. V03Twas -68.4 ±4 MV and VO. ST Was -19.4 d: 2 
mV. kTwas 6.72 + 1.3 mV and kL was 6.73 ± 0.85 mV. The A component was 36.8 ± 6.8 
% and the B component 56.5 ± 7.3 % of the total current in 9 cells. 
The T-component should be most obvious at the peak of the current, and also at more 
negative test potentials, where it is prominent and the L-component is only slightly 
activated. Conversely, the L component should predominate at more positive test 
potentials, and at the end of the pulse (300 ms), since the T-component will have almost 
completely inactivated. The availability of the end-of-pulse current at a test potential of 
+20 m. V (L-component, filled squares) was therefore compared with that of the peak 
current at a test potential of -20 mV (T-component, filled circles), elicited following 5 sec 
conditioning potentials, using as ingle component Boltzmann function: 
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y= A/[I+exp((V, -Vo. s)/k)`]+A Eqn 3.4. 
The end of pulse currents at the +20 mV test pulse had a high voltage-range of inactivation 
(Vo. 5 = -16.4 d: 7.6 mV, k=7.65 d: 1.0 mV, A=9.22 ± 3.84 %, n--8; Figure 33B, solid 
squares). By contrast, the peak currents at the -20 mV test pulse had a low threshold of 
inactivation (Vo. s = -65.3 ± 1.8 mV, k=4.94 ± 2.4 mV, A=5.46 ± 0.54 %, n---6; Figure 
33B, solid circles). These values were not significantly different than the VO. 5T and VO. 5L 
derived from the double-component Boltzmann fitting of the overall current peak at +20 
Mv. 
Taken together, the results of Figures 3.2. and 3.3. indicate that HMSMCs exhibit two 
distinct components of CW' channel current; a T-type component with negative ranges of 
activation and inactivation and a rapid decay, and an L-type component with more positive 
ranges of activation and inactivation, and slower inactivation kinetics. 
3.1.3. PHARMACOLOGY OF L- AND T-COMPONENTS OF IBS 
Mbefradil, a reportedly T-type selective C2' channel antagonist inhibited both T- and L- 
components of IB. in I-IMSMCs. This inhibition was apparently voltage dependent. 300 ms 
duration currents were recorded in 4 cells over a range of membrane potentials from VH - 
80 mV. Figure 3.4A shows an example of the effect of I PM mibefradil on currents at 
potentials from -50 m. V through to +40 m. V at 10 mV increments. At -50, -40, -30 and -20 
mV the transient low threshold T-component which predominated at these potentials was 
nearly completely blocked, whereas the high threshold slowly decaying L-component, 
which began to emerge at -20 and -10 rnV was poorly affected at those potentials. At 
potentials above 0 m. V however, where the L-component predominated, inhibition was 
enhanced as the membrane potential became more positive. In addition, the decay rate of 
the L-component at potentials positive of 0 mV was increased by I pM mibefradfl. For 
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example, from fitting cuffents to a single exponential decay (equ. 3.2), T, at +20 mV, was 
89 ±4 nis in PSS vs. 54 ±8 ms in mibefradiL P<0.01, and at +30 mV, it was 86 -+ 5 ms in 
PSS vs. 55 ±8 ms in the presence of nubefradiL P< 0.05, in the 4 cefls studied. 
These currents were measured at the peak (30-50 ms) and end of pulse (275-300 ms) in 
the presence of 0 (PSS), 0.1 and I pM mibefradil, normalised to the current amplitude at 0 
mV in PSS and surnmarised in Figure 3.4B (peak) and 3.4C (end of pulse). The apparently 
greater inhibition of the T-component (at -30 mV, peak) than of the L-component (at +10 
mV, peak) by 0.1 pM mibefradil was statistically significant (% inhibition at -30 mV was 
62.5 ± 11.5 % vs. 35.9: 1: 9.7 % for +10 mV, P< 0.05 by paired West, n= 3). The L- 
component was clearly blocked by I pM rnibefradil more potently at the end of the pulse 
than at the peak, although this was only statistically significant at 0 mV (P < 0.05, n-- 4). 
Furthermore, at the end of the pulse (Figure 3.4C), where the L-component predominates, 
the potential of maximum current amplitude was apparently shifted to the left by 
approximately 10 mV, as indicated by the enhancement of end of pulse current by 0.1 PM 
mibefradil at -20 mV (current increased by 55.5 : 1-- 21.5 %, P< 0.05, n---3) compared to 
inhibition at potentials positive of -10 mV (eg. current inhibited by 79 A: 16.6 % at +20 
mV, P<0.01, n--3). 
Availability experiments in the presence of mibefradil were not performed. However, an 
effect on the voltage-dependence of inactivation of the L-component in 4 cells was 
suggested by the near complete inhibition of the L-component at +20 m. V (both peak and 
end of pulse) remaining in the presence of I gM mibefradil when the VH was -50 mV, its 
partial recovery (but with faster decay than in control currents) when the holding potential 
was lowered to -80 m. V (without changing the test potential), and then its block again 
when the VH was returned to -50 m. V (Fig 3.41)). 
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3.1.4. FAST Na+, CURRENT IN HIVISIVICS 
To determine whether a fast Ne current contributed to the low threshold transient T- 
component of IB., current was recorded at -20 mV from VH-80 mV in the presence of Ne 
and then when NaCl in the bath solution was replaced by TEA-Cl. In three cells, removal 
of Ne did not inhibit the current (not shown). Furthermore, inhibition of AB. with I IiM 
mibefradil in the same cells did not reveal a very rapidly activating and inactivating inward 
current. In a very few cells however (5 out of approximately 150 cells), a very rapidly 
activating and inactivating inward current superimposed on the L-component was 
observed, suggestive of a Ne current. The current voltage relationship in one cell, with 
normal 132ý- and Ni*- containing bath solution, is shown in Figure 3.5. From VH-50 mV, 
two components to the current are clearly visible. The fast component (IN. ) decayed within 
10 ms and the slow component (L-component of IB. ) was only partially decayed after 
300ms. IN. in this cell activated at potentials positive of -30 mV, reached a maximum 
amplitude at +10 mV and appeared to reverse at around +501+60 mV. The availability of 
IN, in the same cell was also performed. Inactivation was voltage-dependent with a V0.5 Of - 
3 1.1 mV (using equ 3.4). INý, inactivation rate was estimated in 5 cells by fitting currents at 
+10 mV from VH -50 mV to a single exponential function (using equ. 3.1). The decay 
constant (tau) of this very fast current was 2.01 :h0.11 ms. This compares with the T- 
component of IB., which is present in the vast majority of cells, of which tau was 37 ±4 
ms in 7 cells. 
3.1.5. SPONTANEOUS AND OXYTOCIN-INDUCED CHANGES IN 
Ica AND /BaAMPLITUDE 
In order to examine the effect of oxytocin on Ic. or IB,, and at the same time to determine 
the stability of current over long periods, 300 or 500 ms currents at -10 or 0 mV from VH - 
60 mV were recorded at a frequency of 0.1 Hz for up to 15 min in 18 cells (9 with Ic, and 
9 with IB. ). Current amplitude was estimated using the area enclosed by each current trace 
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(the integral). In the majority of cells, after an initial run-up, current amplitude was steady 
for prolonged periods with no evidence of run-down (Fig 3.6A), and on average there was 
a small degree of run-up (in 132' 12 ± 20% at 5 min, 18 ±31% at 10 min and 17 :h 32% at 
15 min, n=6, and in CP 12 4- 13% at 5 min and II± 11% at 10 min, n= 4). In a small 
proportion of cells however (6 out of 18 cells), oscillations in current amplitude both in Ac. 
(n = 2) and 1B. (n = 4) occurred, apparently spontaneously (Fig 3.6B), sometimes after a 5- 
10 min period of quiescence. These oscillations varied in amplitude (between 20 and 60 % 
reduction of current amplitude at the trough of the oscillation), occurred approximately 
once every 1-2 min and continued throughout the recording period. 
To test the buffering power of the 10 mM EGTA in the pipette, the effect of 5 pM (in 3 
ceM) and 10 pM (in 3 cells) cylcopiazonic acid (CPA, an SR C2ATPase inhibitor) in the 
bath solution on 1B. was determined. In all 6 of these cells, no spontaneous oscillations in 
AB. were observed during a 10-20 min recording period, but CPA, applied after the control 
period, inhibited IB. (27.8 17.3 % by 5 VM and 31.1 ± 7.3 % by 10 pM, inhibition of 
integrated current), suggesting that even after at least 5 min perfusion in C2' free PSS and 
dialysis with 10 mM EGTA, intracellular C2' may stiR be released in sufficient quantity to 
inhibit the Q? ' channel current. This inhibition was not reversible after 5-10 min washout 
of CPA. In a further 3 cells, IB. was recorded with 30 mM EGTA, 20 mM 1,2-bis(2- 
aminophenoxy)-ethane-N, N, N'N'-tetraacetic acid (BAPTA) in the pipette solution to 
more firmly buffer intraceRular C2' and with heparin in the pipette solution to prevent 
release of C2+ from internal stores. Despite these measures, spontaneous oscillations still. 
Occurred in two of three cells. 
6 
The effect of 30 nM oxytocin (01) was examined in 15 cells (6 in Ac. and 9 in AB. ), in 
which the current was not oscillating when OT was added. In 10 cells (5 with Ac. and 5 
with AB. ) OT produced sigrlificant inhibition of the current (example in Fig 3.7A). This 
inhibition had two components, a transient component (inhibition was 64.6 ± 16.5 % for 
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Ic, and 58.7 ± 13.2 % for AB. ) followed by a sustained component (inhibition was 23.5 + 
3.4 % for 1c. and 26.2 ± 6.5 % for AB., see Fig 3.7. for statistics). Measurements of current 
density for these cells in the control period, during the transient and sustained components 
of the inhibition by OT and after washout, are presented in Figures 3.713 and 33C for 1c. 
and IB., respectively. In two cells, after an initial transient inhibition OT appeared to induce 
oscillations in Ac. (I cell) and IB. (I cell) that were similar in appearance to the spontaneous 
oscillations in other cells (not shown). These oscillations persisted after OT was washed 
out. 
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FIG. 3.1. EFFECT OF CADMIUM OM Ica AND /Ba IN HMSMCS 
Ca 2+ channel currents elicited by 250 ms depolarisations from VH-50 mV to +10 ' 
mV using either 1.5 mM Ca 
2+ yCa) or 10 mM Ba 
2+ (1u) as charge carrier. An 
example of the cumulative dose-dependent inhibition of Ica by 1,2,5 and 10 pM 
CdC12 (indicated by arrows) is shown in A and the mean ± S. E. M. inhibition of 
integrated current (pA. ms) in 7 cells is shown in B. The effect of 50 pM CdCl2 



















FIG 3.2. CURRENT VOLTAGE RELATIONSHIP OF lBaIN HMSMCS. 
A: Currents elicited by 300 ms depolarizations to between -60 mV and +60 mV in 
a representative cell, from VHof either -80 mV or -50 mV, and the difference 
(subtracting currents from VH -50 mV from currents from VH -80 mV). B: Peak 
amplitude of currents held at -80 mV (V), -50 mV (0) and the difference (0), 
normalised to the +10 W pulse from the -50 mV holding (mean :tS. E. M. in the 
same 6 cells). The dotted lines represent zero current. 
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FIG. 3.3. AVAILABILITY OF Ca 2+ CURRENTS IN HMSMCS 
Availability of /B., in HMSMCs. A: Currents in a representative cell elicited by 300 
ms depolarizations to +20 mV or -20 mV follovving 5s preconditioning pulses to 
between -100 W and +20 W. B: Points are the mean ± S. E. M. of peak current . 
at -20 mV (0, n=6), peak current at +20 MV (C3, n=9) and currents at the end of 
the 300 ms +20 mV depolarization (0, n=9). Data is normalised to the current 
elicited following the -100 mV preconditioning pulse and fitted to single or double 
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FIG 3.4. EFFECTS OF MIBEFRADIL ON L- AND T-COMPONENTS 
OF 113a. 
A: 300 ms currents at a range of membrane potentials from VH -80 mV in the 
absence (black traces) and presence (red traces) of 1 pM mibefradil. The dotted 
lines represent zero current. B&C: Current voltage relationships at -80 mV, 
showing the current in PSS (0) and the effect of 0.1 ( )) and 1 pM mibefradil (V) 
on current at peak (B, 30-50 ms) and end of pulse (C, 275-300 ms) in 4 cells, 
plotting the mean and S. E. M. of measurements, normalised to 0 mV in the 
absence of mibefradil. D: The effect of changing holding potential on block of /Ba 
by mibefradil. From left to right: 200 ms current at +20 mV from VH -50 mV; block 
by 1 pM mibefradil (mib) at +20 mV from VH -50 mV; partial recovery from block 
in continued presence of mib at +20 mV when the VHwas changed to -80 mV; 
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Fig. 3.5. Na"' current in HMSMCs 
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Example of current voltage relationship of fast inward current (/Na). A: 300 ms 
currents at potentials between -60 and +70 mV from VH-50 W. B: Some of the 
same traces as in A, showing only the first 20 ms. Dotted lines represent zero 





FIG. 3.6. OSCILLATING AND NON-OSCILLATING INWARD 
CURRENT IN HMSMCS 
Examples of the two ways in which the amplitude of 1c. and /Ba (measured as 
integrated current) may change with time, recorded at 0W from VH -60 rnV, 
once every 10 seconds. In both cells the period of current run-up is not shown. 
A: In this cell (with 1.5 Ca 2+ in the bath solution), a steady non-oscillating current 
occurs. B: In a different cell (with Ba 24- in the bath solution), a spontaneous 
oscillating current occurs. The insert shows currents representative of the peak 
(p) and trough (t) of an oscillation (indicated by arrows). The dotted line 
represents zero current. In this cell, though not in all, the oscillations began 
almost immediately after recording began (see text). Not all cells with Ica were 
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FIG 3.7. EFFECT OF OXYTOCIN ON /Ba AND 1c. IN HMSMCS 
A: Example of the effect of oxytocin (OT) on /Ba in a representative HMSMC. The 
arrows point to the measurements of representative current traces at each time 
point that were taken for statistical analysis: I= control period, 2= transient 
component of inhibition, 3= sustained component of inhibition and 4= washout. 
The dotted lines represent zero current. The mean and S. E. M. of current 
densities from each of these four time points are plotted in B (Ica, n= 4) and C 
(/B., n= 5). The asterisks indicate significant inhibition of current with respect to 
























3.2.1. L- AND T-TYPE Ca2+ CHANNEL CURRENTS 
L-type Caý' channel current is abundant in I-IMSMCs. This is demonstrated by the effect of 
replacing C2+ with B2+ in the bath solution. The two effects of B2% namely increasing 
current amplitude several-fold and decreasing of current inactivation rate confirm the 
earlier work of Jmari et al. (1986) who, using sucrose gap in strips of pregnant rat 
myornetrium, first demonstrated the voltage- and C2+-sensitive components of L-type 
C2+ current inactivation. The very high sensitivity of current (recorded from VH -50 mV) 
to micrornolar or even sub-micromolar concentrations of CdCl2 is also characteristic of L- 
type C2+ current (Arnedee et al., 1987; Honore et al., 1989) The effect of Cd2' on the T- 
component of IB. was not determined in the present study, although in non-pregnant rat it 
has been shown to be more sensitive to Ne+ than to Cd 2+ (Rendt et aL, 1992). 
Electrophysiological and pharmacological analysis of IB. confirm earlier reports (Inoue et 
al., 1990; Young et aL, 1991; Young et aL, 1993) of both L-type and T-type components 
in RMSMCs. The L-component demonstrated characteristics of a high threshold current, 
activating at potentials close to -40 rnV and inactivating in a positive range of potentials 
(VO. 5 = -16 mV). The T-component by contrast was a low threshold current (activating at 
potentials close to -60 mV and inactivating in a negative range of potentials: Vo. 5 = -65 
mV). The VO. 5 values for L- and T-components were similar to those presented by Young 
et al., (1993) in pregnant human myometrium (-27 rnV for L-type and -70 rnV for T-type), 
and by Mehrke et al., (1994) for L- and T-type currents in aICb-transfected Chinese 
hamster ovary cells (CHO) and human medullary thyroid carcinoma cells (h-WC), 
respectively (Vo. s =- 15 mV for L-type and -45 rnV for T-type). Inactivation time constants 
for L- and T-components (211 ms at +20 mV for L-component and 37 nis at -20 rnV for 
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T-component) were also similar to those described for L- and T- currents by Mehrke et al. 
(1994) (416 ms at +20 mV for L-type and 33 ms at - 10 mV for T-type). 
The T-component at its potential of peak activation (-20 mV) was on average larger than 
the L-component at its potential of peak activation (+10 mV). This agrees with both 
previous reports (Inoue et al., 1990; Young et al., 1993). In fact, in Young et al. (1993) 
the T-component was 34 fold larger than the L-component. 
3.2.2. EFFECT OF MIBEFRADIL ON T- AND L-COMPONENTS OF 
/Ba 
T- and L-components of IB. were also distinguished by their sensitivity to the Caý' channel 
antagonist mibefradil. As shown in Fig 3.4. B, when peak IB. was measured, mibefradil 
was more potent at blocking the T-component (step to -20 or -30 mV from VH-80 mV) 
than the L-component (step to +10 mV or +20 mV from VH-80 mV) at 0.1 and I PM. 
When measured at the end of the pulse, however (Fig 3.4. C), where the current was 
mostly L-component, 0.1 pM mibefradil produced a small but significant leftward shift in 
the current-voltage relationship, such that the current was enhanced at -20 mV but 
inhibited at +20 mV. 
I pM mibefradil also enhanced L-component current decay at positive potentials (+10 to 
+40 mV) but not at negative potentials (-20 & -10 mV). These effects suggest that block 
of the L-type component of IB. may be voltage-dependent. This was confirmed by the 
effect of changing the holding potential on block of the L-component at +20 mV by I VM 
rnibefradil, where block was complete when VHwas -50 mV and recovered partially when 
VHwas lowered to -80 mV. Although similar changes in holding potential were not 
performed to determine whether block of the T-component was voltage-dependent, the T- 
component was blocked equally well at all Potentials where it was the predominant 
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component of IB. Qe -50,40, -30 and -20 mV), suggesting that its block was not voltage- 
dependent. 
Voltage-dependent block of L-type C2+ current by mibefradil also occurred in h-MTC 
cells where the EC5o was 18 and 3 pM from VH-80 and -50 mV, respectively (Merhke et 
al., 1994) and in guinea-pig cardiac myocytes where it was 12 PM from VH-80 mV and 
was 0.23 pM from VH -50 mV (Liang-min & Osterrieder, 1991). In contrast, T-channel 
block in human medullary thyroid carcinoma cells (h-MTC cells) was not voltage- 
dependent (Merhke et aL, 1994). The sensitivity of the T-component to mibefradil in the 
present study is also similar to the T-current in rat azygos vein smooth muscle cells 
(Mishra & Hermsmeyer, 1994a), however, the L-type current in azygos vein SMCs 
differed in its sensitivity to mibefradil from both the present study and the above described 
h-NffC cells and guinea-pig cardiac myocytes. Block of the L-current in the azygos vein 
was neither voltage-dependent (block by I pM mibefradil was similar from VH-80 rnV and 
VH-30 mV) nor use-dependent (indicative of open channel block) but was characteristic of 
resting state block only (Mishra & Hermsmeyer, 1994b). Also in the azygos vein, decay of 
L-type current was not affected by mibefradil at either holding potential. The voltage- 
dependence and leftward shift in the activation of the L-component by rnibefradil in 
HMSMCs resembles the partially agonistic properties of some dihydropyridine Ca2+ 
channel antagonists (eg nifedipine) (Aaronson et al., 1988). This is unusual since 
mibefradil has been shown to bind preferentially to the desmethoxyverapamil binding site 
in cardiac membranes rather than the dihydropyridine binding site (Liang-min & 
Osterrieder, 1991), despite the fact that verapamil blocks L-type Ca2' channels in a use- 
dependent rather than voltage-dependent manner (see chapter 4 for further discussion on 
the three major classes of C2+ antagonist). 
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3.2.3. OTHER FAST INWARD CURRENT IN HIVISIVICS 
A very fast voltage-gated inward current, probably a sodium current (IN. ), was present in a 
very small proportion of cells (5 out of more than a hundred). The threshold and potential 
of peak activation of this current were similar to both the L-component of AB. and the IN, 
described in the pregnant rat myornetrium. (Yoshino et al., 1997), although the speed of 
decay at +10 m. V was slower (2 ms) than in the rat (0.5 ms at +10 mV) and the 
inactivation occurred over a more positive range of potentials (VO. 5 = -31 mV) than in the 
rat (-59 m. V, Yoshino et aL, 1997). The cell capacitance of these 5 cells (25 ±6 pF) was 
below average for pregnant human myornetrium. (98.7 pF, see chapter 2) so it is possible 
that these cells represent a morphologically distinct population. 
3.2.4. PHYSIOLOGICAL RELEVANCE OF Ica AND /Na IN HUMAN 
MYOMETRIUM 
The L-type C2' channel is ubiquitous in the uterus of all mammalian species that have 
been studied, and many in vitro functional studies using three classes of L-type selective 
C2' channel antagonist have demonstrated that C2' influx through L-type C2' channels 
is essential for spontaneous and agonist-induced contraction of pregnant or non-pregnant 
myometrium. in several species, including humans and rats (see Table 1.4. ). The density of 
Ac. in rat myometrium increases during the first trimester of pregnancy and then decreases 
slowly towards term (Yoshino et al., 1997) despite a 7-fold increase in cc, subunit mRNA 
expression at term compared to early pregnancy (Mershon et al., 1994; Tezuka et al., 
1995). In pregnant pigs also, there is a 2-3 fold increase in AB. with respect to non- 
pregnant (ZhuGe & Hsue, 1994). It is not known whether expression of cc, mRNA or 
density of Ac. changes during pregnancy or in labour in the human myometrium. 
Selective inhibition of fast Ne current with TIX either in rats or humans in contrast, was 
unable to inhibit spontaneous or agonist-induced myometrial contractions in vitro (Poli et 
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al., 1990; Phillippe & Basa, 1997a). Alternatively, Nav2.3 channel protein has also been 
co-localised with connexin 43 gap junction protein in the pregnant mouse myometrium 
(Knittle et aL, 1996), suggesting an alternative function for IN. in conduction of electrical 
activity through the tissue, such that IN. may influence co-ordinated contraction of the 
entire uterus in vivo rather than force, duration or frequency of contractions in vitro. 
A possible explanation for the lack of involvement of IN. in myometrial contractility in 
vitro lies in its electrophysiological properties. The negative inactivation (-59 rnV) but 
positive activation threshold (below -50 mV and -30 mV) (Ohya & Sperelakis, 1989; 
Inoue & Sperelakis, 1991; Yoshino et aL, 1997), means that currents induced at the range 
of membrane potentials at which activation and inactivation overlap (also known as the 
window current) will be very small. This contrasts with the L-type Ac. which activates and 
inactivates in a more similar range of membrane potentials, resulting in a larger window 
current. The resting membrane potential of the myometrium, which is more positive than in 
vascular smooth muscle, cardiac myocytes and neurones win result in tonic inactivation of 
a much larger proportion of Naý channels than of L-type CW' channels, so that a much 
smaller proportion of W channels will be available to open during depolarisations. It is 
therefore puzzling why the expression of Nav2.3 mRNA in mouse (Knittle et al., 1996) 
and IN. density in rat (Inoue & Sperelakis, 1991; Yoshino et al., 1997) should so clearly 
increase during gestation in the rat myometrium until at term it is the dominant current, 
and then decline post-parturn. 
The predominance of a T-current in human myometrium. and its apparent absence in the 
majority of studies in rats (Ohya & Sperelakis, 1989; Miyoshi et aL, 1991; Inoue & 
Sperelakis, 1991; Yoshino et aL, 1997), with one exception (Rendt et aL, 1992), is also 
difficult to explain. The existence of T-component in non-pregnant HMSMCs was not 
investigated so it is not known whether expression of this channel changes during 
pregnancy as do IN. and the L-component of 1c. in the rat. These differences in channel 
109 
expression between rat and human may be influenced by regions of the uterus from which 
cells were taken in the different studies, a fact that will be complicated by the basic 
anatomical differences between rat and human uteri (Devedeux el aL, 1993). In the human 
myometrium, for example, currents were only recorded in cells obtained from lower 
segment (isthmus) and not from the main body of the uterus (fundus). It is not known 
whether myocytes from the fundus in humans express more IN. than in myocytes from the 
lower segment. 
A physiological role for T-type Ca2' channels in action potential generation and 
contraction in human myometrium. remains to be determined. This contrasts particularly 
with the cardiac T channel, which because of its concentration in the sino-atrial node and 
Purkinje fibres of the heart, the very negative resting membrane potential in the 
myocardium (- -80 mV), and the negative chronotropic effects of mibefradfl, is likely to be 
involved in cardiac pacemaker activity (Triggle, 1998). Although the likelihood of T- 
channel involvement in contraction is reduced by its negative inactivation threshold, its 
unusually large current density with respect to the L-component may mean that a large 
enough number of channels will still be available to open at the resting membrane 
potential. This, together with its low threshold of activation, resulting in a significant 
window current, albeit over a more negative range of membrane potentials than the L- 
current, may be enough to influence slow wave or action potential generation. The effects, 
if any, of mibefradil on membrane potential and myometrial contractility have not been 
determined. 
3.2.5. INHIBITION OF Ca 2+ CHANNEL CURRENTS BY OXYTOCIN 
Oxytocin is a uterotonic hormone that is present in the plasma throughout pregnancy and 
is involved in mediating labour and parturition. The principle function of OT in this 
process is to promote myornetrial contraction and part of this action clearly involves 
opening of non-selective cation and C2-activated cr channels, which probably account 
110 
for the plateau-type action potentials often induced by OT (Kuriyama & Suzuki, 1976b; 
Kawarabayashi et aL, 1990; Nakao et al., 1997; Arnaudeau et aL, 1994; Shimamura et aL, 
1994b). The most extensively documented action of OT in the myometrium, is arguably its 
effect on release of C2' from intracellular stores via IP3 production (Marc et aL, 1986; 
Schrey et al. 1987; Coleman, et al., 1988; Anwer & Sanborn, 1989; Zhuge et aL, 1995). 
Since OT stimulates contraction therefore, the inhibition of IB. and 1c. in the present study 
is apparently contradictory. It is in agreement however with a similar study in rat (Inoue et 
aL, 1992) where it inhibits Ac., but in disagreement with two studies in pigs (ZhuGe & 
Hsu, 1994; ZhuGe et aL, 1995) where it enhances 1c.. If this inhibition is genuine, a 
possible explanation is an indirect effect on the C2' channel via release of C2" from 
internal stores, since it is known that Ac. is inhibited by intracellular Ca2' (Jmari et aL, 
1986). This may also explain the transient nature of the inhibition, since released CP may 
be bound by the dialysed EGTA, taken back up into the stores or pumped out of the cell. 
This idea is however complicated by the fact that IB. is inhibited as well as Ic. suggesting 
that stored CP may remain in the cell even after prolonged replacement of external C2' 
with B2'. It is unlikely that 132' may in fact replace CP in the stores, since release of 
132' from stores would not inhibit IB. (inactivation of the channel is only sensitive to 
[C2+]i not [B2+]i) (Ganitkevitch et al., 1987). 
It is also unclear how quickly one would expect C2' released from stores to be buffered 
by the 10 mM EGTA in the pipette and how this would be affected by cell size, 
intracellular store structure, proximity of the stores with the plasma membrane and the 
involvement of endogenous buffers. If the inhibition by OT is not indirect via release of 
C2' then the only other likely explanation is a direct action of OT on the channel via 
transduction from its receptor to aG protein. Indeed, there is recent evidence that voltage- 
gated Ca" channels may be inhibited (neuronal non-L-type) or activated (vascular L-type) 
by G protein Py subunits (Dolphin, 1998; Viard et al., 1999). 
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3.2.6. OSCILLATIONS OF Ica AND /Ba 
The spontaneous and OT-induced rhythmic oscillation of both Ic. and IB. in a proportion of 
IIMSMCs is an unusual phenomenon. These currents were recorded under normal 
voltage-clamp and induced by brief depoharisations to -10 or 0 mV, so they probably 
represent movement of ions through L-type Caý' channels as described above. A possible 
explanation for these oscillations Hes in the oscillations in intracellular Caý' that are known 
to occur spontaneously in the myornetriurn or in response to oxytocin stimulation 
(Thornton et al., 1992b; Morgan et al., 1993b; Lynn et al., 1993; Phillippe & Basa, 1997a), 
since L-type Caý' current is sensitive to [CP]i (Ganitkevitch et aL, 1987). These 
oscillations are dependent on extracellular C2' influx (Thornton et aL, 1992b; Phillippe & 
Basa, 1997a). The frequency of oscillations in Ac. and IB. is in a similar order of magnitude 
(1-2 per min) to the above described oscillations in [Ca2']i, suggesting that elevations in 
[C2']i may be responsible for inhibiting Ic. or IB.. 
A possible relationship between intracellular C2+ oscillations and spontaneous transient 
inward currents (STICs) has also been demonstrated in smooth muscle cells of guinea-pig 
trachea (Jansen & Sims, 1994). These transient currents, carried by cr through C2'- 
activated cr channels, were very brief (less than Is duration) and occurred at negative 
membrane potentials where L-type CP channels will be in the resting state (-70 mV), but 
were enhanced by depolarisation-induced C2+ entry. In another similar study in ras- 
transformed 3T3 cells bradykinin-induced oscillations in IB. (frequency 0.1-0.05 Hz) are 
synchronous with [C2+]i oscillations (Higashida et aL, 1992a). The current oscillations 
were however abolished, and no inward current resulted, when BP (50 MM) was 
replaced by C2' or Srý' in the bath solution, suggesting that the oscillations were 
somehow BP-specific (11igashida et aL, 1992b). In addition, these oscillations were 
blocked by antagonists of receptor gated C2+ channels ruling out an involvement of L- 
type voltage-gated Ca2' channels. 
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In the present study, the effect of CPA on IB., even when cells were dialysed with 10 MM 
EGTA and external C2+ was replaced by B2+, suggests that C2+ was still being released 
from the SR. In two out of a further three cells however, IB. oscillations still occurred even 
when extreme measures were taken to buffer [C2+]i by dialysing cells with 30 mM EGTA 
and 20 mM BAPTA and heparin (to prevent C2' release from stores). This may suggest 
that the oscillations in 1c. and IB. are not due entirely to intracellular C2+ but that other 
intracellular mechanisms that modulate L-type channel activity, such as protein kinases or 
G protein Py-subunits (Beech & McHugh, 1996; Dolphin, 1998; Viard et al, 1999), or 
some other yet unknown intrinsic rhythmicity of the channel gating mechanism itself, may 
be involved. The physiological relevance of these oscillations with regards to action 
potential generation or the contractile rhythmicity of the myornetrium, if any, is unknown. 
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Chapter 4 
Ca 2+ Channel Antagonist Properties of 
the Cyclooxygenase-2 Inhibitor 
Nimesulide in HMSMCs of Pregnant 
Women 
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4.1. METHODS AND RESULTS 
4.1.1. EFFECT OF NIMESULIDE AND INDOMETHACIN ON 
MYOMETRIAL CONTRACTILITY 
All experiments in this chapter were performed with freshly dispersed HMSMCs from 
pregnant women at term who were not in active labour. Investigation of the effects of 
nimesulide and indomethacin on myometrial contraction was Performed by Dr Robert 
Sawdy (Dpt. Obstetrics and Gynecology, Queen Charlotte's & Chelsea Hospital, London) 
and the methodology for these experiments is described in detail in Sawdy et al., (1998). 
Briefly, strips of pregnant human myometriurn were mounted under 3g of resting tension 
in an organ bath containing phosphate buffered saline (PBS) bubbled with 95 % 02 and 5 
% C02 at 37 *C, and isometric tension recorded. PBS contained in m. M: NaCl, 119; KCI, 
4.7, CaC12,2.5; MgS049 1.2; NaHC03,25; Na2P04.1.2; EDTA, 0.03; glucose, 5.5, pH 
7.4. Treatment and vehicle (DMSO, maximum 0.1 %) control experiments were run 
simultaneously and contractions in the treatment strip were normaliscd for spontaneous 
changes in the control strips. Three contraction parameters were analysed: 1) total work 
per treatment interval (summed area under all of the contractions during the interval), 2) 
mean work done per contraction (mean area under individual contractions during an 
interval), and 3) mean contraction amplitude during an interval. 
Fig 4.1. illustrates an example of an experiment in which the effect on myometrial 
contractility of several concentrations of nimesulide was recorded. The lower trace shows 
the effect of increasing concentrations of vehicle (DMSO) alone, while the upper trace 
illustrates the relaxant effects of 1,10, and 100 ttm nimesulide. Fig 4.2. shows the 
concentration-dependency of the inhibitory effect of nimesulide on the three contraction 
parameters, which was similar for all three, being partial although not statistically 
significant at 10 pM, but nearly complete and highly significant at 100 IM 
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FIG 4.1. EFFECT OF NIMESULIDE ON SPONTANEOUS 
CONTRACTIONS IN PREGNANT HUMAN MYOMETRIUM 






Cumulative dose-response for nimesulide 
Spontaneous isometric contractions in strips of pregnant human myometrium. 
Upper trace: the effect of 1,10, and 100 ýM nimesulide, applied at 
approximately 1 hr intervals, following a control period and followed by washout. 
Lower trace: simultaneous vehicle (DMSO) control experiment in another strip 
from the same myometrial sample, showing lack of effect of DIVISO at the 
concentrations used to dissolve each concentration of nimesulide. 
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In similar experiments, indomethacin also suppressed myometrial contractions (example 
not shown), although over a somewhat higher concentration range. Indomethacin caused a 
significant block at 100 IM, and essentially abolished contractions at 300 pM. The 
concentration-dependency of the effect of indomethacin on the three indices of 
spontaneous activity is also shown in Figure 4.2. 
4.1.2. INHIBITION OF Ca 2+ CHANNEL CURRENT BY NIMESULIDE 
AND INDOMETHACIN 
The somewhat rapid inhibition of spontaneous contractility by 100 [LM nimesulide and 300 
pM indomethacin, and the fact that the potency of indomethacin was approximately Mold 
less than that of nimesulide, suggests that the effects of these two cyclooxygenase 
inhibitors may not be solely through inhibition of endogenous prostaglandin production 
within the myometrium strips. The effects of the two drugs on calcium channel currents in 
single freshly dispersed IHMSMCs was therefore investigated using the drug 
concentrations that completely inhibited spontaneous contractions. 
For the recording of Ic. and IB., C2+/Cs"/TEA or B2+/CPTEA bath solutions (Table 
2.1. ) and the Cs+-contaffiffig pipette solution (Table 2.2. ) were used. Nimesulide (100 PNI) 
or indomethacin (300 pNI) was applied during repetitive 200 ms depolarizations to +10 
mV applied at 0.1 Hz, from a holding potential of -50 mV, following a2 min control 
period during which the current amplitude was stable. The integral of currents 
(measurement of area under the current trace) were calculated for current in the absence 
(control period) and presence of drug (2-3 min were allowed for the inhibitor to have its 
effect). The effects of both drugs on both IB. (10 mM B2+) and Ic. (1.5 MM Ca2+) were 
assessed. Examples of the effects of 100 pM nimesulide and 3 00 pM indomethacin on IB. 
and Ic, are shown in Fig 4.3. and the mean inhibition of integrated current by nirnesulide 
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and indomethacin are shown in Fig 4AA and 4.413, respectively (inhibition was significant 
in all cases, P<0.05). These experiments therefore show that 100 pM nimesulide and 3 00 
pM indomethacin produce a similar degree of block to each other, but do not block IB. or 
Ic. as much as they block contraction and thath. and Ac. are inhibited to a similar extent. 
2+ In order to determine whether the inhibition of Ca channel current by nimesulide was at 
least in part due to an attenuation of intrinsic basal prostaglandin synthesis, the effect of 
100 [tM nimesulide on IB. was also recorded when the drug was applied after a3 min pre- 
incubation in (and in the continuing presence of ) either 30 IM pro staglandin E2 (PGE2) or 
prostaglandin F2 (PGF2,, ). As is illustrated in Fig 4.4C, the extent of 1B, inhibition in the 
presence of either prostaglandin was similar to that observed in the absence of 
prostaglandin (shown in Fig 4.4. A). 
To ensure that current inhibition was not due to the DMSO vehicle, the effect of the 
highest concentration of DMSO used (0.1%) on 1B. was also examined in 9 cells. Current 
was not significantly affected (integral current corrected for cell size 407 ± 64 pA ms pF, 
vs 446 -1 79 in PSS). In addition, experiments were performed to determine whether 
current inhibition by I OOgM nimesulide and 0.1 % DMSO was affected by the presence or 
absence of DMSO in the control period before nimesulide (dissolved in DMSO) was 
added, in order to separate the effect of nimesulide per se from the effect of DMSO. The 
inhibition was similar in both cases (39± 3%, n=9 vs. 41 ± 3% n= 11, respectively). 
This apparent Ca2+ antagonistic property of the two cyclooxygenase inhibitors, especially 
nimesulide, was considered of sufficient interest that further experiments were performed 
to determine the mechanisms of IB. block by nimesulide, whether the T-component of IB. 
was similarly blocked and whether the potency of block was affected by pH. 
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FIG. 4.2. INHIBITION OF SPONTANEOUS MYOMETRIAL 
CONTRACTIONS BY NIMESULIDE AND INDOMETHACIN 
Concentration-dependency of the inhibition of myometrial contractility by 
nimesulide (0) and indomethacin (0). A: total work done per treatment interval, 
13: work done per contraction, C: peak contraction amplitude. Values are shown 
as mean ± S. E. M. Each concentration of nimesulide was applied to 14 strips of 
myometrium (from 7 biopsies). 10 gM indomethacin was applied to 23 strips from 
11 biopsies, 100 IM indomethacin was applied to 25 strips from 13 biopsies, 300 
[M indomethacin was applied to 7 strips from 3 biopsies. Asterisks indicate 
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Fig 4.3. Block of IEI. and Ica by nimesulide and indomethacin 
Aj B 
D 
Control - Drug Washout 
Examples of currents elicited by 200 ms step depolarisations to +10 mV from VH 
-50 mV, showing the effect of 100 pM nimesulide (NIM) on /Ba (A) and /Ca (B) and 
the effect of 300 pM indomethacin (INDO) on /Eý, (C) and /c,, (D). Black, blue and 
red traces correspond to control current, current in the presence of drug and 
current after washout, respectively. Dotted lines represent zero current. 
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Fig. 4.4. Inhibition of /,,. and 1c. by NIM and INDO, Influence of PGs 















100 pM NIM, 'Ba 
100 pM NIM, lca 
300 pM INDO, /13a 
300 pM INDO, Ica 
100 pM NIM + 30 pM PGF2ctl 'Ba 
100 pM NIM + 30 pM PGE2, 'Ba 
Evidence that block of calcium channel current (mean ± S. E. M. of integrated 
current) by 100 pM nimesulide (NIM) (A) or 300 pM indomethacin (INDO) (B) is 
not affected by the charge carrier (10 mM Ba 2+ (/B. ), n= 11 for NIM &n=5 for 
INDO or 1.5 mM Ca 2+ (/ca), n=7 for NIM &n=6 for INDO). C: Block of neither /Ba 
nor Ic. was affected by preincubation with either 30 gM PGF2a (n = 6) or 30 gM 
PGE2 (n = 6) (not significantly different from block by nimesulide in the absence 
of prostaglandin, panel A). 
122 
4.1.3. VOLTAGE-DEPENDENCE OF CURRENT BLOCKADE BY 
NIMESULIDE. 
In these experiments a concentration of nimesulide (100 pNl) that causes 40-50 % 
inhibition of Caý' current was used. Fig 4.5. illustrates the effects of 100 ýM nimesulide on 
the current-voltage curves in six cells resulting when VHwas either -80 (3A and 3C) or -50 
mV (313 and 3D). Currents were measured at both peak (3A and 3B) and end of pulse (3C 
and 3D) (300 ms). Regardless of the holding potential, both peak and end-of -pulse current 
amplitudes (ie both T- and L- components) were diminished by nimesulide over the whole 
range of potentials. The apparent thresholds of activation and potentials of maximum 
current amplitude at either holding potential, however, were unaffected by nimesulide. A 
complete dose response for the L-component of IB. at +10 mV is presented in Figure 4.11. 
The effect of nimesulide on the availability of the T- and L- components was assessed 
using the protocol described for Fig 3.3, wherein T- and L- components were isolated by 
altering holding and test potentials: For the availability of T-component, peak current at - 
20 m. V was measured, and for the L-component, the current was measured at the end of a 
test pulse to +20 mV. 100 pM nimesulide produced no significant change in Vo. s for either 
L-component (-16.5 :b1.7 mV in 100 pM NIM vs. -16.4 -4- 7.6 m. V in PSS, n--8) or T- 
component (-66.6 + 1.7 mV in 100 pM NIM vs. -65.3 -+ 1.8 mV in PSS, rr--6), indicating 
that no shift occurred in the potential-dependency of availability for either type of current 
(Fig 4.6. ). 
In order to examine possible effects of more prolonged conditioning potentials on the 
response to nimesulide, the effect of 100 IM drug on currents elicited by pulses to +10 
mV were compared when membrane potential was held for several minutes at -40 and -50 
mV. Using measurements of the current integral as an overall estimate of current 
123 
amplitude, there was no significant difference in percent inhibition (resting block) of L- 
component at the two holding potentials (Fig 4.7A). 
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FIG. 4.5. VOLTAGE-DEPENDENCE OF BLOCK OF /Ba BY 
NIMESULIDE 
Influence of 100 pM nimesulide on current/voltage relationships in HMSMCs. A, 
B: Peak current from holding potentials (VH) of -80 MV (A) and -50 MV (B) in 
PSS and 100 pM nimesulide (NIM), Wth data normalised to the current at +10 
mV from VH -50 W. C, D: End of pulse current from VH -80 MV (C) and -50 W 
(D) in PSS and 100 pM nimesulide (NIM), Wth data normalised to the current at 
+10 MV from VH -50 mV. All data points are the mean ± S. E. M. of normalised 
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VH -80 MV, NIM VH -50 mV, NIM 
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Conditioning Potential (mV) 
L-Type, PSS 0 T-Type, PSS 
L-Type, NIM M T-Type, NIM 
Influence of nimesulide on availability of T-type and L-type Ca 2+ currents in 
HMSMCs. 5s pre-conditioning pulses to between -100 mV and +20 mV followed 
by 300 ms depolarizations to either -20 mV (T-type current, n=6, peak current 
measured) or to +20 mV (L-type current, n=8, end of pulse current measured) in 
the absence (PSS) and presence (NIM) of 100 pM nimesulide. 
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Summary of the percent inhibition of L-type (A: integrated current) and T-type (13: 
Peak current) components of /B. in conditions of differing pHjpHj and different 
holding potentials. Inhibition of L-type current was significantly greater from VH - 
40 mV than from VH -50 W (P< 0.01, n= 6-12 cells). tInhibition of L-type current 
was significantly greater at pH 6.8/6.8 and pH 6.8/7.2 than at pH 7.4/7.2 for both 
VH -50 mV (P< 0.05 by ANOVA) and VH -40 mV (P<0.001 by ANOVA). 
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4.1.4. EFFECT OF NIMESULIDE ON Ca 2+ CURRENT KINETICS 
Fig 4.5. illustrates that nimesulide apparently caused a greater inhibition of L-type current 
at the end of the pulse than at the peak of the current, suggesting that it may have 
enhanced the apparent rate of inactivation. Currents elicited by depolarizations to +10 MV 
from VH -50 mV, in the presence and absence of nimesulide, were therefore fitted with a 
single component exponential function, as in chapter 3 (equ. 3.2. ) and the time constant 'r 
was calculated. Since replacement of C2' with B2' changes current kinetics, these 
experiments were also repeated with 1.5 mM C2' as the charge carrier. For IB., T was 
significantly reduced by 100 VM nimesulide (NIM) (PSS, 211 + 29 ms vs. NIM, 105 d: 8 
ms, P<0.01, paired test, a 41 ±6% change, n 12), and also for Ic, (PSS, 116 ± 23 ms 
vs. NIM, 69 -+ 6 ms, P<0.05, paired test, a 
31 6% change, n= 9). The kinetics of T- 
type currents were unaffected by nimesulide (PSS, 37 ±4 ms vs. NIM 33 ±3 ms, n= 7). 
Unlike nimesulide, indomethacin had no consistent effect on the rate of decay of IB. (data 
not shown). 
4.1.5. USE-DEPENDENCY AND RECOVERY FROM INACTIVATION 
OF L-COMPONENT li3a 
The above described enhanced current decay can be explained by binding of nimesulide to 
either the inactivated state or open state of the channel. Since availabilities were not 
affected by nimesufide (see above), the possibility of a use-dependent effect of nimesulide 
on 43. was examined using the following protocol: A control burst of short (50 ms), high 
frequency (4 Hz) steps to +10 mV from a -50 mV holding potential, 300 pM nimesulide 
was applied during a3 min resting period at -50 mV. This was immediately followed by an 
identical burst of short rapid steps to +10 mV in the continued presence of nimesulide. 
Under control conditions, current amplitude fell progressively during the rapid short 
depolarizations, but recovered during the three minute rest (Fig 4.8A), and then feH in a 
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similar manner during a second train of pulses. When nimesulide was added during the rest 
period, current amplitude was immediately decreased during the first of the subsequent 
train of test pulses (Fig 4.8B), and then fell further during the train. Results of a number of 
experiments of this type are shown in Fig 4.8C. Normalization of the data revealed that the 
fall in current amplitude during the pulse train applied in the presence of nimesulide was 
exaggerated compared to that observed during the control period (Fig 4.8D). 
These results suggested that the effect of nimesulide on the current was use-dependent, 
possibly because nimesulide unbinding from the channel was incomplete during high- 
frequency stimulation. In order to investigate this more directly, the effect of nimesulide 
(300 1AD on recovery of the L-typc current from inactivation was also investigated. Cells 
were stepped for 500 ms to +10 mV from a holding potential of -50 mV in the presence or 
absence of nimesulide, and then a second depolarization to +10 m. V was imposed, with the 
interval between the two pulses increased incrementally to determine the time-dependcncy 
of recovery. Figure 4.9. shows that the recovery of these currents from inactivation was 
significantly slowed in the presence of 300 pM nimesulide. 
4.1.6. EFFECT OF LOWERING pH ON BLOCK OF Ca2+ CHANNEL 
CURRENTS BY NIMESULIDE 
Nimesulide is a weak acid with a dissociation constant (pY.. ) of 6.5 (Magni, 1991). 
According to the Henderson-Hassalbach equation: 
pY.. = pH + logto [AHI/[A7], Equ. 4.1., 
where [AH] is the un-ionised drug concentration and [A] is the concentration of the 
ionised fonn of the drug, nimesulide wM be 88.8% ionized at pH 7.4 (pH outside the ceU 
or pl-Q and 83.4% ionized at pH 7.2 (pH inside the pipette and ceU or pHj), and will 
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become less ionized as the pH is decreased. The modulated receptor hypothesis (see 
discussion) states that Na' and C2' channel antagonists in their ionized forms bind 
preferentially to the open state of the channel, and in their neutral forms interact 
predominantly with the inactivated and resting states. Whether the degree of resting block 
by nimesulide and the effect of nimesulide on channel inactivation were altered when both 
pH. and pHi were lowered to 6.8 (ie pl-L/pHi = 6.8/6.8) (66.6% ionization; a trebling of 
the neutral drug concentration) were therefore investigated. 
In addition, in order to evaluate whether the ionized form. of the drug played any role in 
channel blockade, the effect of 100 pM nimesulide on resting block and steady-state 
inactivation was also evaluated in cells where the p1L was 6.8 and pHi was 7.2 (ie pH. /pHj 
= 6.8/7.2). Due to ion trapping, these conditions result in a similar steady-state 
intracellular concentration of neutral drug as with pH 6.8 on both sides of the membrane, 
but increase the steady-state intracellular concentration of ionized drug by 2.5 fold. 
Estimates of the degree of resting block of the T- and L- components of IB. produced by 
100 [tM nimesulide at the pH. /pHj of 7.4n. 2,6.8/6.8 and 6.8n. 2 are described in Fig 4.7. 
The T-component was isolated using 300 ms test depolarizations to -20 mV from VH -90 
mV. Using this protocol, and due to the presence of the large T-current in these cells, peak 
current was approximately 90 % T-component. The L-component of IB, was isolated by 
applying 300 ms steps to either +10 or +20 mV from VH -50 mV and measuring the 
integral of the current (at VH -50 mV, T-current is more than 90 % inactivated). Percent 
inhibition of the L-component but not the T-component of IB. by 100 pM nimesulide was 
significantly greater under both sets of lower pH conditions than at 7.4/7.2 (L-component: 
P<0.05 by ANOVA, n= 9-12 cells; T-component: P= NS by ANOVA, n= 6-7 cells). 
As shown in Fig 4.10., inactivation curves when pH, /pHj = 6.8/6.8 for L-component 
(isolated using a +20 mV test pulse and measuring current at the end of the pulse) and T- 
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component (isolated using a -20 m. V test pulse and measuring peak current) were both 
significantly shifted to the left by 100 ýM nimesulide, giving a mean shift in the Vo. s of - 
7.3 ±1.3 m. V for L-component (from -17.7 ± 1.0 m. V in PSS to -25.0 ± 1.5 mV in NIM, n-7 
6, P< 0.01, paired West) and -4.6 ± 0.8 m. V for T-component (from -63.4 ± 2.1 rnV in 
PSS to -68.0 ± 2.7 mV in NIM, n7-- 6, P< 0.0 1, paired West). Changing the pH per se did 
not significantly affect the availability of either L-component (Vo. 5 -16.5 ± 1.7 mV at 
pH. /pHj = 7.4/7.2) or T-component (Vo. 5 -66.6 ± 1.7 mV at pHo/pHj = 7.4n. 2). 
Nimesulide also produced a similar hyperpolarising shift in the inactivation of both L- and 
T-components of IB. when pH, /pHj = 6.8/7.2. The mean shift in Vo. s was -9.6 d: 2.2 rnV for 
L-component (from -16.2 ± 2.1 mV in PSS to -25.8 ± 1.1 ffiV in nimesulide, n7-6, P< 0.0 1, 
paired West) and -5.9 ± 0.9 mV for T-component (from -61.7 ± 3.3 mV in PSS to -67.6 
4.1 mV in nimesulide, n---7, P< 0.01, paired West). 
To confirm this apparent voltage-dependence of block at the lower pH. /pHj (either 6.8/6.8 
or 6.8/7.2) the apparent inhibition of the L-component of IB. by 100 pM nimesulide was 
further estimated using a more depolarized VH of -40 mV. This blockade was significantly 
greater than from VH -50 m. V, both at pH, /pHj = 6.8/6.8 and 6.8/7.2 (P< 0.05) but not at 
pH. /pHj = 7.4/7.2 (Fig 4.7. ). From VH -40 mV, there was a similar significant variation in 
the degree of inhibition between the three pH conditions from VH -50 rnV (P< 0.001 by 
ANOVA, n7- 6-9 cells). 
A fuH dose-response for inhibition of L-component by nimesulide at pH. /pHj = 7.4/7.2 is 
presented in Fig 4.11. (squares). This mean data was fitted to a four parameter logistic 
function: 
y= (I 00-a)ll +((EC5o/x)Ab) equ. 4.2 
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where a is the percentage of current not inhibited by nimesulide and b is the Hill coefficient 
(normally I for a single binding site). An EC5o of 136 gM and a Hill coefficient of 0.81 
were obtained and a was zero. Further dose-responses were constructed using pHjpHj = 
6.8/6.8 (circles) or 6.8/7.2 (triangles) from VH -40 mV. Sigmoidal curves were also fitted 
to these two sets of mean data and estimates of EC5o values of 35.6 gM and 36.0 pM, and 
Hill coefficients of 1.08 and 1.02, respectively were obtained, and a was also zero in both 
cases. The similar sensitivity of the current to nimesulide under these two sets of 
conditions, together with the similar shift in the availability (see above), suggest that the 
concentration of ionised drug inside the cell (which is 2.5 times greater when pH. /pHj 
6.8/7.2 than when it is 6.8/6.8 or 7.4/7.2) does not influence the degree of inhibition. 
As at normal physiological pH (ie pH. /pHj = 7.4/7.2, see above), current decay of the L- 
component was accelerated by nimesulide when pHdpHi was 6.8/6.8 (tau: PSS, 142 ± 19 
ms vs. 100 pM NIM, 75 ±2 ms, n7-9, P<0.01 paired t-test) and when it was 6.8/7.2 (tau: 
PSS, 161 ± 21 ms vs. 100 pM NIM, 90 ±7 ms, n7-9, P<0.01 paired west). The 
percentage change in tau was similar under all three sets of pH conditions (7.4/7.2: 41 :E6 
%, 6.8/6.8: 41 ±6%, 6.8n. 2: 42: 1: 3 %). 
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FIG 4.8 USE-DEPENDENCE OF /Ba BLOCK BY NIMESULIDE 
Currents elicited by a7 min burst of short and rapid (50 ms, 4 Hz) 
depolarizations to +10 mV from a holding potential of -50 W, followed by a3 
min rest period at -50 mV and then a further 7 min burst of short rapid pulses to 
+10 W. Nimesulide was applied at the start of the rest period and was present 
throughout the second burst of rapid pulses. A: Representative control 
experiment showing traces before (PSS1) and after (PSS2) a3 min rest period, 
in the absence of nimesulide. B: Representative current traces before (PSS) and 
after (NIM, 300 pM. nimesulide) the 3 min rest period, respectively. Every fourth 
current trace is shown. C: Effect of nimesulide on peak current in 4 cells (mean 
S. E. M. ). D: Same data as in C normalised to the zero time point, showing % 
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FIG 4.9. EFFECT OF NIMESULIDE ON /Ba RECOVERY FROM 
INACTIVATION 
500 ms depolarization pulses to +10 mV from VH -50 mV followed at increasing 
intervals by a further 50 ms pulse to +10 W. A&B: Representative traces 
showing currents in the presence of PSS (A) and 300 pM nimesulide (NIM) (B) 
in the same cell. C: % inactivation at each time interval, in the absence (PSS) 
and presence of 300 pM nimesulide (NIM), calculated by taking the peak current 
amplitude at each 50 ms pulse as a percentage of the corresponding 500 ms 
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Influence of nimesulide on availability of T- and L-components of /Ba in HMSMCs 
when pHjpHj is 6.8/6.8.5 s pre-conditioning pulses to between -110 mV and +20 
mV followed by 300 ms depolarizations to either -20 mV (T-component, n=6, 
peak current measured) or to +20 mV (L-component, n=6, end of pulse current 
measured) in the absence (PSS) and presence (NIM) of 100pM nimesulide. 
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Effect of extracellular (pHo) and intracellular pH (pHj) on the concentration- 
dependent inhibition of L-type Ca 2+ current by nimesulide. Points represent the 
mean ± S. E. M. of integrated current at +10 mV in 9-12 cells at each 
concentration. Steady state inhibition at each concentration was reached within 3 
min. 
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4.2. DISCUSSION 
4.2.1. NIMESULIDE 
Nimesulide (N-(4-nitro-2-phenoxyphenyl)-methane-sulfonilamide), is a non-steroidal anti- 
inflammatory drug (NSAID) of the sulfonflamide class. It has been used successfully 
throughout Europe as an anti-inflammatory and analgesic drug and has better 
gastrointestinal tolerability than other NSAIDs. The anti-inflammatory properties of 
nimesulide stem from its ability to inhibit prostaglandin production by the cyclooxygenase 
enzyme (COX), as well as to scavenge leucocyte generated oxygen free radicals and 
inhibit leucocyte phosphodiesterase type IV (Davis & Brogden, 1994). COX exists in two 
isoforms: COX-1 which is constituitively expressed where prostaglandin synthesis is 
constant, and COX-2 which is inducible and associated with inflammation. Within the 
fetoplacental unit, COX-2 and not COX-1 is expressed in fetal membranes and 
myornetrium. and upregulated with labour (Slater et aL, 1995,1997), whereas COX-1 is 
the predominant isoform. in systemic fetal tissues. Nimesulide has a 30-100 fold selectivity 
for COX-2 (Taniguchi et aL, 1995; Miralpeix et aL, 1997) and has been shown not to 
affect prostaglandin synthesis in tissues in which COX-1 is the predominant isoform 
(Bianco et aL, 1991; Tavares et aL, 1995). A preliminary clinical report has suggested that 
it may be a potentially useful tocolytic agent (Sawdy et aL, 1997a), enabling the targeting 
of COX-2 and avoiding the harmful fetal side effects that preclude the use of non-selective 
COX-inhibitors such as indomethacin (Norton et aL, 1993, Table 1.5. ). 
4.2.2. EFFECTS OF NIMESULIDE AND INDOMETHACIN ON 
SPONTANEOUS MYOMETRIAL CONTRACTION IN VITRO 
Both nimesulide and indomethacin suppressed spontaneous contractility of pregnant 
human myometrium. in vitro. A number of previous studies have evaluated the effect of 
indomethacin, with variable results. For example, Vane and Williams (1973) found that II 
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gM indornethacin gradually abolished both spontaneous myornetrial contractions and 
uterine prostaglandin production in pregnant rat uterus and Garrioch (1978) observed that 
50 gM indornethacin gradually abolished spontaneous contractions in non-pregnant and 
pregnant human myornetrial strips. A similar effect of indornethacin on human myometrial 
strips was also demonstrated by Johnson et aL (1975) but at much higher concentrations 
(< 50% inhibition with 278 gM indomethacin). Similarly, Crankshaw & Dyal (1994) more 
recently found that indornethacin up to 100 pM had no effect on spontaneous contractions 
of pregnant human myometrium in vitro. In the present study, indomethacin inhibited 
spontaneous myornetrial activity over a concentration range somewhat lower than that 
found by Johnson et al. (1975), with almost complete inhibition of activity at 3 00 jiM, and 
nimesulide, the effects of which on in vitro myometrial contractility have not previously 
been evaluated, was approximately three-fold more potent than indomethacin. 
From these experiments it was apparent that neither drug was inhibiting contraction at 
concentrations known to inhibit COX activity. For example, nimesulide and indomethacin 
reduced PGE2production by human fetal membranes by 75 % and 82 % respectively at I 
ýtM (Sawdy et aL, 1997b). Therefore the concentrations of both drugs required to 
suppress spontaneous in vitro contractions of human myometrium were approximately 2 
orders of magnitude higher than those needed to inhibit uterine COX. These data agree 
with several previous reports which show that indomethacin, although more potent 
against COX-1 (60-fold), also inhibits COX-2 with micromolar (Mitchell et aL, 1993) or 
even submicromolar ICso values (Miralpeix et aL, 1997, Yamada et aL, 1997). Similarly, 
nimesulide inhibits COX-2 at micromolar or submicromolar concentrations (Casolaro et 
aL, 1993; Miralpeix et al., 1997). 
The fetal membranes (amnion and chorion) and decidua are thought to be the principle 
sites of synthesis of oxytocic prostaglandins (PGE2 and PGF2. ) within the human uterus 
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and fetoplacental unit (Skinner & Challis 1985) and, even though COX-2 mRNA is present 
in pregnant human myometrium. (Slater et aL, 1995,1997), the importance of the 
myometrium. itself as a source of oxytocic prostaglandins is uncertain, since the principle 
prostaglandin product of myometriurn is prostacyclin (Bamford et aL, 1980), which has no 
effect upon contractility (Crankshaw & Dyal, 1994). In contrast to early in vitro 
contractility experiments with indomethacin therefore, where it was concluded that 
intrinsic prostaglandin production was involved in maintenance of the spontaneous 
myornetrial contractions (Vane & Williams, 1973), the observations of the present study 
suggest that neither indomethacin nor nimesulide were likely to be suppressing in vitro 
contractility via an inhibition of prostaglandin production. 
As an alternative mode of action then, perhaps the relaxant effect of the two drugs was 
due to inhibition of myometrial Caý+ channels. In the present study, both nimesulide and 
indornethacin approximately half-maximally reduced both 1B, and Ic. in human myometrial 
myocytes at concentrations which completely inhibited contractility. Nimesulide was 
approximately three-fold more potent as an antagonist of current than indomethacin, 
apparently mirroring the relative potency of the two drugs as inhibitors of myometrial 
contractility. Furthermore, the inhibition of the C2+ channel current was unlikely to be 
secondary to an effect on prostaglandin production by the isolated cells, since the presence 
of either PGE2 or PGF2,, in the solution did not significantly alter the extent of current 
blockade by nimesulide. Indeed, the addition of Prostaglandin itself did not significantly 
affect current amplitude, suggesting that either prostaglandin receptors were damaged by 
the enzymatic digestion, or that the prostaglandins were unable to directly influence 
voltage-gated C2' channel activity under the voltage-clamp conditions used. These results 
are therefore consistent with the possibility that, at least in part, both drugs may act as 
myometrial relaxants via C2' channel blockade. For this reason the mechanisms of CP 
channel blockade by nimesulide, the most potent of the two drugs, were studied in more 
detail. 
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4.2.3. RESTING BLOCK OF L- AND T-TYPE COMPONENTS BY 
NIMESULIDE 
The block of IB. by 100 ptM nimesulide at physiological pH (pIL, = 7.4, pHi = 7.2) did not 
appear to demonstrate any dependency on the holding potential. No shift of the 
inactivation curve of either L-component or T-component of IB. was observed when 5 
second conditioning pulses were used, and block of the current was similar from VH -50 
and -40 mV. Furthermore, nimesulide did not alter the shape of the I-V curve at either 
holding potential (-80 mV or -50 rnV), either when peak current was measured or when 
current was measured at the end off the pulse, and there was no discernible shift in the 
apparent threshold of activation or potential of maximum activation. 
An interesting aspect of block by nimesulide is its lack of selectivity for either L-type or T- 
type currents. As discussed in chapter 3, a role for the T-current in myornetrial 
contractility has not been proved, but its electrophysiological properties suggest that it is 
possible that it may contribute to slow wave or action potential generation. It is possible 
therefore that block of T-type channels may contribute to nimesulide's inhibitory effect on 
myometrial contractility. 
4.2.4. STATE-DEPENDENT CHANNEL BLOCK BY NIMESULIDE 
The observation that considerable block of current was observed during the first 
depolarization following a3 min incubation with nimesulide (Fig 4-8Q, indicated that the 
greatest part of the block developed under these conditions was via binding of nimesulide 
to the channel in its closed (resting) state. However, nimesulide also blocked the L-type 
current significantly more when measured at the end of the 300 ms pulse than at the 
current peak, suggesting that it might accelerate current decay. This was confirmed by 
calculating time constants of current decay in the absence and presence of nimesulide. 
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This effect was similar and significant either with 10 mM 132' or with 1.5 mM C2' as 
charge carrier, and was apparently independent of pH. In addition to accelerating current 
decay, nimesulide significantly enhanced the decline of the current which developed during 
a train of brief high frequency depolarizations, and also significantly slowed recovery of 
the current following a 500 ms voltage step. These enhanced current decay and use- 
dependent properties, suggest that block of IB. by nimesulide may also be promoted by 
channel opening (Yeh et al., 1982; Lee & Tsien, 1983). 
The phenylalkylamines, including verapamil and its derivative D600, and the 
benzothiazepine diltiazem, are predominantly frequencyý. and use-dependent and appear to 
bind preferentially to the open state of the channel (Lee & Tsien, 1986; McDonald et al., 
1993). Furthermore, the degree of use-dependence of a drug may be predicted by the 
degree of ionization of the drug at physiological pH. This is evident with D600 (py.. 8.5, 
93% ionized at pH 7.4) and verapamil (pY,. 9.7,96% ionized at pH 7.3) which are both 
wholly use-dependent at physiological pH (Sanguinetti & Kass, 1984; Uehara & Hume 
1985). Diltiazern is intermediate (pY,. 7.7,67 % ionized at pH 7.4) so that lowering the 
pH to 6.5 increases the percent of ionized drug to 95 % and increases the degree of use- 
dependence (Uehara & Hume, 1985). On the other hand, the dihydropridines such as 
nifedipine (pY.. 1.0), nicardipine, nisoldipine and nitrendipine are wholly neutral and cause 
large hyperpolarizing shifts in the steady-state inactivation, indicative of preferential 
binding to the inactivated state of the channel and demonstrate little or no use-dependence 
at physiological pH (Sanguinetti & Kass, 1984; Uehara & Hume, 1985; Bean et al., 1986; 
Terada et al., 1987). 
Nimesulide differs from these antagonists, in that due to its sulfonflamide group it is a 
weak acid (Magni, 1991). Thus lowering the pH from 7.4 to 6.8 decreases the amount of 
ionized drug and increases the amount of the neutral form of the drug from 11.2 to 33.4 
%. This three-fold increase in concentration of neutral drug paralleled the increased block 
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by nimesulide when pH. /pHj was 6.8/6.8 (Fig 4.7. ). Furthermore, if the ionised form of the 
drug was contributing to resting block, when pH. /pHj was 6.8/7.2, where the 
concentration of ionised drug inside the cell would be increased 2.5 fold by an ion trapping 
effect, and neutral drug concentration would be the same as at 6.8/6.8, the potency of 
nimesulide would be even greater. Since this was not the case, it can be concluded that the 
neutral form of the drug is predominantly responsible for block of the resting channel. 
In addition, nimesulide caused a 7.3 mV leftward shift of the inactivation curve of the L- 
component when the pH was 6.8 both in the bath and pipette solutions. According to Bean 
et al., (1984), this shift can be used to calculate the affinity of the drug for the inactivated 
state (KI), as follows: 
A Vo. 5= kln [ (I + 
NIKR)I(l + NIKI) ] Eqn 4.3. 
Where A Vo. 5 is the shift in the inactivation, k is the inactivation slope factor (mean 6.95 
rnV), and N is the neutral drug concentration. Assuming that only the neutral form of the 
drug binds to the resting state of the channel, the affinity for the resting state, KR, is 
estimated from an approximate EC5o of 13 6 pM at pH 7.4 of which 11.2 % is in the neutral 
form and, assuming that changing the pH does not change the affinity of the drug for the 
channel, giving a KR of 15 pM for the neutral form of the drug. With aA Vo. 5 of -7.3 mV at 
pH 6.8 (where 33.6'% of the drug is neutral), K, is estimated as 4.1 pM for the neutral 
form of the drug. 
The possibility that nimesulide binds with a higher affinity to the inactivated state of the 
channel is entirely consistent with the observation that, at pIL 6.8, when the holding 
potential was set at -40 mV there was significantly more block than when the holding 
potential was -50 mV. The fact that this reduction in holding potential did not cause 
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additional block or shift the current availability of the L-component at pIL 7.4, was most 
likely because the concentration of neutral drug was very low under this condition. 
The absence of a significantly greater hyperpolarising shift in current availability when 
pH. /pHj was 6.8/7.2 compared to when it was 6.8/6.8, suggests that the ionized form of 
the drug does not contribute to inactivated channel blockade. 
Taken together these observations are consistent with the concept that nimesulide blocks 
the C2' channel in resting, inactivated and open states. The block of resting and 
inactivated channels is largely caused by the neutral form of the drug. The effect of 
nimesulide on current decay was similar under all three sets of pH conditions and was not 
apparently influenced by the concentrations and relative proportions of neutral and ionized 
drug in the bath and in the intracellular medium. However, the underlying rate of current 
decay was also accelerated at the lower pH, making interpretation of these data difficult. 
Nimesulide also caused a small but significant leftward shift in the availability of the T- 
component when pIL/pHj was either 6.8/6.8 or 6.8/7.2. The extent to which this effect 
might contribute to nimesulide's potency as a myornetrial relaxant is unclear, given the 
uncertainty over the role of the T-current in myometrial. contractility. 
4.2.5. POTENTIAL FOR TOCOLYSIS AND INFLUENCE OF pH 
It is clear that at normal physiological pH (pH, /pHi = 7.4/7-2) both nimesulide and 
indomethacin were less effective in inhibiting the C2' channel current than in inhibiting 
contractility. The smaller effect on the current may imply that C2' antagonism is only one 
of several mechanisms by which these drugs suppress contractions. It may also, however, 
stem from the methodological differences involved in studying contractility and ion channel 
currents. For example, the duration of the exposure of single cells to nimesulide or 
indomethacin was effectively limited by the durability of the cells under voltage clamp 
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conditions and the possibility of slow run-down of the C2' current. Finally, no data exist 
as to the relationship between Ca" channel blockade and the inhibition of spontaneous 
activity in this tissue, and it may be that partial reduction of the current has a 
disproportionate inhibitory effect on action potential activity and contractions. 
Whether or not the effects of these drugs on the Ca 2+ current bear any relevance to their in 
vivo tocolytic effect is unclear. However, total therapeutic plasma concentrations of 
indornethacin are approximately 1-2 ýLM, of which 90% is bound to -plasma proteins 
(Berman et al., 1980). Both total and free plasma concentrations of indomethacin are 
therefore much lower during therapy than those which inhibited myometrial contractility 
and the C2+ current in vitro. On the other hand, therapeutic total plasma concentrations of 
nimesulide are relatively high, ranging between 6 and 32 ýLM (Davis & Brogden, 1994). 
Nimesulide is 99% bound in plasma (Bree et al., 1993), indicating that its free Plasma 
concentration range is submicrornolar. Nimesulide, however, is lipophilic, and its 
membrane concentration is therefore likely to be much higher than its free plasma 
concentration. It may be for this reason that nimesulide reaches a concentration in female 
reproductive organs which is 33 - 50% of the total plasma concentration (Davis & 
Brogden, 1994). In addition, many of the diverse effects of nimesuNde which are thought 
to contribute to its in vivo anti-inflammatory action have relatively high (> 10 IiNl) EC5o or 
IC50 values when these effects are assayed in vitro (Casolaro et al., 1993; Facino et aL, 
1993; Ottonello et al., 1995). In particular, it has been proposed that many of these actions 
are related to its ability to inhibit phosphodiesterase (PDE) type IV, the principle enzyme 
responsible for degrading leucocyte cANT (Bevilacqua & Magni, 1993), and in 
neutrophils the concentration-dependency of the inhibition of PDE IV by nimesulide has an 
ICso value of 39 gM (Bevilacqua et al., 1994). 
These data suggest that nimesulide's total plasma concentration may better reflect its 
concentration at its sites of action than its free concentration. It is therefore not 
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inconceivable that the effect of nimesulide on the C2' channel current may play some role 
in reducing myometrial motility in vivo. On the other hand, even if this were to be true of 
indomethacin, its total plasma concentration is much too low for this drug to exert any 
CaF' channel blocking action in vivo, whereas its COX-antagonistic activity occurs at very 
low concentrations, so that these probably explain its tocolytic action. 
The increased potency of nimesulide at lower pH is also potentially of relevance to the use 
of nimesulide as a tocolytic agent. Although the pH of the myometrium appears not to 
have been measured during labour, there is substantial circumstantial evidence for a 
significant myometrial acidification at this time. It is thought that during labour there is 
progressive ischemia of the myometrium which is only relieved after delivery. The lactate 
concentration in the maternal venous, circulation increases to 4-5 mM during the final 
stages of labour (Piquard et aL, 1991). This lactate almost certainly originates in the 
myometrium, since peaks in blood lactate have been observed to occur in association with 
labour contractions (Marx & Greeve, 1964). 
Precisely how far the intracellular pH falls during labour is not known; however small 
transient intracellular acidifications were associated with spontaneous contractions of very 
thin strips of rat myornetrium. even in oxygenated solution (Taggart & Wray, 1994). An in 
vivo study of rats showed that artificially induced ischernia reduced pH from 7.3 to 7.0 
(Harrison et aL, 1994). Acidification of the myometrium during labour in women should 
be even more pronounced, since the muscle is thicker and contractions are much more 
prolonged; more prolonged agonist-induced contractions in rat myometrial strips caused a 
much greater acidification than spontaneous contractions (Taggart & Wray, 1994). In 
addition, lactic acid is likely to accumulate in the myometrium, since at delivery there is a 
reduction in maternal arterial pH which is attributed to a flooding of lactic acid into the 
circulation (Cohen et aL, 1970). Both acidification of the myometrium. during the 
contractions of labour, and the increased level of Caý' channel inactivation associated with 
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prolonged slow wave depolarizations, are predicted by the results of this study to greatly 
enhance the in vivo potency of nimesulide as a myometrial relaxant. Nimesulide, which is 
otherwise a rather weak Ca2+ antagonist, may therefore be targeted to myometrial Ca" 




Outward currents in HMSMCs of 
Pregnant and Non-Pregnant women; 
characteristics of the fast transient 
component 
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5.1. METHODS AND RESULTS 
5.1.1. WHOLE CELL CURRENTS 
Components of ionic current were initially identified according to their sensitivity to W 
channel blockers TEA (10 mM) and 4-AP (5 mM). These two pharmacological agents 
were used in this initial characterisation because they had previously been found to be 
effective at separating W current components in vascular and visceral smooth muscles 
(Smirnov and Aaronson, 1992, Smirnov & Aaronson, 1994; Vogalis et aL, 1993; Carl, 
1995). Most 4-AP sensitive delayed rectifier and A-Eke Ký currents are half maximally 
inhibited by sub-millimolar concentrations of 4-AP, so that 5 mM will provide near 
complete block (see Table 1.3). Currents were recorded using normal PSS (containing 1.5 
mM C2') as the bath solution and high W EGTA-buffered PSS in the pipette. Cells from 
non-labouring pregnant women at term were compared with those from non-pregnant 
women of reproductive age (see chapter 2 for details). 
The effects of TEA and 4-AP on current voltage-relationships in representative HMSMCs 
from pregnant and non-pregnant woman, using -80 mV as the holding potential (VH), are 
shown in Figs 5.1. and 5.2., respectively. Measurements of current at the peak (10- 15 ms) 
and end of pulse (450-500 ms) at +60 mV in the presence of TEA and 4-AP for both 
pregnant and non-pregnant HMSMCs are presented in Fig 5.3. Cell hypcrtophy causing 
differences in cell size between non-pregnant and pregnant cclIs, and hence differences in 
current amplitude, is known to occur during pregnancy and similar differences in cell 
capacitance to those described in the present study were found by Wang et al (1998) in the 
rat myometrium. So to correct for these differences (non-pregnant cells were 3-4 fold 
smaller than pregnant, C. = 28.1 4- 2.8 pF, n7-10 in non-pregnant vs. 101 ± 15 pF, n= 18 
in pregnant), current amplitude (pA) was converted to current density (pA/pF) using the 
cell capacitance (pF) as an estimate of cell size. 
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In normal PSS, an outward current was observed at all potentials positive of -40 rnV in 
both pregnant and non-pregnant cells (Panel A, in Fig 5.1. and Fig 5.2. ). This current was 
often very noisy at potentials more positive than 0 mV, was fully activated within 50 ms at 
potentials above 0 rnV and decayed only slightly during 500 ms. The current amplitude 
was several fold greater in cells from pregnant women compared to non-pregnant (5-10 
fold), however when current amplitude was corrected for cell size there was no significant 
difference between the current densities at +60 mV (Fig 5.3. ). 
The addition of 10 mM TEA produced significant but not complete inhibition of the 
outward current in both pregnant and non-pregnant cells (panel B, Figs 5.1. and 5.2. ). The 
amplitude of the TEA sensitive component after 10-15 ms and at the end of pulse (450- 
500 ms) was estimated by subtracting current in the presence of TEA from current in PSS. 
Inhibition was on average 32-33 % at the peak and 68-75 % at the end of the pulse at +60 
mV. The noisiness of current at +40 mV and +60 mV in PSS was abolished in the 
presence of TEA. The difference in the size of the TEA-sensitive current at +60 mV after 
10-15 ms was significantly smaller than at the end of the pulse in both pregnant cells and 
non-pregnant cells, suggesting the presence of a slowly activating TEA-sensitive current 
(Fig 5.3. ). The current remaining in the presence of TEA was occasionally composed of 
transient (rapidly inactivating) and sustained (slowly inactivating) components (as in the 
example shown in Fig 5.213). 
The further addition of 5 mM 4-AP in the continued presence of 10 MM TEA produced 
additional block (Panel C, Figs 5.1. and 5.2. ). The inhibition was on average greater at the 
peak than at the end of the pulse, especially in non-prcgnant cells, where the transient 
component of the current revealed in the presence of TEA was always completely inhibited 
by 4-AP (Fig 3.3. ), suggesting the presence of an A-Eke, rapidly inactivating W current. 
However, there was also a sustained component to the 4-AP sensitive current especially in 
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pregnant cells, suggesting the presence of a delayed rectifier-like, slowly inactivating W 
current. 
In the combined presence of 10 mM TEA and 5 mM 4-AP however, there was in many 
cells a substantial sustained outward current component (Panel C, Figs 5.1. and 5.2. ). In 
pregnant and non-pregnant cells, this 4-AP insensitive current was 21 :L2% and 23 ±2% 
of the total outward current measured at the end of the pulse for pregnant and non- 
pregnant ceRs, respectively (Fig 5.3. ). Under these conditions, in all pregnant (7 out of 7) 
and 2 out of 3 non-pregnant cells examined, a transient inward current component was 
also revealed at membrane potentials between -40 and +20 mV (Panel C, Figs 5.1. and 
5.2., corresponding to Ac., as described in chapter 3). 
Subtraction of the current remaining in the presence of both 5 MM 4-AP and 10 MM TEA 
from the current present in 10 mM TEA alone provided a picture of the 4-AP sensitive 
components (Panel D, Figs 5.1. and 5.2. ). This also enabled the fast transient 4-AP 
sensitive component to be separated from the capacitive current artefacts, which, because 
they were unaffected by the addition of 4-AP, were removed during the subtraction. The 
amplitude of the sustained component of this 4-AP sensitive "difference current"' was 
significantly larger in pregnant compared to non-Pregnant cells (Fig 5.3. ). 
Under the experimental conditions used here, there are therefore four principle 
components to the whole cell outward current, namely the sustained TEA-sensitive, 
transient 4-AP sensitive, sustained 4-AP sensitive and sustained TEA & 4-AP insensitive 
components, and one inward current component, in pregnant and non-pregnant HMSMCs. 
However, not all cells possessed all of these components and there was some variability 
between pregnant and non-pregnant cells. Since there were perhaps not enough cells for 
some of the apparent differences between pregnant and non-pregnant cells to reach 
statistical significance (as suggested by data in Fig 5.3. ), a qualitative assessment was also 
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adopted. To this end, the number of ceRs possessing each of the 4 outward current 
components are presented below (Table 5.1. ). 
TABLE 5.1. OCCURRENCE OF OUTWARD CURRENT 
COMPONENTS IN PREGNANT AND NON-PREGNANT HMSMCS 
ON THE BASIS OF TEA (10 mM) AND 4-AP (5 mM) SENSITIVITY. 
Outward Current Pregnant Non-Pregnant 
Component (total 18 cells) (total 10 cells) 
Sustained 
TEA-sensitive 18(100%) 10(100%) 
Sustained 
4AP-sensitive 13(72%) 4(40%) 
Transient 
4-AP sensitive 9(50%) 8(80%) 
Sustained 
4-AP & TEA 18(100%) 10(100%) 
insensitive 
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FIG 5.1. WHOLE CELL CURRENT IN PREGNANT HMSMCS 
Current voltage relationships in a representative HMSMC from a pregnant 
woman (C,, = 112.4 pF). Currents were elicited by 500 ms depolarisations from 
HP -80 W to between -80 and +60 rnV (20 W increment at a frequency of 0.1 
Hz) in normal PSS (A) and then in 10 mM TEA (B) and both TEA and 5 mM 4-AP- 
(C). The 4-AP sensitive component of the current (derived by subtracting 
currents in C from currents in B) is shown in D. The 4-AP sensitive component 
consists of a fast and a slow component. The fast component is made more 
visible by showing only the first 50 ms of current. Please note the change in 
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FIG. 5.2. WHOLE CELL CURRENT IN NON-PREGNANT HMSMCS - 
Current voltage relationships in a representative HMSMC from a non-pregnant 
woman (Cm = 27.7 pF). Currents were elicited by 500 ms depolarisations frolm'-_' 
HP -80 mV to between -80 and +60 W (20 W increment at a frequency of 0.1 
Hz) in normal PSS (A) and then in 10 mM TEA (B) and both TEA and 5 mM 4-AP 
(C). The 4-AP sensitive component of the current (derived by subtracting 
currents in C from currents in B is shown in D. The 4-AP sensitive component 
consists of a fast and a slow component. The fast component is made morel- 
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FIG 5.3. COMPARISON BETWEEN PREGNANT AND NON- 
PREGNANT HMSMCS 
Effect of TEA and 4-AP on transient and slow components of whole cell currents 
in HMSMCs from pregnant (A, n=18 cells) and non-pregnant women (B, n= 10, 
cells). Transient current amplitude at +60 mV was estimated by measuring at the 
peak (10-15 ms) and slow current by measuring at the end of the pulse (450-500 
ms). Data bars represent the mean ± S. E. M. of current density. There were 
significant differences in the size of TEA-sensitive and 4-AP sensitive current 
components between peak and end of pulse (** P< 0.0001, * P< 0.05). In 
addition, the size of the slowly decaying 4-AP sensitive component (ie. the end 
of pulse measurement) in pregnant cells was significantly greater than in non-_ 
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5.1.2. CHARACTERISTICS OF THE TRANSIENT 4-AP SENSITIVE 
CURRENT 
As in the two examples given in Figs 5.1. and 5.2., in most cells from both pregnant and 
non-pregnant HMSMCs an inward current was only observed after the addition of both 
TEA and 4-AP. This suggests that the transient 4-AP sensitive component of the outward 
current (I") was activating at similar membrane potentials and with similar amplitude and 
kinetics of activation and inactivation to the inward calcium current (Ic. ). To illustrate this 
further, an example of a cell where both currents are present, and there is minimal 
contribution of the sustained delayed rectifier current component, is presented in Fig 5.4, 
showing currents elicited by depolarsations to between -40 mV and +10 mV (at 10 mV 
increments) in the presence of 10 mM TEA (black traces), the presence of 10 MM TEA 
and 5 mM 4-AP (blue traces) and the 4-AP sensitive component (red traces). From this 
example it is clear that Ic. and IKAoverlap quite closely at all potentials shown but that at 
potentials positive of -30 mV a net fast transient outward current is visible in the presence 
of TEA, suggesting that I" was bigger than and/or activating faster than Ic,. The latter 
was confirmed by measuring the time taken for the two currents to reach peak amplitude 
at -20 mV and 0 mV in 4 pregnant HMSMCs. At -20 mV, the time to peak was 13.8 ± 3.6 
ms for IKAand 19.6 ± 2.3 ms for Ic, (P < 0.05, paired t-test) and at 0 mV, it was 10.2 
2.2 ms for IKAand 14.7 ± 2.1 ms for Ic. (P < 0.0 1, paired t test). 
The voltage-dependence of activation and inactivation of IK. A and its sensitivity to removal 
of external CP and replacement with Cd2' was also examined in pregnant HMSMCs (Fig 
5.5). As described above, IKAwas defined as the transient component of the outward 
current inhibited by 5 mM 4-AP. Current voltage relationships (steps to between -80 and 
+20 MV from VH -80 mV, Fig 5.5A) and availabilities (10 s conditioning pulses to 
between -100 and +10 mV followed by a test pulse to +60 mV, Fig 5.5B) were therefore 
performed in the presence of 10 mM TEA, and then TEA and 5 m. M 4-AP and the 4-AP 
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sensitive "difference current" derived. These experiments were performed either with 1.5 
mM C2' (and 10 mM TEA) or with 0 Ca2' and 0.5 mM Cd 21 (and 1 mM TEA, see 
chapter 6) in the bath solutions. The threshold of activation of 1KA with 1.5 MM C2*110 
mM TEA as bath solution was between -80 and -70 mV (7 cells). In the presence of 0.5 
mM Cd2' and ImM TEA however, the threshold of activation in another 2 cells was 
apparently shifted in the positive direction by at least 30 mV (n = 2) (Fig 5.5A). With 1.5 
mM Ca2' and 10 mM TEA in the bath solution, following fitting of normalised data to a 
Boltzmann curve, the inactivation of IKAwas voltage-dependent with Vo. s values of -69.5 
and -70.0 mV and k of 5.0 and 6.0 mV for the two cells, respectively. IKAwas completely 
inactivated after conditioning pulses positive of -50 mV. When 0.5 mM Cd2' replaced Ca 2+ 
in the bath solution however, Vo. 5in another 2 cells was -40.1 and -40.6 mV, k was 4.6 and 
5.5 mV and the current was completely inactivated after conditioning potentials positive of 
-20 mV, a rightward shift of approximately 30 mV (Fig 3.5B). 
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FIG. 5.4. OVERLAP OF 1K, A WITH /Ca IN HMSMCS 
In a non-pregnant cell where the slow 4-AP sensitive current and the 4-AP 
insensitive currents are minimal, overlap of inward current (/Ca, blue traces) and 
transient 4-AP sensitive outward current (/K, A, red traces) is apparent at all 
membrane potentials between -40 and + 10 mV (from VH -80 mV), as shown. The 
net current in TEA (black traces) shows a net fast transient current at potentials 
positive of -30 mV. A similar pattern was observed in 4 pregnant cells (see text). 
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FIG. 5.5. CURRENT-VOLTAGE RELATIONSHIPS AND 
AVAILABILITIES OFIK, A 
Current voltage relationships (A) and availabilities (B) of 1KA, defined as the 
transient component of the 4-AP sensitive current, in pregnant HMSMCs. A: 
Mean and SEM current densities at 20-30 ms from \/, q -80 mV, Vvith either 1.5 
mM Ca 
2+ (0, n=7) or 0.5 mM Cd 
2+ in the bath (0, n=2). B: Mean -and SEM of 
currents measured at +60 W following 10 s conditioning pulses to between -100 
and +10 mV normalised to the current follovving the -100 mV conditioning Pulse, 

















ca 0.3 E 
0 z 
0.0 
Conditioning potential (mV) 
166 
of% 
-Ou -60 -40 -20 0 20 
Membrane Potential 
-100 -80 -60 -40 -20 0 
5.1.3. GLIBENCLAMIDE-SENSITIVE K+ CURRENT IN HMSMCS 
The existence of a glibenclamide-sensitive, ATP dependent W current (IKATp) in pregnant 
HMSMCs was investigated. To isolate this current, cells, were dialysed with normal high 
W pipette solution, but without any ATP (to maximise basefineIK. ATP), and perfUsed with 
C2'-free PSS, containing high W (140 mM KCI replacing NaCI) as the bath solution. This 
was in order to shift the W reversal potential close to 0 mV, thus enabling IK. ATP tObe 
more easily measured as an inward current at -100 mV, where other W currents are 
negligible. I mM TEA was also present in the bath solution to block IK(c. ). 
The example given in Fig 5.6 shows aI second current ramp to between -100 mV and +5 0 
mV from a holding potential of -60 mV. As expected for aW current under these 
conditions, the current was inward at -100 mV(Fig 5.6A, indicated by arrow), outward at 
+50 m. V, with reversal near 0 mV. The inward current at -100 rnV was increased 6-7 fold 
by the addition of I pM levcromakalim, an activatorOf 1KATP (Quayle et aL, 1997) (Fig 
5.613, indicated by arrow) and, in the continued presence of levcromakalim, was blocked 
by 10 pM glibenclamide, a blocker of IKATp (Quayle et aL, 1997) (Fig 5.6C, indicated by 
arrow). The glibenclamide-sensitive current, derived by subtracting current in the presence 
of both levcromakalim and glibenclamide from current in the presence of levcromakalim 
alone, is shown in D. The effects of both levcromakahm and glibenclamide were fully 
reversible on washout (not shown). In order to determine whetherIKATP could still be 
measured under a normal Ký gradient and with ATP in the pipette, the same voltage 
protocol was applied to another cell from the same myornetrial sample, using 5 mM ATP 
in the pipette and normal low W PSS containing 10 MM TEA in the bath. In that cell, 10 
pM glibenclamide had no effect on current amplitude at -100 rnV or at +50 mV. 
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I second duration current ramps to between -100 and +50 mV from HP -60 mV in 
a pregnant HMSMC. A: high K+ PSS containing 1mM TEA. B: the addition of I 
pM levcromakalim (lev). C: the addition of 10 pM glibenclamide (glib). D: 
Glibenclamide-sensitive current, derived by subtracting current in C from current 
in B. Current amplitude at -100 mV is indicated by the arrows. The dotted lines 




5.2.1. TEA SENSITIVE CURRENT 
The ionic currents of HMSMCs are composed of TEA and 4-AP sensitive components and 
components insensitive to the combination of both drugs. The noisy TEA-sensitive 
component almost certainly represents the large conductance (hence the noisiness) 
calcium-activated potassium current (IK(c. )) which has been extensively characterised in rat 
and human myometrium. (Toro et d, 1990b; Perez et aL, 1993; Anwer et aL, 1993; Khan 
et aL, 1993; Perez & Toro, 1994; Meera et aL, 1995; Khan et aL, 1997; Wang et d, 
1998). This component was of similar magnitude in both pregnant and non-pregnant cells. 
This contrasts with the recent study in rat myometrium (Wang et aL, 1998), where IK(c. ) 
formed a considerably larger component of the whole current in cells from non-pregnant 
rats, when cell size was corrected for, and where its activation was shifted in the 
hyperpolarised direction in non-pregnant cells (Vo. 5 = +39 mV) compared to cells from 
pregnant rats (Vo. 5 = +63 mV). 
5.2.2. TRANSIENT 4-AP SENSITIVE CURRENT (1K, A) 
The transient "A-like" component of the 4-AP sensitive current (IKA) has also been 
described previously in human (Erulkar et aL, 1993) and in rat myometriurn (Miyoshi et 
aL, 1991; Erulkar et aL, 1994; Wang et aL, 1998). The voltage dependencies of activation 
and inactivation of I", with 1.5 mM Ca2' in the bath solution in the present study 
(activation threshold and inactivation Vo. s both around -70 mV), differ from those 
attributed to the A-Eke current in cultured leiornyoma cells from non-pregnant women, 
with 5 mM C2' in the bath solution (activation threshold - -40 mV and inactivation Vo. 5 of 
-24 rnV, Erulkar et al., 1993) or in 17p-estradiol treated cells from immature rat uterus 
with 2.5 mM C2' in the bath solution (threshold - -50 rnV and Vo. 5 of -48 mV, Erulkar et 
al., 1994), but were similar to those of the ITo described in freshly dispersed non-pregnant 
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rat myometrial cells, with I mM Ca2' in the bath solution (threshold and VO. s both < -70 
mV, Wang et al., 1998). These differences may be due to the different [C2'],, used in the 
four studies, since Wang et aL, (1998) showed that in the non-pregnant rat myometrium, 
the activation and inactivation of ITo were both shifted in the positive direction by raising 
[Ca2'],, from I to 30 mM. Indeed, A-currents in other tissues have been shown to be 
2+ sensitive to the concentration of most extracellular divalent cations, such as Cd , which, 
when replacing a similar concentration of CP in the bath solution, causes large 
depolarising shifts (between 10 and 30 mV) in the voltage-dependence of both activation 
and inactivation in guinea-pig ureter smooth muscle (Imaizumi et aL, 1990), opossum 
esophageal circular muscle (Akbarali et aL, 1995) and rat and human ventricular myocytes 
(Stengl et al., 1998). 
In pregnant and non-pregnant cells where both &A and 1c. were present, the two currents 
overlapped at potentials between -40 mV and +10 mV. In most of these cells there was no 
net inward current in the absence of 4-AP but rather a net rapid transient outward current 
that increased in amplitude as the membrane potential was increased. This current existed 
mostly because &A activated faster than Ac., as indicated by the faster time to peak of 1KA 
at -20 and 0 mV than of Ac.. A similar overlap of these two currents and faster time to 
peak of &A has also been found in guinea-pig colonic smooth muscle cells (Vogalis el aL, 
1993). Furthermore, in the guinea-pig colon (Vogalis et aL, 1993) as well as guinea-pig 
ureter (Imaizumi et aL, 1990) and opossum esophageal circular muscle (Akbarali et aL, 
1995), the addition of 4-AP under current clamp conditions caused a leftward shift in the 
upstroke of the action potential as well as causing an overall depolarisation. It is believed 
therefore that in these tissues the A-current may be available at the resting membrane 
potential and may activate before and simultaneously with Ac., thus delaying or even 
preventing action potential spike generation. 4-AP has also been shown to depolarise strips 
of pregnant rat myornetrium. (Wilde & Marshall, 1988), but its effect on the upstroke of 
the action potential was not examined. The described electrophysiological. properties of 
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IK, Aare similar to those in the other smooth muscles discussed above and a proportion of 
the channels responsible for this current would be expected to be available at and perhaps 
contribute to the resting membrane potential (around -50 mV in pregnant human 
myometrium, see table 1.1. ). 
In the present study, IK. Aoccuffed more frequently in cells from non-pregnant women (80 
%) than in cells from pregnant women (50 %), but, probably because of the number of 
cells examined, when this difference was examined in terms of mean current density, it was 
not statistically significant. A more pronounced difference was found by Wang et al. 
(1998) in rat myornetriurn where ITo was found in 50 % of non-pregnant myocytes but was 
very rare in pregnant cells. The lack of significance in the present study may also have been 
due to contamination by the 4-AP sensitive delayed rectifier current which was more 
abundant in pregnant cells, although this is unlikely since IKAactivated so much faster than 
the delayed rectifier. 
There is some evidence to suggest however that expression of 1K. Amay be influenced by 
steroid hormones. For example, estrogen treatment in immature rats reduced the incidence 
of myometrial cells expressing &A from 79 % to 30 % (Erulkar et aL, 1994). These 
effects are potentially of physiological relevance because activity of the uterus is associated 
with circulating steroid hormone levels (Csapo, 1956; Marshall, 1962; Abe, 1970). In 
pregnant sheep for example, estradiol rises sharply at or around delivery then falls sharply 
back below gestational levels post-parturn (Thorbum & Challis, 1979; Verhoeff et aL, 
1985b) In humans a similar pattern occurs, although the rise in estrogen level is more 
gradual (Berg & Kuss, 1992). Alternatively, Erulkar et al., 1993 suggest that 1K. Amay 
have a role in cell growth and proliferation, since in human non-pregnant myometrium it 
was much more abundant in leiornyoma cells (a benign myometrial tumor) than in normal 
differentiated cells. 
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5.2.3. "DELAYED RECTIFIER" CURRENTS 
Most cloned delayed rectifier W channel currents (Table 1.3) and many native delayed 
rectifier type W currents are sensitive to 4-AP, with EC50 values in the micromolar range. 
In the present study, the resistance of a substantial component of the outward current to 
block by the combination of 10 mM TEA and 5 mM 4-AP therefore suggests the presence 
of either a single voltage-gated current with low sensitivity to 4-AP (ECso -5 niND, or two 
currents, one with relatively high sensitivity (ECso <I mM) and one with relatively low 
sensitivity to 4-AP (EC5o >> 5 mNI). The presence of a TEA and 4-AP-insensitive 
component of the delayed rectifier current in human and rat myometrium has been implied 
by previous studies, but it has not been characterised in any great detail (Miyoshi et aL, 
1991; Erulkar et aL, 1993; Inoue et aL, 1993; Erulkar et aL, 1994). 
In the present study, the 4-AP sensitive component of the delayed rectifier current was 
significantly greater in pregnant cells than in non-pregnant cells, assuming that this 
difference represents a shift in the relative expression of channel types, rather than a 
change in 4-AP sensitivity of a single channel type. The physiological relevance of this is 
unknown, as is whether delayed rectifier currents are influenced by steroid hormones in a 
manner similar to that of IKA. The only other voltage-gated W current known to be 
influenced by steroid hormones is the slow delayed rectifier minK/KvLQTI (Boyle et al., 
1987b), which is relatively insensitive to 4-AP. 
In a preliminary study published in abstract form, using the same experimental conditions 
as described in this chapter, inactivation of the sustained 4-AP-insensitive component of 
the delayed rectifier current was shown to be voltage-dependent, with a relatively negative 
Vo. s (-67 mV) (Smirnov et al., 1995). The pharmacological and electrophysiological 
characterisation of the delayed rectifier current, following the assumption that there are 
two distinct voltage-gated currents, one 4-AP sensitive and the other 4-AP insensitive, is 
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described and discussed in more detail in chapter 6, in which care was taken to remove or 
dhninish any influence of Ic., IK(c. ) and IKAon current characteristics. 
5.2.4. GLIBENCLAMIDE-SENSITIVE CURRENT 
When current ramps from -100 rnV up to +50 rnV were applied to cells with symmetrical 
W in the pipette and bath solutions, a shallowly sloping current was present, being inward 
at -100 mV and reversing close to 0 mV. In a cell where ATP was excluded from the 
pipette solution, this current was linearly enhanced by levcromakalim and inhibited by 
glibenclamide, suggesting the presence of an ATP-sensitive W current (IKATP) in 
HMSMCs. In another cell with 5 mM ATP in the pipette, this current was not present. 
Direct measurement of KATpcurrent has not previously been reported in the myometrium, 
but its presence has been implied by the action of drugs selective for this channel on 
myornetrial contraction in vitro. In those studies, spontaneous or OT-induced contractions 
of pregnant human and rat myornetrium. were inhibited by levcromakalim, aprikalim, 
pinacidil (all activators of KATP channels), and these effects were partially or completely 
antagonised by the blocker glibenclamide (Cheuk et aL, 1993; Morrison et aL, 1993; Piper 
& Hollingsworth, 1995; Khan et aL, 1998). 
The relaxant effect of channel openers proves that the channels are present but does not 
prove that they are normally involved in controlling the resting membrane potential or 
action potential repolarisation. However, glibenclamide was shown to increase 
spontaneous contractions in non-pregnant but not pregnant human myometrium in vitro 
(Cheuk et aL, 1993), suggesting that expression of myometrial KATPchannels may change 
in response to pregnancy, and in a more recent in vitro study in strips of pregnant human 
myometrium, glibenclamide did not significantly affect the amplitude or decay of the after- 
hyperpolarisation induced by PGE2or PGF2. (Parkington et aL, 1999). Even if the KATP 
channel is down-regulated in pregnancy, however, its ATP sensitivity may be important in 
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labour when the myometrium becomes hypoxic and ATP levels win be expected to be 
lowered. Under these conditions IKATp may be activated sufficiently to induce 
hyperpolarisation, thus providing periods of relaxation between contractions, as has been 
demonstrated in coronary and mesenteric vascular smooth muscle (Quayle et aL, 1997). 
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Chapter 6 
Voltage-Gated Potassium Channel 
Currents in HMSMCs of Pregnant 
Women 
17S 
6.1. METHODS AND RESULTS 
6.1.1. ISOLATION OF "DELAYED RECTIFIER" K" CURRENTS 
All experiments described in this chapter were performed with freshly dispersed HMSMCs 
from pregnant women who were not in active labour. As described in chapter 5, there is an 
outward delayed rectifier current in HMSMCs that appears to have two components, a 
component sensitive to 5 mM 4-AP and a component insensitive to 5 mM 4-AP. The 
detailed characterisation of these two currents required that all other currents (Ic., IK(c. ) 
and IKA) be minimised or completely removed if possible. Ca2+-free PSS was used 
throughout to abolish Ic. and 0.5 mM CdCI2 was added to the bath solution to completely 
block C2' channels thus eliminating the possibility that W efflux through those channels 
were contributing to the outward current at positive membrane potentials. These two 
changes also served to diminish the amplitude of IK(c. ). The majority of the remaining IK(c. ) 
was eliminated by the addition of I pM paxilline, a selective blocker of BKc. channels 
(Sanchez & McManus, 1996), or I mM TEA, to the bath solution. The TEA 
concentration was lowered from 10 to I mM to take into account the possibility that the 
delayed rectifier currents were TEA sensitive, and the sensitivity of the voltage-gated 
currents, as well as Ik(c. ), to TEA is presented later in this chapter (Fig 6.5. ). 
As is shown in chapter 5, IKA is also sensitive to Cd2'. At 0.5 mM, because of the large 
rightward shift in the activation of A", Cd2' caused considerable block of the current at 
membrane potentials negative of 0 mV but less so at more positive potentials (Fig 5.5. ). In 
the majority of subsequent experiments under these conditions, no further A-like currents 
were observed. 
Using the above described modified bath solutions, the addition of 5 mM 4-AP was found 
to have different actions to those described in chapter 5. In some ceRs, 4-AP caused 
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considerable inhibition of the current, leaving very little outward current, while in others 
there was very little inhibition of the substantial outward current or even a slight increase 
when 4-AP was applied. This differential action of 4-AP suggested the idea that there were 
at least two distinct components to the delayed rectifier current which could be 
distinguished by their 4-AP sensitivity, and which varied in their relative proportions 
between cells. Subsequent experiments supported this possibility. 
6.1.2. AVAILABILITY OF THE VOLTAGE-GATED W CURRENT 
One of the important characteristics of the delayed rectifier is its tendency to inactivate at 
depolarised membrane potentials. Therefore, using C2'free PSS contaimi g 0.5 MM CdC12 
and I mM TEA in the bath solution, availability of the delayed rectifier W current was 
investigated with the following experimental protocol. The membrane potential was held at 
-80 mV and 10 second conditioning pre-pulses to between -100 mV and +10 mV were 
applied, followed by a 200 ms test Pulse to +60 ffiV (at 0.03 Hz). This protocol was then 
repeated in the presence of 5 mM 4-AP. 
Fig. 6AA shows the currents elicited by the +60 mV test pulse following conditioning 
voltages to between -100 mV and +10 mV, in one cell. The current began to inactivate 
after conditioning potentials positive of -90 mV, and showed little further inactivation 
positive of -40 mV. The addition of 5 mM 4-AP did not on average affect the overall 
current amplitude following the -100 mV conditioning potential, but appeared to increase 
the component of the current that inactivated following the conditioning pulse to -40 mV, 
without significantly affecting the half-inactivation value (Fig. 6.1B). By contrast, in 
another morphologically similar cell, the same voltage-protocol revealed a current that 
only began to inactivate when conditioning potentials positive of -50 mV were applied, 
and which was almost completely inactivated at 0 mV (Fig. 6.1 Q. This current was almost 
completely blocked by 5 mM 4-AP (not shown, but see Fig. 6.3). 
177 
A similar correlation between the voltage range of current availability and 4-AP sensitivity 
appeared to exist in most cells. This correlation was finiher investigated using several 
approaches. Firstly, cells were divided into 2 groups on the basis of a strong (>70 % 
block) or weak (little or no inhibition, or an increase, in current amplitude) block of the 
current by 5 m. M 4-AP. The availability of the current was assessed in each cell by 
measuring current amplitude at the end of a 200 ms test pulse to +60 mV, which followed 
a conditioning potential between -100 and +10 mV. Fig. 6AD illustrates the mean 
availability of the current in the 4-AP sensitive (filled squares) and insensitive (filled 
circles) groups of cells. The open circles represent the availability of the 4-AP-insensitive 
cells in the presence of 5 mM 4-AP. All data points have been normalised to the current 
amplitude observed after the conditioning step to -100 mV. In the absence and presence of 
4-AP, the amplitude of the test pulse after the -100 conditioning step was 1095 ± 337 and 
1269 ± 429 pA, respectively (non-significant, n= 6). 
The data illustrated in Fig. 6.1 D were fitted to the Boltzmann function in order to derive 
the parameters Vo. 5 (half-inactivation potential), k (slope factor) and A (fraction of the 
current not inactivated). In the absence of 4-AP, VO. 5 of the current in the 4-AP insensitive 
cells was -65 ±3 mV, the non-inactivating component (A) was 36±2% and k was 8±2 
(n = 6). In the presence of 5 mM 4-AP, Vo. 5 in these cells was -68 :L3 mV, the non- 
inactivating component was 37 ±4% and k was 6±2 mV (n = 6). Conversely, the V6.5 of 
the current in the group of cells sensitive to 4-AP was -30 ±I mV. The non-inactivating 
component of the current in this group of cells was 15 d: 4% and k was 5 A: I rnV (n = 6). 
The differences in the half inactivation potentials and size of the non-inactivating 
component between the two groups of cells were highly significant (P < 0.001). 
The low threshold current which was not inhibited or slightly increased by 5-niM 4-AP, 
and which reached its maxfinal extent of inactivation negative of -30 mV (filled circles in 
Fig. 6AD), shall hereafter be referred to as AKI. The high threshold current, which was 
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inhibited by 4-AP and inactivated between -50 mV and 0 mV (fifled squares in Fig. 6.1 D) 
wiH be termed IK2. 
The small degree of overlap which existed between the potential ranges over which IKI and 
AK2 inactivated suggested that it would be possible to investigate the properties of each 
current by utilising different holding potentials. The following 3-step inactivation protocol 
based on the distinctive inactivation properties of these currents was therefore applied. 
Current was recorded at the end of a 200 ms test pulse to +60 mV firstly after holding at 
-80 m. V, then after a 10 second pre-pulse to -40 mV in order to inactivate AKI, and then 
after a 10 second pre-pulse to 0 mV to inactivate AK2. The amplitude of IKI (in cells where 
IKI was the predominant current) was therefore estimated as the current remaining after 
the -40 mV pre-pulse subtracted from the current present after the -80 mV holding 
potential, and the amplitude Of AK2 (in cells where IK2 was the predominant current) was 
estimated from the current remaining after the pre-pulse to 0 mV subtracted from the 
current remaining after the pre-pulse to -40 mV. 
In the 14 cells where the 3 step inactivation protocol was carried out in the absence and 
presence of 5 mM 4-AP, the cells were clearly divided into two groups (Fig. 6.2A). In one 
group (IKI) current was inactivated by pre-pulses to -40 mV and was either unaffected or 
enhanced by 5 mM 4-AP (n = 7, filled squares). No further inactivation was observed in 
these cells when the conditioning potential was set at 0 mV (open squares). In the other 
group (IK2) current was almost completely inhibited by 5 mM 4-AP, and was only slightly 
inactivated at -40 mV (filled circles, n= 7). The current in this group of cells was then 
almost completely inactivated by prepulses to 0 mV (open circles). 
The 3-step inactivation protocol described above was carried out in 42 cells. Fig. 6.2B 
depicts the extent to which the conditioning potential of -40 mV inactivated the outward 
current, relative to the inactivation recorded at 0 mV in each cell. These results show that 
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two distinct groups of cells could be distinguished on the basis of the degree to which the 
conditioning potential-sensitive component was inactivated at -40 mV. The peak on the 
left represents cells in which the outward current showed relatively little inactivation at -40 
mV (ie cells whereIK2was dominant), while the peak on the right represents cells in which 
the outward current was markedly inactivated at -40 mV (cells where IKI was dominant). 
Note that the 4 bars on the extreme right represent cells in which the current was 
somewhat larger after the conditioning step to 0 m. V than it was after the conditioning step 
to -40 ffiV. This effect may have been due to some activation of the minor residual 
component of IK(c. ) or some other unidentified current during the conditioning step to 0 
mV (see discussion). 
The membrane capacitance of the cells comprising each peak in Fig. 6.213 was calculated 
from the area under the capacitative artefacts as an indication of the cell surface area, and 
therefore cell size (Smimov & Aaronson, 1994). The cell capacitance was 99.9 ± 9.6 pF in 
the 24 cells in which AKI predominated, and 110.6 ± 12.6 pF in the 18 cells in which IK2 was 
dominant; these values were not significantly different. As far as could be determined, all 
biopsies were taken from the same region of the myometrium from women at term who 
were not in active labour, and under light microscopy there were no obvious 
morphological differences between the two groups of cells. There was no preferential 
expression of either IKI or AK2 in cells from any one biopsy, each isolation often producing 
some cells with only IKI and some with only IK2- Only on very rare occasions were cells 
found that expressed an equal amplitude of both IKI and AK2. 
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FIGURE 6.1. INACTIVATION OF DELAYED RECTIFIER K* 
CURRENTS 
A-C: Examples of the 4-AP insensitive current recorded at +60 mV following 10 
second conditioning pre-pulses to between -100 and 0 mV (at 10 mV increments) 
in the absence (A) and presence (B) of 5 mM 4-AP. C shows the inactivation of 
the 4-AP sensitive current for potentials between -90 and +10 W in a different 
cell under identical conditions as in A. Currents following the pre-pulses to -80,, 
-40 and 0W are indicated by arrows. The doffed lines represent zero current'. 
D: Mean and S. E. M. end of pulse measurements of the currents represented in 
A-C, normalised to the current elicited following the -100 mV conditioning pre- 
pulse. Points show the 4-AP insensitive current in the absence (0, n= 6) and 
presence of 5 mM 4-AP (0, n= 6) and the 4-AP-sensitive current in the absence 
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FIGURE 6.2. DIFFERENTIAL DISTRIBUTION OF /KiANDIK2 
A: Relationship between inactivation and sensitivity to 5 mM 4-AP for 1K, (n = 7) 
and /Q (n = 7) currents. The percentage of current at +60 mV inactivated after a 
10 second conditioning pre-pulse to either -40 W (/K1,0; IK2,40) or 0W (1Kj, 0; 
/K2,0) is plotted against the percentage change in peak current amplitude 
caused by the application of 5 mM 4-AP during a step to 0W from a holding 
potential of -80 W. B: Frequency distribution of inactivation of the current at +60 
W by a 10 s conditioning pulse to -40 W in 42 cells, expressed as a fraction of 
the total inactivating component using the degree of inactivation by a pre-pulse 
to 0 mV as maximum. Data are binned at intervals of 0.1 (equivalent to 10 % of 
total inactivation). Two peaks are visible, one at 0.2 (corresponding to /K2) and 
one at 0.9 (corresponding to /Ki). 
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6.1.3. ACTIVATION AND DECAY 
Fig. 6.3. illustrates the effect of 5 mM 4-AP, on the outward current recorded over 10 s 
pulses to between -50 mV and +10 mV from a holding potential of -80 mV. Fig. 6.3A and 
B shows currents observed between -50 and +10 mV in a cell where Iki predominated, in 
the absence (A) and presence (B) of 5 mM 4-AP. Fig. 6.3C and D shows current in a cell 
where IK2predominated, in the absence (C) and presence (D) of 5 mM 4-AP. IKI current 
appeared to be slightly enhanced by 5 mM 4-AP in the example shown here, but in a group 
of 5 cells the difference did not reach statistical significance (7 ± 10 % enhancement at 10 
s, n= 5). Ak2on the other hand, was blocked significantly by 5 mM 4-AP (63 111 %, n 
6, P<0.05). 
Fig. 6.3. also illustrates two other differences between IKI and AK2. Firstly, IKI current was 
apparent at -40 to -50 mV, whereas for IK2 current visibly activated between -40 and -30 
mV. Secondly, IKI decayed significantly more slowly than IK2 (66.2 ± 4.7 % decrease in 
amplitude over 10 seconds for AKI vs. 82.7 ± 5.6 % over 10 seconds for AK2, P<0.05). To 
confirm this, 10 s currents were fitted with exponential curves and time constants 
calculated. A, decay was best fitted to a double exponential with a constant whereas IK2 
decay was well fitted to a single exponential with a constant component. For IK, at +10 
mV: ri was 1016 ± 316 ms and was 22 ±4% of total; r2 was 5213 ± 1068 nis and 46 ±5 
% of total, and the constant component was 32 1- 3% of total (n = 6). For IK2 at +10 mV: 
r was 2552± 233 ms and was 89 d: 3% of total, and the constant component was 11 ±3 
% (n = 6). r2 was the largest component of IK I and was significantly larger than the r value 
of IK2 (P < 0.01). The constant component was also significantly greater for IKI than for IK2 
(P < 0.01). Maintaining cells with either Ak, or IK2 present at a holding potential of 0 mV 
for several minutes resulted in little or no net outward current, suggesting that the constant 
component of the 10 s currents was in fact a very slowly inactivating component. The 
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kinetics of activation for IKI and AK2 were determined by fitting current traces to a first 
order power function: 
y= A*(I-expf-(t-K)/T))AI +B equ. 6.1, 
where A is the current amplitude (pA) at the time t (ms) and T is the time constant. Both 
types of current were found to fit better to this function than to exponential or higher 
order power functions. Fig. 6.4. shows the fits (black traces) for representative IKI and AK2 
currents (red traces) at potentials between -40 and +10 mV and the mean time constants 
calculated from those fits in six and five cells, respectively, plotted against membrane 
potentials. As is shown in Fig. 6A, in addition to inactivating more slowly, IKI activated 
significantly more slowly than IK2 at all potentials, and displayed a noticeable delay before 
the exponential phase of the activation, especially at membrane potentials close to the 
threshold. 
6.1.4. BLOCK OF lKiAND/K2BY TEA 
The sensitivity of IKI and IK2 to TEA was determined by investigating the effect of 
increasing concentrations of this agent (1,3,10, and 30 mM) in cells where either IKI or 
IK2 predominated. As described above, IKI was ftirther isolated by defining it as the 
difference current which was present at a holding potential of -80, but not -40 mV, while 
AK2 was defined as the difference current which was present at a holding potential of -40, 
but not 0 mV. In addition, to determine the extent to which IK(c. ) was blocked by I MM 
TEA, a TEA concentration-response curve was constructed when the membrane potential 
was held for several minutes at 0 mV in order to maximise the inactivation of all voltage- 
gated W currents. Fig. 6.5A shows the percent inhibition of IKI, IK2 and IK(c, ) by TEA. AK, 
and AK2 demonstrated partial block by TEA. At I mM, both IKI and AK2 were significantly 
inhibited (by 24 ±8% and 29 ±5% respectively n= 5-6), in contrast to IK(c. ) which was 
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inhibited to a much greater extent (75 ±3%, n=4, P<0.01) compared to both IKI and 
AK2. 
The I-V relationships for IK(c. ) in the absence and presence of I mM TEA (in 1.5 mM C2" 
PSS and without Cd2) are described in Fig. 6.5. The I-V curve, as well as the lack of 
outward current at the holding potential of 0 mV, suggested that IK(c. ) activated positive of 
0 mV. There was a small but insignificant additional inhibition of this current when in 
addition to the application of I mM TEA, C2" was removed and 0.5 mM CdC12 Was 
present (74± 5% in PSS n=4 vs. 80 -+ 6% in CP free PSS with 0.5 mM 
CdC12, n= 4). 
The blockade of IKI by I mM TEA was also measured in the presence of I ýM paxilline, 
defming IKI as the difference current present at a holding potential of -80 but not -40 mV 
in cells where this current predominated. Under these conditions, I mM TEA inhibited the 
current by 27 ±I%, (n = 5). This value was similar to that recorded in the absence of 
paxilline. 
These experiments suggested that I mM TEA caused a small but significant inhibition of 
IKI. To determine whether this partial block by TEA or whether the removal of Ca2' and 
addition of Cd2' were affecting the voltage-dependent characteristics of IKI, availability 
experiments were repeated in CP free PSS containing I pM paxilline, an alternative more 
selective blocker of Ik(c. ), as well as 5 mM 4-AP and 0.5 MM CdC12. Availability 
experiments were also carried out in the presence of normal-CP PSS containing 10 mM 
TEA and 5 mM 4-AP. I pM paxilline was found to cause inhibition of IK(c. ) comparable to 
that caused by 10 mM TEA (using a0 mV holding potential, data not shown). The 
inactivation of IKI under both sets of conditions was similar to that described in Fig. 6.1. 
Half-inactivation potentials and the proportion of non-inactivating current under all three 
sets of conditions are summarised in Table 6.1. Using ANOVA for multiple comparisons, 
there were no significant differences in any of the three parameters between the four sets 
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of conditions, although differences in the size of the non-inactivating component came 
close to statistical significance (P = 0.065). 
In two additional pregnant EMSMCs, one with 10 mM TEA and 5 mM 4-AP already in 
the bath and the other with 10 mM TEA, 5 mM 4-AP and 100 PM clofilium (see below) 
already in the bath, 20 pM niflumic acid was applied, in order to determine the 
contribution, if any, of chloride current to the outward current at +60 mV from an VH of - 
80 mV. At this concentration, niflurnic acid did not inhibit the remaining current. Indeed in 
the first cell the current was in fact increased by - 20 %. 
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mV for IK, (A and B) and /K2 (C and D). A: /Ki in the absence of 4-AP. B: /Ki in the 
presence of 5 mM 4-AP in the same cell as in A. C: IK2 in the absence of 4-AP. D: IK2 in 




Fig 6.4. Activation kinetics of IK, and lk2 

















A and B: Currents elicited by depolarisations to between -40 and +10 mV (red traces) in 
cells where /K1 (A) and /K2 (B) predominate with fitted curves (solid black lines) 
superimposed (see text for fitting procedure). The dotted lines represent zero current. 
C: a plot of time constants (tau) against membrane potential (mean and S. E. M. ) (/K1 =0 
/K2 = 0). Asterisks represent significant differences at P<0.05. 
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FIGURE 6.5. EFFECT OF TEA ONIM 9 IK2AND Iwo 
A: Dose response for TEA, plotting the meant SEM % inhibition of /K, (0, n= 5- 
6), IK2 (0, n= 5-6) and IK(ca) (0, n= 4) against TEA concentration. All three 
currents were significantly inhibited by all concentrations of TEA (P < 0.05). B: I- 
V relationship for IK(ca) in 4 paired cells in the absence (0) and presence (0) of 1 
mM TEA, plotting the mean ± S. E. M. of current (normalised to the current at +60 
mV in the absence of TEA) against membrane potential. IK, and /K2 were 
recorded using the 3 step inactivation protocol (see text). IK(Ca) was recorded in 
normal PSS (1.5 mM Ca2) from a holding potential of 0 mV and a test potential 
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TABLE 6.1. EFFECT OF BATH SOLUTION ON lki INACTIVATION 
CHARACTERISTICS. 
Bath Solution V0.5 k Non-inactivating 
component 
1 pM paxilline, 0.5 M -61± 3 mV 8+0.4 mV 43 ±3% 
CdC12,5 mM 4-AP (n = 5) (n = 5) (n = 5) 
1 mM TEA, 0.5 M CdC12 -65 ±3 mV 8±2mV 36 ±2 % 
(n = 6) (n = 6) (n = 6) 
1M TEA, 0.5 mM CdC12, -66 ±2 mV 9d: 4mV 36± 1% 
5M 4-AP (n=6) (n = 6) (n = 6) 
10 mM TEA, 1.5 mM CaC12, -67 ±3 mV 8±2mV 30± 5% 
5 mM 4-AP (n=5) (n = 5) (n = 5) 
Half-inactivation potentials (VO-5), slope factor (k) and percentage of IK, at +60 mV which 
does not inactivate, calculated by fitting steady-state inactivation data to Boltzmann 
distribution. There were no significant differences in any of the three variables between 
the four sets of conditions (using ANOVA for multiple comparisons). 
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6.1.5. VOLTAGE-DEPENDENCE OF ACTIVATION OF IKI 
The threshold of activation of IKI when paxilline was used to block IK(c. ) was also similar 
to that seen with I mM TEA. To investigate this further, the I- V relationship of IKI was 
constructed using depolarisations to between -80 mV and +60 mV from a holding 
potential of -80 mV, in a C2+'free bath solution containing I pM paxilline, 0.5 mM CdCl2 
and 5 ffiM 4-AP. Fig. 6.6. shows example traces (A), the mean nonnalised I-V relationship 
(B) and the normalised current activation relationship calculated from this data (C, n= 5). 
The activation relationship ýhortonductance) was calculated from the equation y= II(V. - 
E, ) where I is current amplitude, V. is the membrane potential and E, is the reversal 
potential (calculated as -83 mV). These data were then fitted to the Boltzmann equation 
and the mean half activation potential and slope factor in the 5 cells were calculated as 
+1.2 ± 4.4 ffiV (indicated by dotted black line) and -16 ±I mV, respectively (Fig 6.6C). 
The mean normalised availability curve and mean half inactivation potential for IKI with I 
pM paxilline, 0.5 ffiM CdCI2 and 5 mM 4-AP in the bath solution (red lines) are also 
shown in Fig 6.6C, super-imposed on the normalised activation curve. The solid red line 
shows inactivation inclusive of the non-inactivating component of IKI. Alternatively, taking 
into account the possibility that only a part of the non-inactivating component is IKI, the 
inactivation curve with the non-inactivating component removed is also shown (dashed red 
line). This second curve bisects the activation curve at a membrane potential where the 
current is not fully inactivated, implying a window current (at membrane potentials at 
which activation and inactivation are balanced in favour of activation a steady-state current 
may result) for IKI between -60 mV and -20 mV, with a peak at about -36 mV. 
6.1.6. EFFECTS OF 4-AP AND CLOFILIUM ON lKi AND IK2 
The effects of increasing concentrations of 4-AP (0,1,2,5,10, and 20 fflM) on IK I and IK2 
were detennined using the 3-step inactivation protocol described above (prepulses to -80, 
-40 and 0 mV), and are shown in Fig. 63A and B, respectively. In Fig. 63C and D, the 
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relative inhibition (or enhancement) by each concentration of 4-AP on Ik, and on IK2 
components respectively, are plotted. IKI was significantly enhanced by 10 and 20 mM 4- 
AP (P < 0.05, n= 5), whereas IK2 was significantly inhibited by all concentrations of 4-AP 
tested (P < 0.001 for each concentration, n= 5). 
The effects of several concentrations of clofilium (a blocker of voltage-gated W currents) 
on IKI and a single concentration (100 gNl) on IK2. in representative cellsare shown in 
Figs. 6.8A & B, respectively. Currents were elicited by 10 second pulses to 0 mV from a 
holding potential of -80 mV in CP free PSS containing 0.5 mM CdCl2 and I mM TEA. 
The predominance of either IK, or AK2 was confirmed in each cell with the 3-step 
inactivation protocol. Decay of IKI was enhanced in a concentration-dependent manner by 
clofiliurn such that at 100 pK the current was nearly abolished after 10 s. Percent block of 
IKI at peak and end of pulse are presented in Fig. 6.8C (n = 5-8). In cells where IK2 was the 
predominant current (as in Fig 6.8B, also defined using the 3-step inactivation protocol), 
IK2 was also profoundly inhibited by 100 pM clofilium (90 ±5% at 200-300 ms; 96: L 3% 
at 10 s, n= 4). The effect of 100 pM clofilium. on IKI was also evaluated over a range of 
membrane potentials between -80 mV and +60 mV in 4 cells, with normal C2'-PSS 
containing 10 mM TEA and 5 mM 4-AP in the bath solution. The resultant mean 
normalised I-V curve is presented in Fig 6.81). Clofilium was less potent at potentials 
positive to 0 mV, however this was only significant at +60 mV (90 :L3% block at 0 mV 
vs. 68 ±6% at +60 mV, P<0.05). The non-inactivating component of IKI, defined as the 
fraction of the current at +60 mV not inactivated following a 10 s conditioning pulse to 0 
mV, was also less sensitive to 100 pM cloflium. (3 9± 10 % block, n=6, P<0.05). 
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FIG 6.6. VOLTAGE-DEPENDENCE OF ACTIVATION OF /Ki 
A: /K1 Currents elicited by 300 ms depolarisations to between -80 and +60 mV 
from a holding potential of -80 mV, using 1 pM paxilline, 0.5 mM CdCl2and 5 mM 
4-AP in a Ca2+ free bath solution. B: Plot of current measured at the end of the 
300 ms pulse against membrane potential, normalised to the current at +60 mV 
(0, mean ± S. E. M., n= 5). C: Activation relationship of /Ki plotting current, 
converted to conductance by the equation y= II(Vm - E, ) (see text) and 
normalised to the +60 mV values, against membrane potential (0, mean ± 
S. E. M., n= 5). The mean inactivation curve derived for /Kj using the same bath 
conditions (see table 6.1. ) is also plotted, with (solid red line) and without 
(dashed red line) the "non-inactivating component". The dotted black and red 
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FIGURE 6.7. EFFECT OF 4-AP ON /KiANDIK2 
(A and B): Plots of 4-AP concentration against measurements of currents elicited 
by +60 MV test pulses following 10 second conditioning pre-pulses to -80 W (1Kj 
= 0, /K2 = 13), -40 mV (1Kj = 9, /K2 = 0) and 0 mV (1K, = A, IK2 = V). Points are the 
mean ± S. E. M. of currents normalised to the current after the -80 W pre-pulse in 
the absence of 4-AP. A: 5 cells demonstrating 1K, as the predominant current and 
B: 5 cells demonstrating IK2 as the predominant current. C and D: 4-AP dose 
response for 1K, (C) and IK2 (D) plotting the mean ± S. E. M. percent inhibition of 
current against 4-AP concentration. 1K, and /K2 were defined using the 3-step 
inactivation protocol (see text). Asterisks show significant enhancement of 1K, 
P<0.05) and inhibition of IK2 (**P < 0.001). 
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FIGURE 6.8. EFFECT OF CLOFILIUM ON /KiANDIK2 
A: Currents elicited by 10 second pulses to 0W from a holding potential of -80 
mV, in a cell where 1K, predominated in the absence and presence of 3,10,30 
and 100 pM clofilium. The dotted lines represent zero current. B: Effect of 100 
pM clofilium on /K2under identical conditions as for 1K, in A. C: Dose response for 
the effect of clofiliurn on IKI, plotting the mean and S. E. M. (n = 5-7) percentage 
inhibition measured at 200-300 ms (0) and 10 s (C)) against clofiliurn 
concentration. D: IN relationship for IKI With 10 mM TEA and 5 mM 4-AP in 
Ca2+-PSS bath solution in the absence (0) and presence (0) of 100 pM 
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6.2. DISCUSSION 
As suggested in chapter 5, the delayed rectifier W current in RMSMCs from pregnant 
women possesses two distinct components QKI and IK2). Here, the characteristics of IK, 
and IK2 and their similarity with other native W currents in myometrium and other 
contractile tissues and with cloned Kv channels is discussed. The possible physiological 
function of IKI in the myometrium is also evaluated. 
6.2.1. ISOLATION OF IKI ANDIK2 
The isolation of IKI and IK2 required the elimination of the other currents present in these 
cells. Ik(c. ) was routinely minimised firstly by excluding Caý' from, and adding 0.5 mM 
Cd2' to, the bath solution. This had the additional benefits of blocking the voltage-gated 
C2" current, and diminishing IKA (see chapter 5), since no transient 4-AP sensitive current 
was present under these conditions. The three parameters of the voltage-dependence of 
inactivation of IKI (VO. 5, k and non-inactivating component) were not altered by the 
replacement of 1.5 mM C2+ with 0.5 mM Cd 2+ in the bath solution. Secondly, either I 
mM TEA or 1 ýLM of the selective antagonist paxilline (Sanchez & McManus, 1996) was 
utilised to block IK(c. ). Both combinations of conditions reduced the outward current 
measured at +60 mV from a holding potential of 0 mV, by about 80 %. The inactivation of 
the voltage-gated currents at this holding potential, combined with the concentration- 
dependence of the block of this current by TEA (Fig. 6.5. ), suggest strongly that the 
current inhibited under these conditions was almost entirely IK(ca). IK(ca) activated only at 
potentials positive of 0 mV under the conditions used in this study but comprised a 
substantial component of the whole cell current at more positive potentials. It was 
inhibited by TEA with an approximate Ed50 of 0.3 mM. 
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In most experiments it was also required that IKI and AK2 be isolated from each other. This 
was accomplished using several approaches. Aki was always studied in cells where it was 
the predominant current, as confirmed using the 3-step inactivation protocol described 
above. In some of those cells (eg results shown in Figures 6.4 and 6.8. ), IK2 contributed 
such a small component of current that it was ignored. In others the IK2 component, was 
blocked using 5 mM 4-AP (eg results shown in Fig. 6.6. and Table 6.1). Finally, in the 
remaining experiments (results shown in Figures 6.5. and 6.7. ) IKI was defined as the 
difference between the currents recorded at +60 mV after the cell was subjected to 
conditioning potentials at -40 and -80 mV. SiMilarlY, IK2 was always investigated in cells in 
which it predominated. In cases where this predominance was not extreme, it was defined 
as the difference between the currents recorded at +60 mV after the cell was subjected to 
conditioning potentials at -40 and 0 mV (Figures 6.5. and 6.7. ). 
6.2.2. CHARACTERISTICS OF IKI; COMPARISONS WITH OTHER 
NATIVE IKS 
IK, has not been previously described in the human myometrium. This current activated 
slowly and with a distinct delay and inactivated slowly. It had a negative apparent 
threshold of activation (between -60 and -50 mV), but with a shallow voltage-dependcncc 
of activation, such that the mid-point of activation was above 0 mV, and had a negative 
voltage-dependence of inactivation (VO. 5 between -61 ffiV and -67 mV). Unlike most 
cloned delayed rectifier-type K' channels (see Table 1.3. ), IKI was not blocked by 4-AP. It 
was, however, inhibited by TEA, with an EC50 close to 3 mM, and by clofilium. with an 
ECso close to 10 pM. 
Inactivation and TEA and 4-AP sensitivity 
IK, is similar in some of its properties to a component of the K* current recently described 
in pregnant and non-pregnant rat myornetrium (Wang et aL, 1998). The C, component. of 
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the whole cell IK in that study was 59 % of the total current and had a Vo. s of inactivation 
(using 10 s prepulses and test potential of +70 mV) of -60 mV. This current was also 
partiaRy sensitive to TEA (2 n2vo and 4-AP (> 5mNI). 
Native currents with similar characteristics to IKI (4-AP-resistance and negative voltage- 
dependence of inactivation) have also been described in colonic smooth muscle of guinea- 
pig (Vogalis et al., 1993) and dog (Thombury et al., 1992b; Carl, 1995), as well as in rat 
hippocampus (Segal & Barker, 1984). In their study, Vogalis et al., (1993) also used TEA 
(5 nA4) to block the C2'-activated current, but used 2s conditioning pre-pulses in 
availability experiments to derive a Vo. 5 of -55 mV, compared to the more negative value in 
the present study using 10 second pre-pulses. Assuming the two currents are related, this 
discrepancy might be due to the very slow inactivation rate of this current such that a true 
steady state would not have been reached after 2 s, hence shifting the inactivation curve to 
the right. The 4-AP insensitive current described in the canine colon (Thornbury et al., 
1992b; Carl, 1995) also had aVO. 5 of close to -65 mV and was TEA-sensitive (ECso 7.7 
mNO but inactivated much more rapidly than IKI. In the present study the availability0f IKI 
was not significantly influenced by partial block with either I or 10 mM TEA. The 1K 
described in rat hippocampus (Segal & Barker, 1984) had an activation threshold of -50 
mV, aVO. 5of inactivation of -63 mV, an EC5o for TEA of 10 m. M and was insensitive to 4- 
AP. 
Non-inactivating component of IKI 
The "non-inactivating component" of IKi measured at the +60 mV test pulse during the 3- 
step inactivation protocol (30-43 % of total) also mirrored that of the currents described 
by Vogalis et al., (1993) and Carl (1995), where the 4-AP-resistant currents inactivated by 
only 50 % and 80 %, respectively. Assuming that the currents described in these three 
studies do in fact share the same inactivation properties, then the differences in size of the 
non-inactivating component may result, at least in part, from the different conditioning 
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pulse durations used (2 s in Volgalis et al., (1993), 10 s in the present study, and 20 s in 
Carl (1995)). 
The absence of a substantial outward current resistant to I mM TEA in cells held for 
several minutes at 0 mV and the complete block of AKI by 100 gM clofilium, at this 
potential supports the suggestion that the true non-inactivating component of IKI at 0 mV 
was very small or non-existent. At +60 mV the test potential used in availability 
experiments, and in the 3-step inactivation protocol used to identify IKI and IK2 
components of the W current, however, the non-inactivating component was only partially 
blocked by 100 pM clofilium. This may mean that only a proportion of the current 
remaining at +60 mV after 10 s pre-pulses to 0 mV represents non-inactivated IKI, and the 
remainder some other current. There are at least four possible candidates for this other 
current, including residual IK(c. ), Acl, IKATp and an other unidentified voltage-gated 
current. 
There is more likely to be a substantial residual component of IK(ca) at +60 mV than at 0 
m. V, because of the positive activation threshold of IK(c. ) under these experimental 
conditions (Fig 6.5B). However, since I pM paxilline appears to be as potent as 10 mM 
T'EA in blocking IK(c. ) when the VH was 0 mV, it is less likely that the majority of the non- 
inactivating component is residual IK(c. ). The size of the non-inactivating component 
appeared to be smaller when I mM TEA was present than when I pM paxilline was 
present and yet smaller when 10 mM TEA was present. This difference, if genuine, could 
be explained by the TEA sensitivity of IKt. 
A significant contribution of Icl, which has been described in human and rat myometrium at 
the single channel level (Coleman & Parkington, 1987; Wang et aL, 1998), to the non- 
inactivating component of AK, at +60 mV is unlikely because niflumic acid did not inhibit 
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this current. The presence of 0.5 mM Cd2+ in most experiments also prevented the 
outward movement of K' through C2+ channels contributing to this current. 
As described in chapter 5, there is also a KATP-like current in HMSMCs. This was present 
in one cell when ATP was excluded from the pipette but not in another where 5 mM ATP 
was present. It is possible however, that a small component of the outward current at +60 
mV is contributed by a KATp current that is relatively insensitive to ATP, as has been 
shown to exist in other smooth muscles (Yamada et aL, 1997). 
If the non-inactivating component is not entirely IKI (or AM) and is actually represented 
partly by a distinct current, it is therefore most likely that it is another voltage-gated 
current. The most probable candidate for this is the minK/KvLQTI channel which is 
expressed in rat uterus, activates and inactivates extremely slowly and has a similar 
sensitivity to clofilium. as IKI. However, it is also partially 4-AP sensitive and less TEA- 
sensitive than IKI (Boyle et al., 1987a; Attali et al., 1992). 
Block by clofillum 
The block of IKI (and IK2) by the class III antiarhythmic drug clofilium was concentration- 
dependent (EC50 between 10 and 30 gNI). It was also time dependent, as illustrated by the 
greater block by 3 pM at the end of 10 second pulses to 0 mV than after 200-300 ms and 
the apparent enhancement of current decay during the 10 second pulses. The 
concentration-dependency resembles that described for the block of the cloned human 
delayed rectifier channels Kvl. 3 and Kvl. 5, with approximate ECsos of 50 and 60 pM, 
respectively (Attali et aL, 1992; Malayev et al., 1995). The enhanced decay of Kvl. 5 
current induced by clofilium was not dependent on membrane potential and the availability 
was not affected (Malayev et aL, 1995), thus suggesting that clofilium blocks delayed 
rectifier currents in a use-dependent, open channel-selective manner. In the present study, 
clofilium blocked the current remaining in the presence of 10 mM TEA and 5 mM 4-AP 
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equally at membrane potentials between -40 m. V and 0 mV but significantly less at +60 
mV. If the block of IKI by clofilium is not voltage-dependent, then this confirms the above 
discussed assumption that another current may be activating at potentials above 0 m. V. IKI 
does not resemble either Kvl. 3 or Kvl. 5 in any of its other properties. 
6.2.3. SIMILARITIES BETWEEN lKiAND Kv2.1. 
Iki shares many of its electrophysiological properties with the Kv2.1 channel (see tables 
1.2. and 1.3. ) which is expressed in and has been cloned from rat and human tissues and 
characterised in transfection systems. Kv2.1 activation is voltage-dependent and activates 
slowly with a noticeable delay, which is more pronounced at negative membrane potentials 
(Pak et al., 1991 a; Shi et al., 1994; Klemic et al., 1998). This characteristic appears to be 
shared by all members of the shab-related Kv2 family of channels. The threshold of 
activation ranged between -3 0 mV and -5 0 mV (Pak et al., 199 1 a; Shi et al., 1994; Klcmic 
et al., 1998) and the Vo. s of activation was 0 rnV (Klemic et al., 1998). The inactivation 
kinetics are also slow but with a Vo. s of inactivation on average more positive than that of 
IKI (between -30 and -45 mV; (Pak et al., 1991a; Shi el al., 1994; Klernic et al., 1998). 
Klemic et al. (1998) recently showed that the voltage-dependence of inactivation of rat 
Kv2.1 was U-shaped with a maximum near to 0 mV, and that the speed of inactivation in 
long pulses was dependent on the amplitude of the depolarisation (90 % inactivation after 
19 s at 0 rnV but only 30 % inactivation after 19 s at +80 rnV). They also showed that 
recovery from inactivation of this channel was > 10-fold faster than inactivation but that 
the channel inactivated faster during rapid repetitive pulses than during a single long pulse, 
concluding that it inactivates faster from a closed state than from the open state. 
The sensitivity of cloned Kv2.1 to TEA and 4-AP is also similar to that of IKI, although 
there was some variability between studies. The EC50 of Kv2.1 for TEA was between 3 
and 10 mM and the EC50 for 4-AP was between 3 mM and > 100 mM (Pak el al., 199 1 a; 
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Kirsch & Drew, 1993; Shi et al., 1994; Kuku1jan et aL, 1995; Deal et al., 1996; Patel et 
aL, 1997). 
Ile characteristics of Kv2.1 are also influenced by co-expression with members of other, 
electrically silent, a-subunit krailics. For example, co-expression with Kv5. l or Kv6. I 
slowed channel deactivation, slowed inactivation at potentials between 0 and +40 mV but 
speeded it up at potentials between -30 and 0 mV, and speeded up the recovery from 
inactivation of Kv2.1 (Kramer et al., 1998). Also, co-expression with Kv9.3 caused a 
leftward shift in the activation (from -30 to -50 mV) and inactivation (Vo. s from -30 to -45 
MV), slowed deactivation, and reduced the sensitivity of Kv2.1 to TEA (ECso from 3 to 
9.5 mN4) and 4-AP (ECso from 4.5 to 32 mM) (Patel et al., 1997). The co-expression of 
Kv2.1 with Kv9.3 (both of which are expressed in mt pulmonary artery myocytes) also 
conferred ATP-sensitivity to the channel, wherein removal of intracellular ATP inhibited 
channel activity, suggesting a possible function for this channel in hypoxic vasoconstriction 
of the pulmonary circulation (Patel et aL, 1997). 
6.2.4. CHARACTERISTICS OF IK2 
The second component of the delayed rectifier W current in HMSMCs, IK2, was 4-AP- 
sensitive (approximate EC5o of I mm) displaying an inactivation V6.5 of -30 mV, a 
threshold of activation between -30 mV and -20 mV and a rate of inactivation much faster 
than Aki. The availability of this current was similar to the sustained component of the 4- 
AP sensitive current dcscritbed in human non-pregnant myometrium (Erulkar et aL, 1993) 
and to the C2 component of the whole cell K' current in pregnant and non-prcgnant rat 
myometrium (Wang et aL, 1998), which was on average 23 % of the total W current and 
had a Vo. s of inactivation of -21 mV. The C2 current of Wang et al. (1998) had a similar 
sensitivity to TEA as C, (> 2 mMD and the Axi current of the present study, but its 4-AP 
sensitivity was not clearly separated from that of Q. The faster activation and inactivation 
Of AK2 compared to IKI and its sensitivity to 4-AP suggest that the channel or channels 
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responsible for AK2 in the myometrium are likely to be delayed rectifier-type members of the 
KvI channel family (see Tables 1.2 and 1.3), with the possible exception of KvI. 2 and 
Kvl. 5, which are both very insensitive to TEA (EC5o > 100 MM) (Grissmer et aL, 1994; 
Overturf et al., 1994). 
6.2.5. DISTRIBUTION OF /KiANDIK2 
The relative expression of the voltage-gated W currents described in this study varied 
from one cell to the next, most cells possessing either IKI or IK2 as the predominant 
voltage-gated current. Whether this means that different myocyte cell types or cells in a 
different state of differentiation express different K' currents is not known. Other 
influencing factors, such as age, are possible but unlikely, since cells with either IKI or IK2 
were often obtained from the same myometrial specimen. This finding clearly contrasts 
with that in the pregnant rat myometrium, where the two components of the W current 
corresponding to IKI and IK2, C, andC2, both appeared to be expressed in all cells, as 
shown by the clearly biphasic voltage-dependence of inactivation of that current (Wang el 
al., 1998). 
6.2.6. POSSIBLE PHYSIOLOGICAL RELEVANCE OF lKi AND /K2 
The excitability and contractile rhythmicity of the myornetrium, are dependent on the 
myometrial. resting membrane potential and slow wave/action potential generation, 
respectively (Lodge & Sproat, 1981; Harding et aL, 1982; Parkington el aL, 1988; 
Buhimschi et al., 1997). In smooth muscle, W channels are believed to be important 
determinants of ther resting membrane potential (Jmari et aL, 1986; Wilde & Marshall, 
1988; Anwer et aL, 1993), modulating the amplitude and frequency of slow wave 
depolarisations (Wilde & Marshall, 1988) and modulating action potential spike frequency 
and duration (Jmari et aL, 1986; Amedee et aL, 1987; Wilde & Marshall, 1988). Even 
though it is difficult to extrapolate from data obtained under voltage-clamp in single 
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isolated myocytes to spontaneous electrical activity in strips of contracting muscle in vitro 
or the whole uterus in vivo, the electrophysiological and pharmacological characteristics of 
AKI and Ik2described in the present study may suggest functions for these W currents in 
myometrial electrical activity and contraction. 
Resting potential and slow waves 
The data presented in Fig 6.6 suggests that IKI may have a window current between -60 
and -20 mV with a maximum steady state current amplitude at about -36 mV. This means 
that channels responsible for this current are likely to be open, and therefore may 
contribute to the resting membrane potential (which in pregnant human myometriurn is 
somewhere between -45 and -65 m. V, Table I. I. ). Furthermore, this current will also be 
expected to flow during the upstroke of the slow wave, which is usually a depolarisation of 
2-10 mV from the resting level (Nakao et al., 1997; Parkington et al., 1999), thus tending 
to drive the membrane potential back to the resting level, slowing the rate of 
depolarisation and affecting the frequency of action potential bursts. The activation 
threshold Of AK2 (between -30 and -20 mV) in contrast, suggests that this current is less 
likely to contribute to the resting membrane potential or the upstroke of the slow wave. 
Action potentials 
The regenerative action potential depolarisations will serve to activate the channels 
responsible for IKI and also IK2. The deactivation kinetics of IKI and IK2 were not 
determined in the present study, but if IKI deactivation was found to be as slow as the 
cloned Kv2.1 channel (Kramer et aL, 1998), this, together with its slow inactivation 
kinetics would indicate a role in the spacing of the repetitive spikes within a burst, or the 
duration of a plateau-type action potential, and perhaps even ultimately terminating the 
slow wave depolarisation upon which the action potentials are superimposed. Even though 
IK2 inactivation is faster than that of Iki, it is still likely to remain for the duration of a 
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typical action potential burst and would therefore also be expected to contribute to action 
potential repolarisation and slow wave termination. 
Very few studies have evaluated the effect of blockers of voltage-gated K' channels on 
myometrial electrical activity or contraction. It has been shown that 4-AP depolarises 
strips of pregnant rat myometrium. (Wilde & Marshall, 1988), and TEA (at 2 mM, a 
concentration that partially blocks IKI and IK2) depolarises strips of pregnant human 
myometrium. (Parkington et al., 1999). The effect of 4-AP however, may not only be an 
effect on IK2, but also on &A, which may exist at or near the resting membrane potential 
(see chapter 5). The involvement of AKI in myometrial electrical activity cannot be 
accurately determined until a specific blocker is found and the only known selective 
blocker of Kv2.1 is hanatoxin, a tarantula spider venom (Swartz & MacKinnon, 1995), 
which at the moment is not commercially available. In future studies, molecular biology 
techniques will be used to attempt identification of the channel or channels responsible for 
IKI and, if it proves to be selectively expressed in the myometrium, or at least limited to 
rhythmic tissues, development of drugs which selectively modulate its activity, may lead to 
a new approach to the selective control of myometrial activity. 
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Chapter 7 
Summary, Conclusions and Future 
Directions 
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7.1. CALCIUM CHANNEL CURRENTS 
T-and L-components of 6 
Low threshold (r-type) and high threshold (L-type) voltage-gated calcium channel 
currents (Ic. ) are abundant in pregnant human myometrium, whereas voltage-gated sodium 
channel currents (IN. ) are very scarce. This contrasts with the rat, where IN. is abundant 
and T-type Ic. is scarce. The electrophysiological characteristics of the L-component 
current are well suited for a role of this current in action potential generation and these 
data are consistent with the effectiveness of L-type CP channel antagonists, but not Ne 
channel antagonists, at inhibiting spontaneous or agonist-induced myometrial contractions 
in vitro or in vivo. The clectrophysiological characteristics of the T-type current suggest 
that it may also be involved in slow wave depolarisation or action potential generation. 
This latter hypothesis may be tested by the use of T-selective Ca2' channel antagonists 
(such as nuibefradil) in contraction and membrane potential experiments. 
Oscillations and block by oxytocin 
The spontaneous oscillations in current amplitude that occur in some cells, apparently 
irrespective of charge carrier (C2' or BaF) or the degree of intracellular C2' buffering 
either indicate a resistance of the intracellular C2' stores to depletion and the limitations 
of intracellular buffering methods used, or suggest that myometrial C2' channels may be 
under a form of cyclical regulation by intracellular factors as well as, or other than, [Ca2']i. 
Alternative mechanisms which may be investigated include protein kinase-dependent 
phosphorylation-dephosphorylation of the channel or its interaction with G protein Py 
subunits, as shown to occur in other cell types. Sffiiilarly, the inhibition of Ic. or IB. by 
oxytocin occurs either indirectly via IP3-induced C2+ release from the SR or via other 
receptor-G protein transduction mechanisms. 
213 
Nimesulide 
The COX-2 selective cyclooxygenase, blocker nimesulide inhibits spontaneous myornetrial 
contractions and Caý' channel currents in vitro, but at concentrations higher than those 
required to inhibit COX-2 activity in fetal membranes. The block of Ca2' current in 
isolated myocytes by nimesulide occurs independently of endogenous prostaglandin 
production, indicating that the inhibition of myometrial contractions in vitro is 
predominantly via Qe' channel blockade. This blockade may also contribute to the 
tocolytic action of nimesulide in vivo. The enhanced potency of resting block and 
enhanced voltage-dcpcndence of block by nimcsulide at lower pH implies that its Ca 2+ 
antagonistic properties may be enhanced in the acidotic myometrium during the 
contractions of labour, thus potentiaUy improving its tocolytic efficacy and avoiding the 
serious cardiovascular side effects associated with conventional Ca2' channel antagonists, 
as well as the serious fetal side effects associated with COX-I selective, or non-selective 
COX inhibitors, such as indomethacin. 
7.2 POTASSIUM CHANNEL CURRENTS 
A-like Current 
Many myocytes from both pregnant and non-pregnant myometrium possess a transient 4- 
AP sensitive outward current, or A-current (IK, A)- In some ceHs this current overlaps with 
the inward calcium current (Ic. ) at membrane potentials between -40 mV and +10 mV. In 
such ceUs, IK. A is often larger than, and always activates faster than Ic., producing a net 
transient outward current over the whole membrane potential range. The voltage- 
dependence of activation and inactivation of this current is strongly sensitive to external 
Cd2+ concentration, as shown previously for Cd 2+ and other divalent cations, including 
C2+ , in other smooth muscles. The electrophysiological characteristics of this current 
suggest that its expression may promote myometrial quiescence. Further comparisons 
between the W currents of pregnant and non-pregnant ceRs and current clamp membrane 
214 
potential experiments are needed to test this hypothesis and determine whether IK. A 
contributes to the resting membrane potential or influences the upstroke of the action 
potential spikes. 
G libenclamide-sensitive current 
Preliminary data demonstrated the e)dstence in human myometrium. of a glibenclamide- 
sensitive IC' current that is activated by levcromakalim, probably corresponding to the 
IK, ATpcurrent described in other smooth muscles, and probably responsible for part of the 
myometrial relaxant effects of drugs such as levcromakalim and pinacidil. Further studies 
are planned in which the nucleotide dependency of IKATp, its contribution to resting 
membrane potential, and the effects of agonists and second messenger systems will be 
evaluated. 
Delayed Rectifier Currents 
Two delayed rectifier W currents are described in the human myometrium. IK, is a 4-AP 
insensitive voltage-gated IC' current with a low-threshold of activation and inactivation, 
which activates and inactivates slowly and which is sensitive to clofilium and high 
concentrations of TEA. IK2 is a 4-AP-sensitive voltage-gated W current with a high 
threshold of activation and inactivation, which activates and inactivates faster than IK, but 
still much slower than IKA, and is as sensitive to clofilium and high concentrations of TEA 
as IKI. In myocytes from pregnant women, the distribution of A K, andIK2was such that 
most cells expressed either IKI or IK2 as the predominant current. IK, and IK2 correspond to 
the 4-AP insensitive and 4-AP sensitive components of the W current described in other 
rhythmic tissues, including rat myometrium. The electrophysiological properties of IKI 
resemble in many respects the Kv2.1 channel, especially when it is co-expressed with 
electrically silent regulatory cc-subunits Kv5.1, Kv6.1 and Kv9.3, which have been cloned 
215 
from rat and human tissues. The properties of IKI also suggest possible functions in the 
control of myometrial resting membrane potential and slow wave depoIarisation, and hence 
rhythmicity of myometrial contraction. Future work aims to test these hypotheses using 
voltage and current clamp electrophysiologicaI experiments in isolated single cells, as well 
as contraction experiments in strips of myometrium, following the appropriation of 
selective blockers or activators of these currents. Molecular biology techniques will be 
used to determine whether Kv2.1 and electrically silent regulatory cc-subunits are 
expressed in human myornetrium, and whether their expression changes during pregnancy 
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